<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2054516-B1" country="EP" doc-number="2054516" kind="B1" date="20140108" family-id="38997509" file-reference-id="293439" date-produced="20180826" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146588364" ucid="EP-2054516-B1"><document-id><country>EP</country><doc-number>2054516</doc-number><kind>B1</kind><date>20140108</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-07788181-A" is-representative="NO"><document-id mxw-id="PAPP154850556" load-source="docdb" format="epo"><country>EP</country><doc-number>07788181</doc-number><kind>A</kind><date>20070802</date><lang>EN</lang></document-id><document-id mxw-id="PAPP207567851" load-source="docdb" format="original"><country>EP</country><doc-number>07788181.1</doc-number><date>20070802</date></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140551509" ucid="EP-06118347-A" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>06118347</doc-number><kind>A</kind><date>20060802</date></document-id></priority-claim><priority-claim mxw-id="PPC140547771" ucid="EP-06120994-A" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>06120994</doc-number><kind>A</kind><date>20060920</date></document-id></priority-claim><priority-claim mxw-id="PPC140548483" ucid="EP-06121856-A" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>06121856</doc-number><kind>A</kind><date>20061005</date></document-id></priority-claim><priority-claim mxw-id="PPC140548654" ucid="EP-06121928-A" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>06121928</doc-number><kind>A</kind><date>20061006</date></document-id></priority-claim><priority-claim mxw-id="PPC140548795" ucid="EP-06123066-A" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>06123066</doc-number><kind>A</kind><date>20061027</date></document-id></priority-claim><priority-claim mxw-id="PPC140557948" ucid="EP-06123237-A" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>06123237</doc-number><kind>A</kind><date>20061031</date></document-id></priority-claim><priority-claim mxw-id="PPC140547245" ucid="EP-07788181-A" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>07788181</doc-number><kind>A</kind><date>20070802</date></document-id></priority-claim><priority-claim mxw-id="PPC140551517" ucid="EP-2007058043-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>EP</country><doc-number>2007058043</doc-number><kind>W</kind><date>20070802</date></document-id></priority-claim><priority-claim mxw-id="PPC140554884" ucid="US-83680406-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>83680406</doc-number><kind>P</kind><date>20060810</date></document-id></priority-claim><priority-claim mxw-id="PPC140555550" ucid="US-85125006-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>85125006</doc-number><kind>P</kind><date>20061012</date></document-id></priority-claim><priority-claim mxw-id="PPC140555734" ucid="US-85125806-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>85125806</doc-number><kind>P</kind><date>20061012</date></document-id></priority-claim><priority-claim mxw-id="PPC140547537" ucid="US-85126506-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>85126506</doc-number><kind>P</kind><date>20061012</date></document-id></priority-claim><priority-claim mxw-id="PPC140553226" ucid="US-85971706-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>85971706</doc-number><kind>P</kind><date>20061117</date></document-id></priority-claim><priority-claim mxw-id="PPC140555694" ucid="US-86809506-P" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>86809506</doc-number><kind>P</kind><date>20061201</date></document-id></priority-claim></priority-claims><dates-of-public-availability><intention-to-grant-date><date>20130722</date></intention-to-grant-date></dates-of-public-availability><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL1989325402" load-source="docdb">C07K  14/415       20060101ALI20080328BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989325403" load-source="docdb">C12N  15/82        20060101AFI20080328BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL1989325404" load-source="docdb">A01H   1/00        20060101ALI20080328BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-1713625940" load-source="docdb" scheme="CPC">Y02A  40/146       20180101 LA20180104BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1861413847" load-source="docdb" scheme="CPC">C12N  15/8261      20130101 FI20161222BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1861414478" load-source="docdb" scheme="CPC">C12N   9/16        20130101 LI20161222BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1861420083" load-source="docdb" scheme="CPC">C07K  14/415       20130101 LI20160603BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1861420249" load-source="docdb" scheme="CPC">C12Y 301/03011     20130101 LI20161222BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1934629546" load-source="docdb" scheme="CPC">C12N  15/8241      20130101 LI20160603BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132369725" lang="DE" load-source="patent-office">PFLANZEN MIT VERBESSERTEN EIGENSCHAFTEN SOWIE VERFAHREN ZUR HERSTELLUNG DAVON</invention-title><invention-title mxw-id="PT132369726" lang="EN" load-source="patent-office">PLANTS HAVING IMPROVED CHARACTERISTICS AND A METHOD FOR MAKING THE SAME</invention-title><invention-title mxw-id="PT132369727" lang="FR" load-source="patent-office">INSTALLATIONS DOTÉES DE CARACTÉRISTIQUES DE RENDEMENT AMÉLIORÉES ET PROCÉDÉ DE FABRICATION DE CELLES-CI</invention-title></technical-data><related-documents><relation type="division-into"><child-doc ucid="EP-09178579.0"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>09178579.0</doc-number><date>20091210</date></document-id></child-doc><parent-doc ucid="EP-07788181-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>07788181</doc-number><kind>A</kind><date>20070802</date></document-id><parent-grant-document ucid="EP-2054516-B1"><document-id><country>EP</country><doc-number>2054516</doc-number><kind>B1</kind><date>20140108</date></document-id></parent-grant-document></parent-doc></relation><relation type="division-into"><child-doc ucid="EP-09178586.5"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>09178586.5</doc-number><date>20091210</date></document-id></child-doc><parent-doc ucid="EP-07788181-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>07788181</doc-number><kind>A</kind><date>20070802</date></document-id><parent-grant-document ucid="EP-2054516-B1"><document-id><country>EP</country><doc-number>2054516</doc-number><kind>B1</kind><date>20140108</date></document-id></parent-grant-document></parent-doc></relation><relation type="division-into"><child-doc ucid="EP-09178588.1"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>09178588.1</doc-number><date>20091210</date></document-id></child-doc><parent-doc ucid="EP-07788181-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>07788181</doc-number><kind>A</kind><date>20070802</date></document-id><parent-grant-document ucid="EP-2054516-B1"><document-id><country>EP</country><doc-number>2054516</doc-number><kind>B1</kind><date>20140108</date></document-id></parent-grant-document></parent-doc></relation><relation type="division-into"><child-doc ucid="EP-09178590.7"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>09178590.7</doc-number><date>20091210</date></document-id></child-doc><parent-doc ucid="EP-07788181-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>07788181</doc-number><kind>A</kind><date>20070802</date></document-id><parent-grant-document ucid="EP-2054516-B1"><document-id><country>EP</country><doc-number>2054516</doc-number><kind>B1</kind><date>20140108</date></document-id></parent-grant-document></parent-doc></relation><relation type="division-into"><child-doc ucid="EP-09178866.1"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>09178866.1</doc-number><date>20091211</date></document-id></child-doc><parent-doc ucid="EP-07788181-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>07788181</doc-number><kind>A</kind><date>20070802</date></document-id><parent-grant-document ucid="EP-2054516-B1"><document-id><country>EP</country><doc-number>2054516</doc-number><kind>B1</kind><date>20140108</date></document-id></parent-grant-document></parent-doc></relation><relation type="division-into"><child-doc ucid="EP-12185022.6"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>12185022.6</doc-number><date>20120919</date></document-id></child-doc><parent-doc ucid="EP-07788181-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>07788181</doc-number><kind>A</kind><date>20070802</date></document-id><parent-grant-document ucid="EP-2054516-B1"><document-id><country>EP</country><doc-number>2054516</doc-number><kind>B1</kind><date>20140108</date></document-id></parent-grant-document></parent-doc></relation><relation type="division-into"><child-doc ucid="EP-12185025.9"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>12185025.9</doc-number><date>20120919</date></document-id></child-doc><parent-doc ucid="EP-07788181-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>07788181</doc-number><kind>A</kind><date>20070802</date></document-id><parent-grant-document ucid="EP-2054516-B1"><document-id><country>EP</country><doc-number>2054516</doc-number><kind>B1</kind><date>20140108</date></document-id></parent-grant-document></parent-doc></relation><relation type="division-into"><child-doc ucid="EP-12185028.3"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>12185028.3</doc-number><date>20120919</date></document-id></child-doc><parent-doc ucid="EP-07788181-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>07788181</doc-number><kind>A</kind><date>20070802</date></document-id><parent-grant-document ucid="EP-2054516-B1"><document-id><country>EP</country><doc-number>2054516</doc-number><kind>B1</kind><date>20140108</date></document-id></parent-grant-document></parent-doc></relation><relation type="division-into"><child-doc ucid="EP-12185029.1"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>12185029.1</doc-number><date>20120919</date></document-id></child-doc><parent-doc ucid="EP-07788181-A"><document-id load-source="patent-office" format="epo"><country>EP</country><doc-number>07788181</doc-number><kind>A</kind><date>20070802</date></document-id><parent-grant-document ucid="EP-2054516-B1"><document-id><country>EP</country><doc-number>2054516</doc-number><kind>B1</kind><date>20140108</date></document-id></parent-grant-document></parent-doc></relation></related-documents><parties><applicants><applicant mxw-id="PPAR919534843" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>CROPDESIGN NV</last-name><address><country>BE</country></address></addressbook></applicant><applicant mxw-id="PPAR919533374" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>CROPDESIGN N.V.</last-name></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR919519912" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>FRANKARD VALERIE</last-name><address><country>BE</country></address></addressbook></inventor><inventor mxw-id="PPAR919508186" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>FRANKARD, VALERIE</last-name></addressbook></inventor><inventor mxw-id="PPAR919022771" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>FRANKARD, VALERIE</last-name><address><street>Avenue des Croix du Feu 84</street><city>1410 Waterloo</city><country>BE</country></address></addressbook></inventor><inventor mxw-id="PPAR919516178" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>MIRONOV VLADIMIR</last-name><address><country>BE</country></address></addressbook></inventor><inventor mxw-id="PPAR919513446" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>MIRONOV, VLADIMIR</last-name></addressbook></inventor><inventor mxw-id="PPAR919022769" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>MIRONOV, VLADIMIR</last-name><address><street>Zebrastraat 11</street><city>9000 Gent</city><country>BE</country></address></addressbook></inventor><inventor mxw-id="PPAR919517927" load-source="docdb" sequence="3" format="epo"><addressbook><last-name>REUZEAU CHRISTOPHE</last-name><address><country>FR</country></address></addressbook></inventor><inventor mxw-id="PPAR919514405" load-source="docdb" sequence="3" format="intermediate"><addressbook><last-name>REUZEAU, CHRISTOPHE</last-name></addressbook></inventor><inventor mxw-id="PPAR919022772" load-source="patent-office" sequence="3" format="original"><addressbook><last-name>REUZEAU, CHRISTOPHE</last-name><address><city>24350 La Chapelle Gonaguet</city><country>FR</country></address></addressbook></inventor><inventor mxw-id="PPAR919538172" load-source="docdb" sequence="4" format="epo"><addressbook><last-name>SANZ MOLINERO ANA ISABEL</last-name><address><country>BE</country></address></addressbook></inventor><inventor mxw-id="PPAR919509005" load-source="docdb" sequence="4" format="intermediate"><addressbook><last-name>SANZ MOLINERO, ANA ISABEL</last-name></addressbook></inventor><inventor mxw-id="PPAR919022770" load-source="patent-office" sequence="4" format="original"><addressbook><last-name>SANZ MOLINERO, ANA ISABEL</last-name><address><street>Bernheimlaan 38</street><city>9050 Gentbrugge</city><country>BE</country></address></addressbook></inventor></inventors><assignees><assignee mxw-id="PPAR919022773" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>CropDesign N.V.</last-name><iid>100105060</iid><address><street>Technologiepark 3</street><city>9052 Zwijnaarde</city><country>BE</country></address></addressbook></assignee></assignees><agents><agent mxw-id="PPAR919022774" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Drohmann, Christian</last-name><suffix>et al</suffix><iid>101302794</iid><address><street>BASF SE Global Intellectual Property GVX/A - C6</street><city>67056 Ludwigshafen</city><country>DE</country></address></addressbook></agent></agents></parties><international-convention-data><pct-or-regional-filing-data ucid="EP-2007058043-W"><document-id><country>EP</country><doc-number>2007058043</doc-number><kind>W</kind><date>20070802</date><lang>EN</lang></document-id></pct-or-regional-filing-data><pct-or-regional-publishing-data ucid="WO-2008015263-A2"><document-id><country>WO</country><doc-number>2008015263</doc-number><kind>A2</kind><date>20080207</date><lang>EN</lang></document-id></pct-or-regional-publishing-data><designated-states><ep-contracting-states><country mxw-id="DS549892107" load-source="docdb">AT</country><country mxw-id="DS549869406" load-source="docdb">BE</country><country mxw-id="DS549784826" load-source="docdb">BG</country><country mxw-id="DS549784179" load-source="docdb">CH</country><country mxw-id="DS549878390" load-source="docdb">CY</country><country mxw-id="DS549892108" load-source="docdb">CZ</country><country mxw-id="DS549869407" load-source="docdb">DE</country><country mxw-id="DS549878391" load-source="docdb">DK</country><country mxw-id="DS549878392" load-source="docdb">EE</country><country mxw-id="DS549923697" load-source="docdb">ES</country><country mxw-id="DS549784827" load-source="docdb">FI</country><country mxw-id="DS549784828" load-source="docdb">FR</country><country mxw-id="DS549869408" load-source="docdb">GB</country><country mxw-id="DS549878393" load-source="docdb">GR</country><country mxw-id="DS549892109" load-source="docdb">HU</country><country mxw-id="DS549784180" load-source="docdb">IE</country><country mxw-id="DS549878402" load-source="docdb">IS</country><country mxw-id="DS549784833" load-source="docdb">IT</country><country mxw-id="DS549878403" load-source="docdb">LI</country><country mxw-id="DS549872755" load-source="docdb">LT</country><country mxw-id="DS549892110" load-source="docdb">LU</country><country mxw-id="DS549872756" load-source="docdb">LV</country><country mxw-id="DS549872757" load-source="docdb">MC</country><country mxw-id="DS549802210" load-source="docdb">MT</country><country mxw-id="DS549784834" load-source="docdb">NL</country><country mxw-id="DS549784201" load-source="docdb">PL</country><country mxw-id="DS549802211" load-source="docdb">PT</country><country mxw-id="DS549784835" load-source="docdb">RO</country><country mxw-id="DS549784202" load-source="docdb">SE</country><country mxw-id="DS549802212" load-source="docdb">SI</country><country mxw-id="DS549923698" load-source="docdb">SK</country><country mxw-id="DS549872762" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data><office-specific-data><eptags><ep-no-a-document-published>*</ep-no-a-document-published></eptags></office-specific-data></bibliographic-data><description mxw-id="PDES63960787" lang="EN" load-source="patent-office"><!-- EPO <DP n="1"> --><p id="p0001" num="0001">The present invention relates generally to the field of molecular biology and concerns a method for improving various plant characteristics by modulating expression in a plant of a nucleic acid encoding a GRP (Growth Related Protein). The present invention also concerns plants having modulated expression of a nucleic acid encoding a GRP polypeptide, which plants have improved characteristics relative to corresponding wild type plants or other control plants. The invention also provides constructs useful in the methods of the invention.</p><p id="p0002" num="0002">The ever-increasing world population and the dwindling supply of arable land available for agriculture fuels research towards increasing the efficiency of agriculture. Conventional means for crop and horticultural improvements utilise selective breeding techniques to identify plants having desirable characteristics. However, such selective breeding techniques have several drawbacks, namely that these techniques are typically labour intensive and result in plants that often contain heterogeneous genetic components that may not always result in the desirable trait being passed on from parent plants. Advances in molecular biology have allowed mankind to modify the germplasm of animals and plants. Genetic engineering of plants entails the isolation and manipulation of genetic material (typically in the form of DNA or RNA) and the subsequent introduction of that genetic material into a plant. Such technology has the capacity to deliver crops or plants having various improved economic, agronomic or horticultural traits.</p><p id="p0003" num="0003">A trait of particular economic interest is increased yield. Yield is normally defined as the measurable produce of economic value from a crop. This may be defined in terms of quantity and/or quality. Yield is directly dependent on several factors, for example, the number and size of the organs, plant architecture (for example, the number of branches), seed production, leaf senescence and more. Root development, nutrient uptake, stress tolerance and early vigour may also be important factors in determining yield. Optimizing the abovementioned factors may therefore contribute to increasing crop yield.</p><p id="p0004" num="0004">Seed yield is a particularly important trait, since the seeds of many plants are important for human and animal nutrition. Crops such as corn, rice, wheat, canola and soybean account for over half the total human caloric intake, whether through direct consumption of the seeds themselves or through consumption of meat products raised on processed seeds. They are also a source of sugars, oils and many kinds of metabolites used in industrial processes. Seeds contain an embryo (the source of new shoots and roots) and an endosperm (the source of nutrients for embryo growth during germination and during early growth of seedlings). The development of a seed involves many genes, and requires the transfer of metabolites from the<!-- EPO <DP n="2"> --> roots, leaves and stems into the growing seed. The endosperm, in particular, assimilates the metabolic precursors of carbohydrates, oils and proteins and synthesizes them into storage macromolecules to fill out the grain.</p><p id="p0005" num="0005">Another important trait for many crops is early vigour. Improving early vigour is an important objective of modern rice breeding programs in both temperate and tropical rice cultivars. Long roots are important for proper soil anchorage in water-seeded rice. Where rice is sown directly into flooded fields, and where plants must emerge rapidly through water, longer shoots are associated with vigour. Where drill-seeding is practiced, longer mesocotyls and coleoptiles are important for good seedling emergence. The ability to engineer early vigour into plants would be of great importance in agriculture. For example, poor early vigour has been a limitation to the introduction of maize (Zea mays L.) hybrids based on Corn Belt germplasm in the European Atlantic.</p><p id="p0006" num="0006">A further important trait is that of improved abiotic stress tolerance. Abiotic stress is a primary cause of crop loss worldwide, reducing average yields for most major crop plants by more than 50% (<nplcit id="ncit0001" npl-type="s"><text>Wang et al., Planta (2003) 218: 1-14</text></nplcit>). Abiotic stresses may be caused by drought, salinity, extremes of temperature, chemical toxicity and oxidative stress. The ability to improve plant tolerance to abiotic stress would be of great economic advantage to farmers worldwide and would allow for the cultivation of crops during adverse conditions and in territories where cultivation of crops may not otherwise be possible.</p><p id="p0007" num="0007">Crop yield may therefore be increased by optimising one of the above-mentioned factors.</p><p id="p0008" num="0008">Depending on the end use, the modification of certain yield traits may be favoured over others. For example for applications such as forage or wood production, or bio-fuel resource, an increase in the vegetative parts of a plant may be desirable, and for applications such as flour, starch or oil production, an increase in seed parameters may be particularly desirable. Even amongst the seed parameters, some may be favoured over others, depending on the application. Various mechanisms may contribute to increasing seed yield, whether that is in the form of increased seed size or increased seed number.</p><p id="p0009" num="0009">One approach to increasing yield (seed yield and/or biomass) in plants may be through modification of the inherent growth mechanisms of a plant, such as the cell cycle or various signalling pathways involved in plant growth or in defense mechanisms.<!-- EPO <DP n="3"> --></p><p id="p0010" num="0010">It has now been found that various characteristics may be improved in plants by modulating expression in a plant of a nucleic acid encoding a GRP polypeptide in a plant. The GRP polypeptide as described herein is an Ankyrin - Zinc finger polypeptide (AZ). The improved characteristics comprise yield related traits, such as enhanced yield and/or enhanced growth, or modified content of storage compounds.</p><heading id="h0001"><b>Background</b></heading><heading id="h0002"><u>Ankyrin - Zinc finger polypeptide</u></heading><p id="p0011" num="0011">Plant biomass is yield for forage crops like alfalfa, silage corn and hay. Many proxies for yield have been used in grain crops. Chief amongst these are estimates of plant size. Plant size can be measured in many ways depending on species and developmental stage, but include total plant dry weight, above-ground dry weight, above-ground fresh weight, leaf area, stem volume, plant height, rosette diameter, leaf length, root length, root mass, tiller number and leaf number. Many species maintain a conservative ratio between the size of different parts of the plant at a given developmental stage. These allometric relationships are used to extrapolate from one of these measures of size to another (e.g. <nplcit id="ncit0002" npl-type="s"><text>Tittonell et al 2005 Agric Ecosys &amp; Environ 105: 213</text></nplcit>). Plant size at an early developmental stage will typically correlate with plant size later in development. A larger plant with a greater leaf area can typically absorb more light and carbon dioxide than a smaller plant and therefore will likely gain a greater weight during the same period (<nplcit id="ncit0003" npl-type="s"><text>Fasoula &amp; Tollenaar 2005 Maydica 50:39</text></nplcit>). This is in addition to the potential continuation of the micro-environmental or genetic advantage that the plant had to achieve the larger size initially. There is a strong genetic component to plant size and growth rate (e.g. ter <nplcit id="ncit0004" npl-type="s"><text>Steege et al 2005 Plant Physiology 139:1078</text></nplcit>), and so for a range of diverse genotypes plant size under one environmental condition is likely to correlate with size under another (<nplcit id="ncit0005" npl-type="s"><text>Hittalmani et al 2003 Theoretical Applied Genetics 107:679</text></nplcit>). In this way a standard environment is used as a proxy for the diverse and dynamic environments encountered at different locations and times by crops in the field.</p><p id="p0012" num="0012">Harvest index, the ratio of seed yield to aboveground dry weight, is relatively stable under many environmental conditions and so a robust correlation between plant size and grain yield can often be obtained (e.g.<nplcit id="ncit0006" npl-type="s"><text> Rebetzke et al 2002 Crop Science 42:739</text></nplcit>). These processes are intrinsically linked because the majority of grain biomass is dependent on current or stored photosynthetic productivity by the leaves and stem of the plant (<nplcit id="ncit0007" npl-type="b"><text>Gardener et al 1985 Physiology of Crop Plants. Iowa State University Press, pp68-73</text></nplcit>). Therefore, selecting for plant size, even<!-- EPO <DP n="4"> --> at early stages of development, has been used as an indicator for future potential yield (e.g. <nplcit id="ncit0008" npl-type="s"><text>Tittonell et al 2005 Agric Ecosys &amp; Environ 105: 213</text></nplcit>). When testing for the impact of genetic differences on stress tolerance, the ability to standardize soil properties, temperature, water and nutrient availability and light intensity is an intrinsic advantage of greenhouse or plant growth chamber environments compared to the field. However, artificial limitations on yield due to poor pollination due to the absence of wind or insects, or insufficient space for mature root or canopy growth, can restrict the use of these controlled environments for testing yield differences. Therefore, measurements of plant size in early development, under standardized conditions in a growth chamber or greenhouse, are standard practices to provide indication of potential genetic yield advantages.</p><p id="p0013" num="0013">Transcription is performed by RNA polymerases. These polymerases are usually associated with other proteins (transcription factors) that determine the specificity of the transcription process. The transcription factors bind to cis-regulatory elements of the gene and may also mediate binding of other regulatory proteins. Stegmaier et al. proposed a classification of transcription factors based on their DNA-binding domains. 5 superclasses were discriminated, based on the presence of: 1) basic domains, 2) zinc-coordinating domains, 3) helix-turn-helix domains, 4) beta scaffold domains with minor groove contacts and 0) other domains (<nplcit id="ncit0009" npl-type="s"><text>Stegmaier et al., Genome informatics 15, 276-286, 2004</text></nplcit>). The group of transcription factors comprising zinc-coordinating domains is quite divers and may be further classified according to their conserved cysteine and histidine residues, including the WRKY domains, C6 zinc clusters, DM and GCM domains.</p><p id="p0014" num="0014">Besides DNA binding motifs, transcription factors may also comprise protein-protein interaction motifs. One such motif is the ankyrin motif. It is present in very diverse families of proteins, usually as a repeat of 2 to over 20 units. Each unit contains two antiparallel helices and a beta-hairpin.</p><p id="p0015" num="0015">Although many plant proteins with zinc finger domains are well characterised, little is known about plant proteins comprising the C3H1 zinc finger motif. PEI1, a transcription factor that reportedly plays a role in embryo development, has a zinc finger motif that resembles the C3H1 motif but lacks an ankyrin motif (<nplcit id="ncit0010" npl-type="s"><text>Li and Thomas, Plant Cell 10, 383-398, 1998</text></nplcit>). <patcit id="pcit0001" dnum="WO0244389A"><text>WO 02/44389</text></patcit> describes AtSIZ, a transcription factor isolated from <i>Arabidopsis.</i> Expression of <i>AtSIZ</i> under control of the CaMV35S promoter was found to promote transcription of stress-induced genes, and plants with increased expression of <i>AtSIZ</i> reportedly had a higher survival rate under salt stress than control plants, but no analysis was provided with respect to seed yield. It was postulated that AtSIZ could be used for increasing resistance in plants to osmotic stress.<!-- EPO <DP n="5"> --></p><heading id="h0003"><b>Summary</b></heading><p id="p0016" num="0016">Surprisingly, it has now been found that modulating expression of a nucleic acid encoding a GRP polypeptide gives plants having improved characteristics relative to control plants.</p><p id="p0017" num="0017">The present specification describes that modulating expression in a plant of a nucleic acid encoding the AZ polypeptide from <i>Arabidopsis</i> (AtAZ) or a homologue thereof gives plants having increased yield relative to control plants. The specification describes a method for increasing plant yield, comprising modulating expression in a plant of a nucleic acid encoding the AZ polypeptide or a homologue thereof. Advantageously, performance of the methods according to the present invention results in plants having increased yield, particularly seed yield, relative to corresponding wild type plants.<!-- EPO <DP n="6"> --> The present specification also describes nucleic acid sequences and constructs useful in performing such methods.<!-- EPO <DP n="7"> --></p><p id="p0018" num="0018">The present invention provides subject matter as set forth in any one and all of items (1) to (22) below:
<ol><li>1. Method for increasing seed yield of plants relative to corresponding wild type plants, comprising introducing and expressing in a plant an AZ nucleic acid or a variant thereof, wherein said AZ nucleic acid encodes an AZ polypeptide or a homologue thereof, wherein the homologue gives plants having increased yield, and wherein said AZ polypeptide or the homologue thereof comprises two ankyrin repeats and two C3H1 Zinc finger domains, and wherein said ankyrin repeats are located upstream of the C3H1 Zinc fingec domains.</li><li>2. Method according to item 1, wherein the AZ polypeptide comprises at least one of the following motifs:
<ul><li>(P/A)CSRAY(S/T)HDWTEC (motif 1, SEQ ID NO: 3)</li><li>HPGENARRRDPR (motif 2, SEQ ID: NO: 4)</li><li>HG(V/I)FE(C/S)WLHP(A/S)QY(R/K)TRLCK (motif 3, SEQ ID NO: 5)</li><li>CFFAH (motif 4, SEQ ID NO: 6).</li></ul></li><li>3. Method according to item 1 or 2, wherein said AZ nucleic acid encodes an AZ polypeptide of SEQ ID NO: 2 or a homologue thereof.</li><li>4. Method according to any one of items 1 to 3, wherein said variant is a portion of an AZ nucleic acid or a sequence capable of hybridising to an AZ nucleic acid, which portion or hybridising sequence encodes an AZ polypeptide comprising two ankyrin repeats and two C3H1 Zinc finger domains, and wherein said ankyrin repeats are located upstream of the C3H1 Zinc finger domains</li><li>5. Method according to any one of items 1 to 4, wherein said AZ nucleic acid or variant thereof is overexpressed in a plant.</li><li>6. Method according to any one of items 1 to 5, wherein said AZ nucleic acid or variant thereof is of plant origin, preferably from a dicotyledonous plant, more preferably from the family Brassicaceae, most preferably the nucleic acid is from Arabidopsis thaliana.</li><li>7. Method according to any one of items 1 to 6, wherein said AZ nucleic acid or variant thereof is operably linked to a seed specific promoter.</li><li>8. Method according to item 7, wherein said seed-specific promoter is a WSI18 promoter.</li><li>9. Method according to any one of items 1 to 8, wherein said increased seed yield comprises increased thousand kernel weight.</li><li>10. Construct comprising;
<ol><li>(i) an <i>AZ</i> nucleic acid or a variant thereof as defined in any of items 1 to 4 and 6;</li><li>(ii) a seed-specific WSI18 promoter or a constitutive GOS2 promoter operably linked to the nucleic acid sequence of (i)</li></ol><!-- EPO <DP n="8"> --></li><li>11. Construct according to item 10, wherein said WSI18 promoter is as represented by SEQ ID NO: 55 or SEQ ID NO: 9.</li><li>12. Construct according to item 10, wherein said GOS2 promoter is as represented by SEQ ID NO: 56 or SEQ ID NO: 54.</li><li>13. Plant transformed with a construct according to any one of items 10 to 12.</li><li>14. Method for the production of a transgenic plant having increased seed yield compared to corresponding wild type plants, which method comprises:
<ol><li>(i) introducing and expressing in a plant or plant cell an <i>AZ</i> nucleic acid or variant thereof as defined in any of items 1 to 4 and 6; and</li><li>(ii) cultivating the plant cell under conditions promoting plant growth and development,</li></ol></li><li>15. Transgenic plant according to item 13, wherein said plant is a monocotyledonous plant such as sugar cane or wherein the plant is a cereal, such as rice, maize, wheat, barley, millet, rye, oats or sorghum.</li><li>16. Harvestable parts of a plant according to any one of items 13 or 15, wherein said harvestable parts comprise a construct according to any one of items 10 to 12.</li><li>17. Harvestable parts of a plant according to item 16 wherein said harvestable parts are seeds.</li><li>18. Products directly derived from a plant according to item 13 or 15 and/or from harvestable parts of a plant according to items 16 or 17, wherein said products comprise a construct according to any one of items 10 to 12.</li><li>19. Use of an AZ nucleic acid or variant thereof as defined in any of items 1 to 4 and 6, or use of an AZ polypeptide or a homologue thereof, in increasing seed yield, relative to corresponding wild type plants.</li><li>20. Use according to item 19, wherein said increased seed yield comprises increased thousand kernel weight.</li><li>21. Use of an AZ nucleic acid or variant thereof as defined in any of items 1 to 4 and 6, or use of an AZ polypeptide or a homologue thereof, as a molecular marker.</li><li>22. Use of a construct according to any of items 10 to 12 in a method for making plants having increased seed yield relative to control plants.</li></ol><!-- EPO <DP n="9"> --></p><heading id="h0004"><b>Definitions</b></heading><heading id="h0005"><u>Polypeptide (s)/Protein(s)</u></heading><p id="p0019" num="0019">The terms "polypeptide" and "protein" are used interchangeably herein and refer to amino acids in a polymeric form of any length, linked together by peptide bonds.</p><heading id="h0006"><u>Polynucleotide(s)/Nudeic acid(s)/Nucleic acid sequence(s)/nucleotide sequence(s)</u></heading><p id="p0020" num="0020">The terms "polynucleotide(s)", "nucleic acid sequence(s)", "nucleotide sequence(s)", "nucleic acid(s)", "nucleic acid molecule" are used interchangeably herein and refer to nucleotides, either ribonucleotides or deoxyribonucleotides or a combination of both, in a polymeric unbranched form of any length.</p><heading id="h0007"><u>Control plant(s)</u></heading><p id="p0021" num="0021">The choice of suitable control plants is a routine part of an experimental setup and may include corresponding wild type plants or corresponding plants without the gene of interest. The control plant is typically of the same plant species or even of the same variety as the plant to be assessed. The control plant may also be a nullizygote of the plant to be assessed. Nullizygotes are individuals missing the transgene by segregation. A "control plant" as used herein refers not only to whole plants, but also to plant parts, including seeds and seed parts.</p><heading id="h0008"><u>Homologue(s)</u></heading><p id="p0022" num="0022">"Homologues" of a protein encompass peptides, oligopeptides, polypeptides, proteins and enzymes having amino acid substitutions, deletions and/or insertions relative to the unmodified<!-- EPO <DP n="10"> --> protein in question and having similar biological and functional activity as the unmodified protein from which they are derived.</p><p id="p0023" num="0023">A deletion refers to removal of one or more amino acids from a protein.</p><p id="p0024" num="0024">An insertion refers to one or more amino acid residues being introduced into a predetermined site in a protein. Insertions may comprise N-terminal and/or C-terminal fusions as well as intra-sequence insertions of single or multiple amino acids. Generally, insertions within the amino acid sequence will be smaller than N- or C-terminal fusions, of the order of about 1 to 10 residues. Examples of N- or C-terminal fusion proteins or peptides include the binding domain or activation domain of a transcriptional activator as used in the yeast two-hybrid system, phage coat proteins, (histidine)-6-tag, glutathione S-transferase-tag, protein A, maltose-binding protein, dihydrofolate reductase, Tag·100 epitope, c-myc epitope, FLAG<sup>®</sup>-epitope, IacZ, CMP (calmodulin-binding peptide), HA epitope, protein C epitope and VSV epitope.</p><p id="p0025" num="0025">A substitution refers to replacement of amino acids of the protein with other amino acids having similar properties (such as similar hydrophobicity, hydrophilicity, antigenicity, propensity to form or break α-helical structures or β-sheet structures). Amino acid substitutions are typically of single residues, but may be clustered depending upon functional constraints placed upon the polypeptide; insertions will usually be of the order of about 1 to 10 amino acid residues. The amino acid substitutions are preferably conservative amino acid substitutions. Conservative substitution tables are well known in the art (see for example Creighton (1984) Proteins. W.H. Freeman and Company (Eds) and Table 1 below).
<tables id="tabl0001" num="0001"><table frame="all"><title><b>Table 1:</b> Examples of conserved amino acid substitutions</title><tgroup cols="4"><colspec colnum="1" colname="col1" colwidth="17mm"/><colspec colnum="2" colname="col2" colwidth="46mm"/><colspec colnum="3" colname="col3" colwidth="17mm"/><colspec colnum="4" colname="col4" colwidth="46mm"/><thead><row><entry valign="top"><b>Residue</b></entry><entry valign="top"><b>Conservative Substitutions</b></entry><entry valign="top"><b>Residue</b></entry><entry valign="top"><b>Conservative Substitutions</b></entry></row></thead><tbody><row><entry>Ala</entry><entry>Ser</entry><entry>Leu</entry><entry>Ile; Val</entry></row><row><entry>Arg</entry><entry>Lys</entry><entry>Lys</entry><entry>Arg; Gln</entry></row><row><entry>Asn</entry><entry>Gln; His</entry><entry>Met</entry><entry>Leu; Ile</entry></row><row><entry>Asp</entry><entry>Glu</entry><entry>Phe</entry><entry>Met; Leu; Tyr</entry></row><row><entry>Gln</entry><entry>Asn</entry><entry>Ser</entry><entry>Thr; Gly</entry></row><row><entry>Cys</entry><entry>Ser</entry><entry>Thr</entry><entry>Ser; Val</entry></row><row><entry>Glu</entry><entry>Asp</entry><entry>Trp</entry><entry>Tyr</entry></row><row><entry>Gly</entry><entry>Pro</entry><entry>Tyr</entry><entry>Trp; Phe</entry></row><row><entry>His</entry><entry>Asn; Gln</entry><entry>Val</entry><entry>Ile; Leu</entry></row><row><entry>Ile</entry><entry>Leu, Val</entry><entry/><entry/></row></tbody></tgroup></table></tables><!-- EPO <DP n="11"> --></p><p id="p0026" num="0026">Amino acid substitutions, deletions and/or insertions may readily be made using peptide synthetic techniques well known in the art, such as solid phase peptide synthesis and the like, or by recombinant DNA manipulation. Methods for the manipulation of DNA sequences to produce substitution, insertion or deletion variants of a protein are well known in the art. For example, techniques for making substitution mutations at predetermined sites in DNA are well known to those skilled in the art and include M13 mutagenesis, T7-Gen in vitro mutagenesis (USB, Cleveland, OH), QuickChange Site Directed mutagenesis (Stratagene, San Diego, CA), PCR-mediated site-directed mutagenesis or other site-directed mutagenesis protocols.</p><heading id="h0009"><u>Derivatives</u></heading><p id="p0027" num="0027">"Derivatives" include peptides, oligopeptides, polypeptides which may, compared to the amino acid sequence of the naturally-occurring form of the protein, such as the protein of interest, comprise substitutions of amino acids with non-naturally occurring amino acid residues, or additions of non-naturally occurring amino acid residues. "Derivatives" of a protein also encompass peptides, oligopeptides, polypeptides which comprise naturally occurring altered (glycosylated, acylated, prenylated, phosphorylated, myristoylated, sulphated etc.) or non-naturally altered amino acid residues compared to the amino acid sequence of a naturally-occurring form of the polypeptide. A derivative may also comprise one or more non-amino acid substituents or additions compared to the amino acid sequence from which it is derived, for example a reporter molecule or other ligand, covalently or non-covalently bound to the amino acid sequence, such as a reporter molecule which is bound to facilitate its detection, and non-naturally occurring amino acid residues relative to the amino acid sequence of a naturally-occurring protein. Furthermore, "derivatives" also include fusions of the naturally-occurring form of the protein with tagging peptides such as FLAG, HIS6 or thioredoxin (for a review of tagging peptides, see <nplcit id="ncit0011" npl-type="s"><text>Terpe, Appl. Microbiol. Biotechnol. 60, 523-533, 2003</text></nplcit>).</p><heading id="h0010"><u>Ortholoque(s)/Paraloque(s)</u></heading><p id="p0028" num="0028">Orthologues and paralogues encompass evolutionary concepts used to describe the ancestral relationships of genes. Paralogues are genes within the same species that have originated through duplication of an ancestral gene; orthologues are genes from different organisms that have originated through speciation, and are also derived from a common ancestral gene.</p><heading id="h0011"><u>Domain</u></heading><p id="p0029" num="0029">The term "domain" refers to a set of amino acids conserved at specific positions along an alignment of sequences of evolutionarily related proteins. While amino acids at other positions can vary between homologues, amino acids that are highly conserved at specific positions indicate amino acids that are likely essential in the structure, stability or function of a protein.<!-- EPO <DP n="12"> --> Identified by their high degree of conservation in aligned sequences of a family of protein homologues, they can be used as identifiers to determine if any polypeptide in question belongs to a previously identified polypeptide family.</p><heading id="h0012"><u>Motif/Consensus sequence/Signature</u></heading><p id="p0030" num="0030">The term "motif" or "consensus sequence" or "signature" refers to a short conserved region in the sequence of evolutionarily related proteins. Motifs are frequently highly conserved parts of domains, but may also include only part of the domain, or be located outside of conserved domain (if all of the amino acids of the motif fall outside of a defined domain).</p><heading id="h0013"><u>Hybridisation</u></heading><p id="p0031" num="0031">The term "hybridisation" as defined herein is a process wherein substantially homologous complementary nucleotide sequences anneal to each other. The hybridisation process can occur entirely in solution, i.e. both complementary nucleic acids are in solution. The hybridisation process can also occur with one of the complementary nucleic acids immobilised to a matrix such as magnetic beads, Sepharose beads or any other resin. The hybridisation process can furthermore occur with one of the complementary nucleic acids immobilised to a solid support such as a nitro-cellulose or nylon membrane or immobilised by e.g. photolithography to, for example, a siliceous glass support (the latter known as nucleic acid arrays or microarrays or as nucleic acid chips). In order to allow hybridisation to occur, the nucleic acid molecules are generally thermally or chemically denatured to melt a double strand into two single strands and/or to remove hairpins or other secondary structures from single stranded nucleic acids.</p><p id="p0032" num="0032">The term "stringency" refers to the conditions under which a hybridisation takes place. The stringency of hybridisation is influenced by conditions such as temperature, salt concentration, ionic strength and hybridisation buffer composition. Generally, low stringency conditions are selected to be about 30°C lower than the thermal melting point (T<sub>m</sub>) for the specific sequence at a defined ionic strength and pH. Medium stringency conditions are when the temperature is 20°C below T<sub>m</sub>, and high stringency conditions are when the temperature is 10°C below T<sub>m</sub>. High stringency hybridisation conditions are typically used for isolating hybridising sequences that have high sequence similarity to the target nucleic acid sequence. However, nucleic acids may deviate in sequence and still encode a substantially identical polypeptide, due to the degeneracy of the genetic code. Therefore medium stringency hybridisation conditions may sometimes be needed to identify such nucleic acid molecules.<!-- EPO <DP n="13"> --></p><p id="p0033" num="0033">The Tm is the temperature under defined ionic strength and pH, at which 50% of the target sequence hybridises to a perfectly matched probe. The T<sub>m</sub> is dependent upon the solution conditions and the base composition and length of the probe. For example, longer sequences hybridise specifically at higher temperatures. The maximum rate of hybridisation is obtained from about 16°C up to 32°C below T<sub>m</sub>. The presence of monovalent cations in the hybridisation solution reduce the electrostatic repulsion between the two nucleic acid strands thereby promoting hybrid formation; this effect is visible for sodium concentrations of up to 0.4M (for higher concentrations, this effect may be ignored). Formamide reduces the melting temperature of DNA-DNA and DNA-RNA duplexes with 0.6 to 0.7°C for each percent formamide, and addition of 50% formamide allows hybridisation to be performed at 30 to 45°C, though the rate of hybridisation will be lowered. Base pair mismatches reduce the hybridisation rate and the thermal stability of the duplexes. On average and for large probes, the Tm decreases about 1 °C per % base mismatch. The Tm may be calculated using the following equations, depending on the types of hybrids:
<ol><li>1) DNA-DNA hybrids (<nplcit id="ncit0012" npl-type="s"><text>Meinkoth and Wahl, Anal. Biochem., 138: 267-284, 1984</text></nplcit>):<maths id="math0001" num=""><math display="block"><msub><mi mathvariant="normal">T</mi><mi mathvariant="normal">m</mi></msub><mo>=</mo><mn>81.5</mn><mo>⁢</mo><mi mathvariant="normal">°</mi><mo>⁢</mo><mi mathvariant="normal">C</mi><mo>+</mo><mn>16.6</mn><mo>×</mo><mi mathvariant="normal">l</mi><mo>⁢</mo><mi mathvariant="normal">o</mi><mo>⁢</mo><msub><mi mathvariant="normal">g</mi><mn>10</mn></msub><mo>⁢</mo><msup><mfenced open="[" close="]"><msup><mrow><mi mathvariant="normal">N</mi><mo>⁢</mo><mi mathvariant="normal">a</mi></mrow><mo>+</mo></msup></mfenced><mi mathvariant="normal">a</mi></msup><mo>+</mo><mn>0.41</mn><mo>×</mo><mo>%</mo><mfenced open="[" close="]" separators=""><mi mathvariant="normal">G</mi><mo>/</mo><msup><mi mathvariant="normal">C</mi><mi mathvariant="normal">b</mi></msup></mfenced><mo>-</mo><mn>500</mn><mo>×</mo><mn>0.61</mn><mo>×</mo><mo>%</mo><mspace width="1em"/><mi>formamide</mi></math><img id="ib0001" file="imgb0001.tif" wi="148" he="9" img-content="math" img-format="tif"/></maths></li><li>2) DNA-RNA or RNA-RNA hybrids:<maths id="math0002" num=""><math display="block"><msub><mi mathvariant="normal">T</mi><mi mathvariant="normal">m</mi></msub><mo>=</mo><mn>79.8</mn><mo>+</mo><mn>18.5</mn><mo>×</mo><mfenced separators=""><mi mathvariant="normal">l</mi><mo>⁢</mo><mi mathvariant="normal">o</mi><mo>⁢</mo><msub><mi mathvariant="normal">g</mi><mn>10</mn></msub><mo>⁢</mo><msup><mfenced open="[" close="]"><msup><mrow><mi mathvariant="normal">N</mi><mo>⁢</mo><mi mathvariant="normal">a</mi></mrow><mo>+</mo></msup></mfenced><mi mathvariant="normal">a</mi></msup></mfenced><mo>+</mo><mn>0.58</mn><mfenced separators=""><mo>%</mo><mi mathvariant="normal">G</mi><mo>/</mo><msup><mi mathvariant="normal">C</mi><mi mathvariant="normal">b</mi></msup></mfenced><mo>+</mo><mn>11.8</mn><mfenced separators=""><mo>%</mo><mi mathvariant="normal">G</mi><mo>/</mo><msup><mi mathvariant="normal">C</mi><mi mathvariant="normal">b</mi></msup></mfenced><mo>-</mo><mn>820</mn><mo>⁢</mo><msup><mrow><mo>/</mo><mi mathvariant="normal">L</mi></mrow><mi mathvariant="normal">c</mi></msup></math><img id="ib0002" file="imgb0002.tif" wi="130" he="7" img-content="math" img-format="tif"/></maths></li><li>3) oligo-DNA or oligo-RNA<sup>d</sup> hybrids:
<ul><li>For &lt;20 nucleotides: T<sub>m</sub>= 2 (I<sub>n</sub>)</li><li>For 20-35 nucleotides: T<sub>m</sub>= 22 + 1.46 (I<sub>n</sub>)</li></ul></li></ol>
<sup>a</sup> or for other monovalent cation, but only accurate in the 0.01-0.4 M range.<br/>
<sup>b</sup> only accurate for %GC in the 30% to 75% range.<br/>
<sup>c</sup> L = length of duplex in base pairs.<br/>
<sup>d</sup> oligo, oligonucleotide; I<sub>n</sub>, = effective length of primer = 2×(no. of G/C)+(no. of A/T).</p><p id="p0034" num="0034">Non-specific binding may be controlled using any one of a number of known techniques such as, for example, blocking the membrane with protein containing solutions, additions of heterologous RNA, DNA, and SDS to the hybridisation buffer, and treatment with Rnase. For non-homologous probes, a series of hybridizations may be performed by varying one of (i) progressively lowering the annealing temperature (for example from 68°C to 42°C) or (ii) progressively lowering the formamide concentration (for example from 50% to 0%). The skilled artisan is aware of various parameters which may be altered during hybridisation and which will either maintain or change the stringency conditions.<!-- EPO <DP n="14"> --></p><p id="p0035" num="0035">Besides the hybridisation conditions, specificity of hybridisation typically also depends on the function of post-hybridisation washes. To remove background resulting from non-specific hybridisation, samples are washed with dilute salt solutions. Critical factors of such washes include the ionic strength and temperature of the final wash solution: the lower the salt concentration and the higher the wash temperature, the higher the stringency of the wash. Wash conditions are typically performed at or below hybridisation stringency. A positive hybridisation gives a signal that is at least twice of that of the background. Generally, suitable stringent conditions for nucleic acid hybridisation assays or gene amplification detection procedures are as set forth above. More or less stringent conditions may also be selected. The skilled artisan is aware of various parameters which may be altered during washing and which will either maintain or change the stringency conditions.</p><p id="p0036" num="0036">For example, typical high stringency hybridisation conditions for DNA hybrids longer than 50 nucleotides encompass hybridisation at 65°C in 1x SSC or at 42°C in 1x SSC and 50% formamide, followed by washing at 65°C in 0.3x SSC. Examples of medium stringency hybridisation conditions for DNA hybrids longer than 50 nucleotides encompass hybridisation at 50°C in 4x SSC or at 40°C in 6x SSC and 50% formamide, followed by washing at 50°C in 2x SSC. The length of the hybrid is the anticipated length for the hybridising nucleic acid. When nucleic acids of known sequence are hybridised, the hybrid length may be determined by aligning the sequences and identifying the conserved regions described herein. 1×SSC is 0.15M NaCl and 15mM sodium citrate; the hybridisation solution and wash solutions may additionally include 5x Denhardt's reagent, 0.5-1.0% SDS, 100 µg/ml denatured, fragmented salmon sperm DNA, 0.5% sodium pyrophosphate.</p><p id="p0037" num="0037">For the purposes of defining the level of stringency, reference can be made to <nplcit id="ncit0013" npl-type="b"><text>Sambrook et al. (2001) Molecular Cloning: a laboratory manual, 3rd Edition, Cold Spring Harbor Laboratory Press, CSH, New York</text></nplcit> or to <nplcit id="ncit0014" npl-type="b"><text>Current Protocols in Molecular Biology, John Wiley &amp; Sons, N.Y. (1989 and yearly updates</text></nplcit>).</p><heading id="h0014"><u>Splice variant</u></heading><p id="p0038" num="0038">The term "splice variant" as used herein encompasses variants of a nucleic acid sequence in which selected introns and/or exons have been excised, replaced, displaced or added, or in which introns have been shortened or lengthened. Such variants will be ones in which the biological activity of the protein is substantially retained; this may be achieved by selectively retaining functional segments of the protein. Such splice variants may be found in nature or may be manmade. Methods for predicting and isolating such splice variants are well known in the art (see for example <nplcit id="ncit0015" npl-type="s"><text>Foissac and Schiex (2005) BMC Bioinformatics 6: 25</text></nplcit>).<!-- EPO <DP n="15"> --></p><heading id="h0015"><u>Allelic variant</u></heading><p id="p0039" num="0039">Alleles or allelic variants are alternative forms of a given gene, located at the same chromosomal position. Allelic variants encompass Single Nucleotide Polymorphisms (SNPs), as well as Small Insertion/Deletion Polymorphisms (INDELs). The size of INDELs is usually less than 100 bp. SNPs and INDELs form the largest set of sequence variants in naturally occurring polymorphic strains of most organisms.</p><heading id="h0016"><u>Gene shuffling/Directed evolution</u></heading><p id="p0040" num="0040">Gene shuffling or directed evolution consists of iterations of DNA shuffling followed by appropriate screening and/or selection to generate variants of nucleic acids or portions thereof encoding proteins having a modified biological activity (<nplcit id="ncit0016" npl-type="s"><text>Castle et al., (2004) Science 304(5674): 1151-4</text></nplcit>; <patcit id="pcit0002" dnum="US5811238A"><text>US patents 5,811,238</text></patcit> and <patcit id="pcit0003" dnum="US6395547A"><text>6,395,547</text></patcit>).</p><heading id="h0017"><u>Regulatory element/Control sequence/Promoter</u></heading><p id="p0041" num="0041">The terms "regulatory element", "control sequence" and "promoter" are all used interchangeably herein and are to be taken in a broad context to refer to regulatory nucleic acid sequences capable of effecting expression of the sequences to which they are ligated. The term "promoter" typically refers to a nucleic acid control sequence located upstream from the transcriptional start of a gene and which is involved in recognising and binding of RNA polymerase and other proteins, thereby directing transcription of an operably linked nucleic acid. Encompassed by the aforementioned terms are transcriptional regulatory sequences derived from a classical eukaryotic genomic gene (including the TATA box which is required for accurate transcription initiation, with or without a CCAAT box sequence) and additional regulatory elements (i.e. upstream activating sequences, enhancers and silencers) which alter gene expression in response to developmental and/or external stimuli, or in a tissue-specific manner. Also included within the term is a transcriptional regulatory sequence of a classical prokaryotic gene, in which case it may include a -35 box sequence and/or -10 box transcriptional regulatory sequences. The term "regulatory element" also encompasses a synthetic fusion molecule or derivative that confers, activates or enhances expression of a nucleic acid molecule in a cell, tissue or organ.</p><p id="p0042" num="0042">A "plant promoter" comprises regulatory elements, which mediate the expression of a coding sequence segment in plant cells. Accordingly, a plant promoter need not be of plant origin, but may originate from viruses or micro-organisms, for example from viruses which attack plant cells. The "plant promoter" can also originate from a plant cell, e.g. from the plant which is transformed with the nucleic acid sequence to be expressed in the inventive process and<!-- EPO <DP n="16"> --> described herein. This also applies to other "plant" regulatory signals, such as "plant" terminators. The promoters upstream of the nucleotide sequences useful in the methods of the present invention can be modified by one or more nucleotide substitution(s), insertion(s) and/or deletion(s) without interfering with the functionality or activity of either the promoters, the open reading frame (ORF) or the 3'-regulatory region such as terminators or other 3' regulatory regions which are located away from the ORF. It is furthermore possible that the activity of the promoters is increased by modification of their sequence, or that they are replaced completely by more active promoters, even promoters from heterologous organisms. For expression in plants, the nucleic acid molecule must, as described above, be linked operably to or comprise a suitable promoter which expresses the gene at the right point in time and with the required spatial expression pattern.</p><p id="p0043" num="0043">For the identification of functionally equivalent promoters, the promoter strength and/or expression pattern of a candidate promoter may be analysed for example by operably linking the promoter to a reporter gene and assaying the expression level and pattern of the reporter gene in various tissues of the plant. Suitable well-known reporter genes include for example beta-glucuronidase or beta-galactosidase. The promoter activity is assayed by measuring the enzymatic activity of the beta-glucuronidase or beta-galactosidase. The promoter strength and/or expression pattern may then be compared to that of a reference promoter (such as the one used in the methods of the present invention). Alternatively, promoter strength may be assayed by quantifying mRNA levels or by comparing mRNA levels of the nucleic acid used in the methods of the present invention, with mRNA levels of housekeeping genes such as 18S rRNA, using methods known in the art, such as Northern blotting with densitometric analysis of autoradiograms, quantitative real-time PCR or RT-PCR (<nplcit id="ncit0017" npl-type="s"><text>Heid et al., 1996 Genome Methods 6: 986-994</text></nplcit>). Generally by "weak promoter" is intended a promoter that drives expression of a coding sequence at a low level. By "low level" is intended at levels of about 1/10,000 transcripts to about 1/100,000 transcripts, to about 1/500,0000 transcripts per cell. Conversely, a "strong promoter" drives expression of a coding sequence at high level, or at about 1/10 transcripts to about 1/100 transcripts to about 1/1000 transcripts per cell.</p><heading id="h0018"><u>Operably linked</u></heading><p id="p0044" num="0044">The term "operably linked" as used herein refers to a functional linkage between the promoter sequence and the gene of interest, such that the promoter sequence is able to initiate transcription of the gene of interest.</p><heading id="h0019"><u>Constitutive promoter</u></heading><!-- EPO <DP n="17"> --><p id="p0045" num="0045">A "constitutive promoter" refers to a promoter that is transcriptionally active during most, but not necessarily all, phases of growth and development and under most environmental conditions, in at least one cell, tissue or organ. Table 2a below gives examples of constitutive promoters.
<tables id="tabl0002" num="0002"><table frame="all"><title><b>Table 2a:</b> Examples of constitutive promoters</title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="35mm"/><colspec colnum="2" colname="col2" colwidth="92mm"/><thead><row><entry valign="top"><b>Gene Source</b></entry><entry valign="top"><b>Reference</b></entry></row></thead><tbody><row><entry>Actin</entry><entry><nplcit id="ncit0018" npl-type="s"><text>McElroy et al, Plant Cell, 2: 163-171, 1990</text></nplcit></entry></row><row><entry>HMGP</entry><entry><patcit id="pcit0004" dnum="wo2004070039a"><text>WO 2004/070039</text></patcit></entry></row><row><entry>CAMV 35S</entry><entry><nplcit id="ncit0019" npl-type="s"><text>Odell et al, Nature, 313: 810-812, 1985</text></nplcit></entry></row><row><entry>CaMV 19S</entry><entry><nplcit id="ncit0020" npl-type="s"><text>Nilsson et al., Physiol. Plant. 100:456-462, 1997</text></nplcit></entry></row><row><entry>GOS2</entry><entry><nplcit id="ncit0021" npl-type="s"><text>de Pater et al, Plant J Nov;2(6):837-44, 1992</text></nplcit>, <patcit id="pcit0005" dnum="wo2004065596a"><text>WO 2004/065596</text></patcit></entry></row><row><entry>Ubiquitin</entry><entry><nplcit id="ncit0022" npl-type="s"><text>Christensen et al, Plant Mol. Biol. 18: 675-689, 1992</text></nplcit></entry></row><row><entry>Rice cyclophilin</entry><entry><nplcit id="ncit0023" npl-type="s"><text>Buchholz et al, Plant Mol Biol. 25(5): 837-43, 1994</text></nplcit></entry></row><row><entry>Maize H3 histone</entry><entry><nplcit id="ncit0024" npl-type="s"><text>Lepetit et al, Mol. Gen. Genet. 231:276-285, 1992</text></nplcit></entry></row><row><entry>Alfalfa H3 histone</entry><entry><nplcit id="ncit0025" npl-type="s"><text>Wu et al. Plant Mol. Biol. 11:641-649, 1988</text></nplcit></entry></row><row><entry>Actin 2</entry><entry><nplcit id="ncit0026" npl-type="s"><text>An et al, Plant J. 10(1); 107-121, 1996</text></nplcit></entry></row><row><entry>34S FMV</entry><entry><nplcit id="ncit0027" npl-type="s"><text>Sanger et al., Plant. Mol. Biol., 14, 1990: 433-443</text></nplcit></entry></row><row><entry>Rubisco small subunit</entry><entry><patcit id="pcit0006" dnum="us4962028a"><text>US 4,962,028</text></patcit></entry></row><row><entry>OCS</entry><entry><nplcit id="ncit0028" npl-type="s"><text>Leisner (1988) Proc Natl Acad Sci USA 85(5): 2553</text></nplcit></entry></row><row><entry>SAD1</entry><entry><nplcit id="ncit0029" npl-type="s"><text>Jain et al., Crop Science, 39 (6), 1999: 1696</text></nplcit></entry></row><row><entry>SAD2</entry><entry><nplcit id="ncit0030" npl-type="s"><text>Jain et al., Crop Science, 39 (6), 1999: 1696</text></nplcit></entry></row><row><entry>nos</entry><entry><nplcit id="ncit0031" npl-type="s"><text>Shaw et al. (1984) Nucleic Acids Res. 12(20):7831-7846</text></nplcit></entry></row><row><entry>V-ATPase</entry><entry><patcit id="pcit0007" dnum="wo0114572a"><text>WO 01/14572</text></patcit></entry></row><row><entry>Super promoter</entry><entry><patcit id="pcit0008" dnum="wo9514098a"><text>WO 95/14098</text></patcit></entry></row><row><entry>G-box proteins</entry><entry><patcit id="pcit0009" dnum="wo9412015a"><text>WO 94/12015</text></patcit></entry></row></tbody></tgroup></table></tables></p><heading id="h0020"><u>Ubiquitous promoter</u></heading><p id="p0046" num="0046">A ubiquitous promoter is active in substantially all tissues or cells of an organism.</p><heading id="h0021"><u>Developmentally-regulated promoter</u></heading><p id="p0047" num="0047">A developmentally-regulated promoter is active during certain developmental stages or in parts of the plant that undergo developmental changes.</p><heading id="h0022"><u>Inducible promoter</u></heading><p id="p0048" num="0048">An inducible promoter has induced or increased transcription initiation in response to a chemical (for a review see <nplcit id="ncit0032" npl-type="s"><text>Gatz 1997, Annu. Rev. Plant Physiol. Plant Mol. Biol., 48:89-108</text></nplcit>),<!-- EPO <DP n="18"> --> environmental or physical stimulus, or may be "stress-inducible", i.e. activated when a plant is exposed to various stress conditions, or a "pathogen-inducible" i.e. activated when a plant is exposed to exposure to various pathogens.</p><heading id="h0023">Organ-specific/Tissue-specific promoter</heading><p id="p0049" num="0049">An organ-specific or tissue-specific promoter is one that is capable of preferentially initiating transcription in certain organs or tissues, such as the leaves, roots, seed tissue etc. For example, a "root-specific promoter" is a promoter that is transcriptionally active predominantly in plant roots, substantially to the exclusion of any other parts of a plant, whilst still allowing for any leaky expression in these other plant parts. Promoters able to initiate transcription in certain cells only are referred to herein as "cell-specific".</p><p id="p0050" num="0050">A seed-specific promoter is transcriptionally active predominantly in seed tissue, but not necessarily exclusively in seed tissue (in cases of leaky expression). The seed-specific promoter may be active during seed development and/or during germination. The seed specific promoter may be endosperm/aleurone/embryo specific. Examples of seed-specific promoters are shown in Tables 2b to 2e below. Further examples of seed-specific promoters are given in <nplcit id="ncit0033" npl-type="s"><text>Qing Qu and Takaiwa (Plant Biotechnol. J. 2, 113-125, 2004</text></nplcit>), which disclosure is incorporated by reference herein as if fully set forth.
<tables id="tabl0003" num="0003"><table frame="all"><title><b>Table 2b:</b> Examples of seed-specific promoters</title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="69mm"/><colspec colnum="2" colname="col2" colwidth="97mm"/><thead><row><entry valign="top"><b>Gene source</b></entry><entry valign="top"><b>Reference</b></entry></row></thead><tbody><row><entry>seed-specific genes</entry><entry><nplcit id="ncit0034" npl-type="s"><text>Simon et al., Plant Mol. Biol. 5: 191, 1985</text></nplcit>;</entry></row><row><entry/><entry><nplcit id="ncit0035" npl-type="s"><text>Scofield et al., J. Biol. Chem. 262: 12202, 1987</text></nplcit>.;</entry></row><row><entry/><entry><nplcit id="ncit0036" npl-type="s"><text>Baszczynski et al., Plant Mol. Biol. 14: 633, 1990</text></nplcit>.</entry></row><row><entry>Brazil Nut albumin</entry><entry><nplcit id="ncit0037" npl-type="s"><text>Pearson et al., Plant Mol. Biol. 18: 235-245, 1992</text></nplcit>.</entry></row><row><entry>legumin</entry><entry><nplcit id="ncit0038" npl-type="s"><text>Ellis et al., Plant Mol. Biol. 10: 203-214, 1988</text></nplcit>.</entry></row><row><entry>glutelin (rice)</entry><entry><nplcit id="ncit0039" npl-type="s"><text>Takaiwa et al., Mol. Gen. Genet. 208: 15-22, 1986</text></nplcit>;</entry></row><row><entry/><entry><nplcit id="ncit0040" npl-type="s"><text>Takaiwa et al., FEBS Letts. 221: 43-47, 1987</text></nplcit>.</entry></row><row><entry>zein</entry><entry><nplcit id="ncit0041" npl-type="s"><text>Matzke et al Plant Mol Biol, 14(3):323-32 1990</text></nplcit></entry></row><row><entry>napA</entry><entry><nplcit id="ncit0042" npl-type="s"><text>Stalberg et al, Planta 199: 515-519, 1996</text></nplcit>.</entry></row><row><entry>wheat LMW and HMW glutenin-1</entry><entry><nplcit id="ncit0043" npl-type="s"><text>Mol Gen Genet 216:81-90, 1989</text></nplcit>; <nplcit id="ncit0044" npl-type="s"><text>NAR 17:461-2, 1989</text></nplcit></entry></row><row><entry>wheat SPA</entry><entry><nplcit id="ncit0045" npl-type="s"><text>Albani et al, Plant Cell, 9: 171-184, 1997</text></nplcit></entry></row><row><entry>wheat α, β, γ-gliadins</entry><entry><nplcit id="ncit0046" npl-type="s"><text>EMBO J. 3:1409-15, 1984</text></nplcit></entry></row><row><entry>barley Itr1 promoter</entry><entry><nplcit id="ncit0047" npl-type="s"><text>Diaz et al. (1995) Mol Gen Genet 248(5):592-8</text></nplcit></entry></row><row><entry>barley B1, C, D, hordein</entry><entry><nplcit id="ncit0048" npl-type="s"><text>Theor Appl Gen 98:1253-62, 1999</text></nplcit>; <nplcit id="ncit0049" npl-type="s"><text>Plant J 4:343-55, 1993</text></nplcit>; <nplcit id="ncit0050" npl-type="s"><text>Mol Gen Genet 250:750-60, 1996</text></nplcit></entry></row><!-- EPO <DP n="19"> --><row><entry>barley DOF</entry><entry><nplcit id="ncit0051" npl-type="s"><text>Mena et al, The Plant Journal, 116(1): 53-62, 1998</text></nplcit></entry></row><row><entry>blz2</entry><entry><patcit id="pcit0010" dnum="ep99106056a"><text>EP99106056.7</text></patcit></entry></row><row><entry>synthetic promoter</entry><entry><nplcit id="ncit0052" npl-type="s"><text>Vicente-Carbajosa et al., Plant J. 13: 629-640, 1998</text></nplcit>.</entry></row><row><entry>rice prolamin NRP33</entry><entry><nplcit id="ncit0053" npl-type="s"><text>Wu et al, Plant Cell Physiology 39(8) 885-889, 1998</text></nplcit></entry></row><row><entry>rice a-globulin Glb-1</entry><entry><nplcit id="ncit0054" npl-type="s"><text>Wu et al, Plant Cell Physiology 39(8) 885-889, 1998</text></nplcit></entry></row><row><entry>rice OSH1</entry><entry><nplcit id="ncit0055" npl-type="s"><text>Sato et al, Proc. Natl. Acad. Sci. USA, 93: 8117-8122, 1996</text></nplcit></entry></row><row><entry>rice α-globulin REB/OHP-1</entry><entry><nplcit id="ncit0056" npl-type="s"><text>Nakase et al. Plant Mol. Biol. 33: 513-522, 1997</text></nplcit></entry></row><row><entry>rice ADP-glucose pyrophosphorylase</entry><entry><nplcit id="ncit0057" npl-type="s"><text>Trans Res 6:157-68, 1997</text></nplcit></entry></row><row><entry>maize ESR gene family</entry><entry><nplcit id="ncit0058" npl-type="s"><text>Plant J 12:235-46, 1997</text></nplcit></entry></row><row><entry>sorghum α-kafirin</entry><entry><nplcit id="ncit0059" npl-type="s"><text>DeRose et al., Plant Mol. Biol 32:1029-35, 1996</text></nplcit></entry></row><row><entry>KNOX</entry><entry><nplcit id="ncit0060" npl-type="s"><text>Postma-Haarsma et al, Plant Mol. Biol. 39:257-71, 1999</text></nplcit></entry></row><row><entry>rice oleosin</entry><entry><nplcit id="ncit0061" npl-type="s"><text>Wu et al, J. Biochem. 123:386, 1998</text></nplcit></entry></row><row><entry>sunflower oleosin</entry><entry><nplcit id="ncit0062" npl-type="s"><text>Cummins et al., Plant Mol. Biol. 19: 873-876, 1992</text></nplcit></entry></row><row><entry>PRO0117, putative rice 40S ribosomal protein</entry><entry><patcit id="pcit0011" dnum="wo2004070039a"><text>WO 2004/070039</text></patcit></entry></row><row><entry>PRO0136, rice alanine aminotransferase</entry><entry>unpublished</entry></row><row><entry>PRO0147, trypsin inhibitor ITR1 (barley)</entry><entry>unpublished</entry></row><row><entry>PRO0151, rice WSI18</entry><entry><patcit id="pcit0012" dnum="wo2004070039a"><text>WO 2004/070039</text></patcit></entry></row><row><entry>PRO0175, rice RAB21</entry><entry><patcit id="pcit0013" dnum="wo2004070039a"><text>WO 2004/070039</text></patcit></entry></row><row><entry>PRO005</entry><entry><patcit id="pcit0014" dnum="wo2004070039a"><text>WO 2004/070039</text></patcit></entry></row><row><entry>PRO0095</entry><entry><patcit id="pcit0015" dnum="wo2004070039a"><text>WO 2004/070039</text></patcit></entry></row><row><entry>α-amylase (Amy32b)</entry><entry><nplcit id="ncit0063" npl-type="s"><text>Lanahan et al, Plant Cell 4:203-211, 1992</text></nplcit>; <nplcit id="ncit0064" npl-type="s"><text>Skriver et al, Proc Natl Acad Sci USA 88:7266-7270, 1991</text></nplcit></entry></row><row><entry>cathepsin β-like gene</entry><entry><nplcit id="ncit0065" npl-type="s"><text>Cejudo et al, Plant Mol Biol 20:849-856, 1992</text></nplcit></entry></row><row><entry>Barley Ltp2</entry><entry><nplcit id="ncit0066" npl-type="s"><text>Kalla et al., Plant J. 6:849-60, 1994</text></nplcit></entry></row><row><entry>Chi26</entry><entry><nplcit id="ncit0067" npl-type="s"><text>Leah et al., Plant J. 4:579-89, 1994</text></nplcit></entry></row><row><entry>Maize B-Peru</entry><entry><nplcit id="ncit0068" npl-type="s"><text>Selinger et al., Genetics 149;1125-38,1998</text></nplcit></entry></row></tbody></tgroup></table></tables>
<tables id="tabl0004" num="0004"><table frame="all"><title><b>Table 2c:</b> examples of endosperm-specific promoters</title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="56mm"/><colspec colnum="2" colname="col2" colwidth="110mm"/><thead><row><entry valign="top"><b>Gene source</b></entry><entry valign="top"><b>Reference</b></entry></row></thead><tbody><row><entry>glutelin (rice)</entry><entry><nplcit id="ncit0069" npl-type="s"><text>Takaiwa et al. (1986) Mol Gen Genet 208:15-22</text></nplcit>; <nplcit id="ncit0070" npl-type="s"><text>Takaiwa et al. (1987) FEBS Letts. 221:43-47</text></nplcit></entry></row><row><entry>zein</entry><entry><nplcit id="ncit0071" npl-type="s"><text>Matzke et al., (1990) Plant Mol Biol 14(3): 323-32</text></nplcit></entry></row><!-- EPO <DP n="20"> --><row><entry>wheat LMW and HMW glutenin-1</entry><entry><nplcit id="ncit0072" npl-type="s"><text>Colot et al. (1989) Mol Gen Genet 216:81-90</text></nplcit>, <nplcit id="ncit0073" npl-type="s"><text>Anderson et al. (1989) NAR 17:461-2</text></nplcit></entry></row><row><entry>wheat SPA</entry><entry><nplcit id="ncit0074" npl-type="s"><text>Albani et al. (1997) Plant Cell 9:171-184</text></nplcit></entry></row><row><entry>wheat gliadins</entry><entry><nplcit id="ncit0075" npl-type="s"><text>Rafalski et al. (1984) EMBO 3:1409-15</text></nplcit></entry></row><row><entry>barley Itr1 promoter</entry><entry><nplcit id="ncit0076" npl-type="s"><text>Diaz et al. (1995) Mol Gen Genet 248(5):592-8</text></nplcit></entry></row><row><entry>barley B1, C, D, hordein</entry><entry><nplcit id="ncit0077" npl-type="s"><text>Cho et al. (1999) Theor Appl Genet 98:1253-62</text></nplcit>; <nplcit id="ncit0078" npl-type="s"><text>Muller et al. (1993) Plant J 4:343-55</text></nplcit>; <nplcit id="ncit0079" npl-type="s"><text>Sorenson et al. (1996) Mol Gen Genet 250:750-60</text></nplcit></entry></row><row><entry>barley DOF</entry><entry><nplcit id="ncit0080" npl-type="s"><text>Mena et al, (1998) Plant J 116(1): 53-62</text></nplcit></entry></row><row><entry>blz2</entry><entry><nplcit id="ncit0081" npl-type="s"><text>Onate et al. (1999) J Biol Chem 274(14):9175-82</text></nplcit></entry></row><row><entry>synthetic promoter</entry><entry><nplcit id="ncit0082" npl-type="s"><text>Vicente-Carbajosa et al. (1998) Plant J 13:629-640</text></nplcit></entry></row><row><entry>rice prolamin NRP33</entry><entry><nplcit id="ncit0083" npl-type="s"><text>Wu et al, (1998) Plant Cell Physiol 39(8) 885-889</text></nplcit></entry></row><row><entry>rice globulin Glb-1</entry><entry><nplcit id="ncit0084" npl-type="s"><text>Wu et al. (1998) Plant Cell Physiol 39(8) 885-889</text></nplcit></entry></row><row><entry>rice globulin REB/OHP-1</entry><entry><nplcit id="ncit0085" npl-type="s"><text>Nakase et al. (1997) Plant Molec Biol 33: 513-522</text></nplcit></entry></row><row><entry>rice ADP-glucose pyrophosphorylase</entry><entry><nplcit id="ncit0086" npl-type="s"><text>Russell et al. (1997) Trans Res 6:157-68</text></nplcit></entry></row><row><entry>maize ESR gene family</entry><entry><nplcit id="ncit0087" npl-type="s"><text>Opsahl-Ferstad et al. (1997) Plant J 12:235-46</text></nplcit></entry></row><row><entry>sorghum kafirin</entry><entry><nplcit id="ncit0088" npl-type="s"><text>DeRose et al. (1996) Plant Mol Biol 32:1029-35</text></nplcit></entry></row></tbody></tgroup></table></tables>
<tables id="tabl0005" num="0005"><table frame="all"><title><b>Table 2d:</b> Examples of embryo specific promoters:</title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="35mm"/><colspec colnum="2" colname="col2" colwidth="84mm"/><thead><row><entry valign="top"><b>Gene source</b></entry><entry valign="top"><b>Reference</b></entry></row></thead><tbody><row><entry>rice OSH1</entry><entry><nplcit id="ncit0089" npl-type="s"><text>Sato et al, Proc. Natl. Acad. Sci. USA, 93: 8117-8122, 1996</text></nplcit></entry></row><row><entry>KNOX</entry><entry><nplcit id="ncit0090" npl-type="s"><text>Postma-Haarsma et al, Plant Mol. Biol. 39:257-71, 1999</text></nplcit></entry></row><row><entry>PRO0151</entry><entry><patcit id="pcit0016" dnum="wo2004070039a"><text>WO 2004/070039</text></patcit></entry></row><row><entry>PRO0175</entry><entry><patcit id="pcit0017" dnum="wo2004070039a"><text>WO 2004/070039</text></patcit></entry></row><row><entry>PRO005</entry><entry><patcit id="pcit0018" dnum="wo2004070039a"><text>WO 2004/070039</text></patcit></entry></row><row><entry>PRO0095</entry><entry><patcit id="pcit0019" dnum="wo2004070039a"><text>WO 2004/070039</text></patcit></entry></row></tbody></tgroup></table></tables>
<tables id="tabl0006" num="0006"><table frame="all"><title><b>Table 2e:</b> Examples of aleurone-specific promoters:</title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="37mm"/><colspec colnum="2" colname="col2" colwidth="129mm"/><thead><row><entry valign="top">Gene source</entry><entry valign="top">Reference</entry></row></thead><tbody><row><entry>α-amylase (Amy32b)</entry><entry><nplcit id="ncit0091" npl-type="s"><text>Lanahan et al, Plant Cell 4:203-211, 1992</text></nplcit>; <nplcit id="ncit0092" npl-type="s"><text>Skriver et al, Proc Natl Acad Sci USA 88:7266-7270, 1991</text></nplcit></entry></row><row><entry>cathepsin β-like gene</entry><entry><nplcit id="ncit0093" npl-type="s"><text>Cejudo et al, Plant Mol Biol 20:849-856, 1992</text></nplcit></entry></row><row><entry>Barley Ltp2</entry><entry><nplcit id="ncit0094" npl-type="s"><text>Kalla et al., Plant J. 6:849-60, 1994</text></nplcit></entry></row><row><entry>Chi26</entry><entry><nplcit id="ncit0095" npl-type="s"><text>Leah et al., Plant J. 4:579-89, 1994</text></nplcit></entry></row><!-- EPO <DP n="21"> --><row><entry>Maize B-Peru</entry><entry><nplcit id="ncit0096" npl-type="s"><text>Selinger et al., Genetics 149;1125-38, 1998</text></nplcit></entry></row></tbody></tgroup></table></tables></p><p id="p0051" num="0051">A green tissue-specific promoter as defined herein is a promoter that is transcriptionally active predominantly in green tissue, substantially to the exclusion of any other parts of a plant, whilst still allowing for any leaky expression in these other plant parts.</p><p id="p0052" num="0052">Another example of a tissue-specific promoter is a meristem-specific promoter, which is transcriptionally active predominantly in meristematic tissue, substantially to the exclusion of any other parts of a plant, whilst still allowing for any leaky expression in these other plant parts.</p><heading id="h0024"><u>Terminator</u></heading><p id="p0053" num="0053">The term "terminator" encompasses a control sequence which is a DNA sequence at the end of a transcriptional unit which signals 3' processing and polyadenylation of a primary transcript and termination of transcription. The terminator can be derived from the natural gene, from a variety of other plant genes, or from T-DNA. The terminator to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene.</p><heading id="h0025"><u>Modulation</u></heading><p id="p0054" num="0054">The term "modulation" means in relation to expression or gene expression, a process in which the expression level is changed by said gene expression in comparison to the control plant, the expression level may be increased or decreased. The original, unmodulated expression may be of any kind of expression of a structural RNA (rRNA, tRNA) or mRNA with subsequent translation. The term "modulating the activity" shall mean any change of the expression of the inventive nucleic acid sequences or encoded proteins, which leads to increased yield and/or increased growth of the plants.</p><heading id="h0026"><u>Expression</u></heading><p id="p0055" num="0055">The term "expression" or "gene expression" means the transcription of a specific gene or specific genes or specific genetic construct. The term "expression" or "gene expression" in particular means the transcription of a gene or genes or genetic construct into structural RNA (rRNA, tRNA) or mRNA with or without subsequent translation of the latter into a protein. The process includes transcription of DNA and processing of the resulting mRNA product.</p><heading id="h0027"><u>Increased expression/overexpression</u></heading><p id="p0056" num="0056">The term "increased expression" or "overexpression" as used herein means any form of expression that is additional to the original wild-type expression level.<!-- EPO <DP n="22"> --></p><p id="p0057" num="0057">Methods for increasing expression of genes or gene products are well documented in the art and include, for example, overexpression driven by appropriate promoters, the use of transcription enhancers or translation enhancers. Isolated nucleic acids which serve as promoter or enhancer elements may be introduced in an appropriate position (typically upstream) of a non-heterologous form of a polynucleotide so as to upregulate expression of a nucleic acid encoding the polypeptide of interest. For example, endogenous promoters may be altered in vivo by mutation, deletion, and/or substitution (see, <patcit id="pcit0020" dnum="US5565350A"><text>Kmiec, US 5,565,350</text></patcit>; <patcit id="pcit0021" dnum="WO9322443A"><text>Zarling et al., WO9322443</text></patcit>), or isolated promoters may be introduced into a plant cell in the proper orientation and distance from a gene as described herein so as to control the expression of the gene.</p><p id="p0058" num="0058">If polypeptide expression is desired, it is generally desirable to include a polyadenylation region at the 3'-end of a polynucleotide coding region. The polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA. The 3' end sequence to be added may be derived from, for example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene.</p><p id="p0059" num="0059">An intron sequence may also be added to the 5' untranslated region (UTR) or the coding sequence of the partial coding sequence to increase the amount of the mature message that accumulates in the cytosol. Inclusion of a spliceable intron in the transcription unit in both plant and animal expression constructs has been shown to increase gene expression at both the mRNA and protein levels up to 1000-fold (<nplcit id="ncit0097" npl-type="s"><text>Buchman and Berg (1988) Mol. Cell biol. 8: 4395-4405</text></nplcit>; <nplcit id="ncit0098" npl-type="s"><text>Callis et al. (1987) Genes Dev 1:1183-1200</text></nplcit>). Such intron enhancement of gene expression is typically greatest when placed near the 5' end of the transcription unit. Use of the maize introns Adh1-S intron 1, 2, and 6, the Bronze-1 intron are known in the art. For general information see: <nplcit id="ncit0099" npl-type="b"><text>The Maize Handbook, Chapter 116, Freeling and Walbot, Eds., Springer, N.Y. (1994</text></nplcit>).</p><heading id="h0028"><u>Endogenous gene</u></heading><p id="p0060" num="0060">Reference herein to an "endogenous" gene not only refers to the gene in question as found in a plant in its natural form (i.e., without there being any human intervention), but also refers to that same gene (or a substantially homologous nucleic acid/gene) in an isolated form subsequently (re)introduced into a plant (a transgene). For example, a transgenic plant containing such a transgene may encounter a substantial reduction of the transgene expression and/or<!-- EPO <DP n="23"> --> substantial reduction of expression of the endogenous gene. The isolated gene may be isolated from an organism or may be manmade, for example by chemical synthesis.</p><heading id="h0029"><u>Decreased expression</u></heading><p id="p0061" num="0061">Reference herein to "decreased expression" or "reduction or substantial elimination" of expression is taken to mean a decrease in endogenous gene expression and/or polypeptide levels and/or polypeptide activity relative to control plants. The reduction or substantial elimination is in increasing order of preference at least 10%, 20%, 30%, 40% or 50%, 60%, 70%, 80%, 85%, 90%, or 95%, 96%, 97%, 98%, 99% or more reduced compared to that of control plants.</p><p id="p0062" num="0062">For the reduction or substantial elimination of expression an endogenous gene in a plant, a sufficient length of substantially contiguous nucleotides of a nucleic acid sequence is required. In order to perform gene silencing, this may be as little as 20, 19, 18, 17, 16, 15, 14, 13, 12, 11, 10 or fewer nucleotides, alternatively this may be as much as the entire gene (including the 5' and/or 3' UTR, either in part or in whole). The stretch of substantially contiguous nucleotides may be derived from the nucleic acid encoding the protein of interest (target gene), or from any nucleic acid capable of encoding an orthologue, paralogue or homologue of the protein of interest. Preferably, the stretch of substantially contiguous nucleotides is capable of forming hydrogen bonds with the target gene (either sense or antisense strand), more preferably, the stretch of substantially contiguous nucleotides has, in increasing order of preference, 50%, 60%, 70%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99%, 100% sequence identity to the target gene (either sense or antisense strand). A nucleic acid sequence encoding a (functional) polypeptide is not a requirement for the various methods discussed herein for the reduction or substantial elimination of expression of an endogenous gene.</p><p id="p0063" num="0063">This reduction or substantial elimination of expression may be achieved using routine tools and technique. A method for the reduction or substantial elimination of endogenous gene expression is by introducing and expressing in a plant a genetic construct into which the nucleic acid (in this case a stretch of substantially contiguous nucleotides derived from the gene of interest, or from any nucleic acid capable of encoding an orthologue, paralogue or homologue of any one of the protein of interest) is cloned as an inverted repeat (in part or completely), separated by a spacer (non-coding DNA).</p><p id="p0064" num="0064">In such a method, expression of the endogenous gene is reduced or substantially eliminated through RNA-mediated silencing using an inverted repeat of a nucleic acid or a part thereof (in this case a stretch of substantially contiguous nucleotides derived from the gene of<!-- EPO <DP n="24"> --> interest, or from any nucleic acid capable of encoding an orthologue, paralogue or homologue of the protein of interest), preferably capable of forming a hairpin structure. The inverted repeat is cloned in an expression vector comprising control sequences. A non-coding DNA nucleic acid sequence (a spacer, for example a matrix attachment region fragment (MAR), an intron, a polylinker, etc.) is located between the two inverted nucleic acids forming the inverted repeat. After transcription of the inverted repeat, a chimeric RNA with a self-complementary structure is formed (partial or complete). This double-stranded RNA structure is referred to as the hairpin RNA (hpRNA). The hpRNA is processed by the plant into siRNAs that are incorporated into an RNA-induced silencing complex (RISC). The RISC further cleaves the mRNA transcripts, thereby substantially reducing the number of mRNA transcripts to be translated into polypeptides. For further general details see for example, <patcit id="pcit0022" dnum="WO9853083A"><text>Grierson et al. (1998) WO 98/53083</text></patcit>; <patcit id="pcit0023" dnum="WO9953050A"><text>Waterhouse et al. (1999) WO 99/53050</text></patcit>).</p><p id="p0065" num="0065">Performance of the methods as described herein does not rely on introducing and expressing in a plant a genetic construct into which the nucleic acid is cloned as an inverted repeat, but any one or more of several well-known "gene silencing" methods may be used to achieve the same effects.</p><p id="p0066" num="0066">One such method for the reduction of endogenous gene expression is RNA-mediated silencing of gene expression (downregulation). Silencing in this case is triggered in a plant by a double stranded RNA sequence (dsRNA) that is substantially similar to the target endogenous gene. This dsRNA is further processed by the plant into about 20 to about 26 nucleotides called short interfering RNAs (siRNAs). The siRNAs are incorporated into an RNA-induced silencing complex (RISC) that cleaves the mRNA transcript of the endogenous target gene, thereby substantially reducing the number of mRNA transcripts to be translated into a polypeptide. Preferably, the double stranded RNA sequence corresponds to a target gene.</p><p id="p0067" num="0067">Another example of an RNA silencing method involves the introduction of nucleic acid sequences or parts thereof (in this case a stretch of substantially contiguous nucleotides derived from the gene of interest, or from any nucleic acid capable of encoding an orthologue, paralogue or homologue of the protein of interest) in a sense orientation into a plant. "Sense orientation" refers to a DNA sequence that is homologous to an mRNA transcript thereof. Introduced into a plant would therefore be at least one copy of the nucleic acid sequence. The additional nucleic acid sequence will reduce expression of the endogenous gene, giving rise to a phenomenon known as co-suppression. The reduction of gene expression will be more pronounced if several additional copies of a nucleic acid sequence are introduced into the<!-- EPO <DP n="25"> --> plant, as there is a positive correlation between high transcript levels and the triggering of co-suppression.</p><p id="p0068" num="0068">Another example of an RNA silencing method involves the use of antisense nucleic acid sequences. An "antisense" nucleic acid sequence comprises a nucleotide sequence that is complementary to a "sense" nucleic acid sequence encoding a protein, i.e. complementary to the coding strand of a double-stranded cDNA molecule or complementary to an mRNA transcript sequence. The antisense nucleic acid sequence is preferably complementary to the endogenous gene to be silenced. The complementarity may be located in the "coding region" and/or in the "non-coding region" of a gene. The term "coding region" refers to a region of the nucleotide sequence comprising codons that are translated into amino acid residues. The term "non-coding region" refers to 5' and 3' sequences that flank the coding region that are transcribed but not translated into amino acids (also referred to as 5' and 3' untranslated regions).</p><p id="p0069" num="0069">Antisense nucleic acid sequences can be designed according to the rules of Watson and Crick base pairing. The antisense nucleic acid sequence may be complementary to the entire nucleic acid sequence (in this case a stretch of substantially contiguous nucleotides derived from the gene of interest, or from any nucleic acid capable of encoding an orthologue, paralogue or homologue of the protein of interest), but may also be an oligonucleotide that is antisense to only a part of the nucleic acid sequence (including the mRNA 5' and 3' UTR). For example, the antisense oligonucleotide sequence may be complementary to the region surrounding the translation start site of an mRNA transcript encoding a polypeptide. The length of a suitable antisense oligonucleotide sequence is known in the art and may start from about 50, 45, 40, 35, 30, 25, 20, 15 or 10 nucleotides in length or less. An antisense nucleic acid sequence as described herein may be constructed using chemical synthesis and enzymatic ligation reactions using methods known in the art. For example, an antisense nucleic acid sequence (e.g., an antisense oligonucleotide sequence) may be chemically synthesized using naturally occurring nucleotides or variously modified nucleotides designed to increase the biological stability of the molecules or to increase the physical stability of the duplex formed between the antisense and sense nucleic acid sequences, e.g., phosphorothioate derivatives and acridine substituted nucleotides may be used. Examples of modified nucleotides that may be used to generate the antisense nucleic acid sequences are well known in the art. Known nucleotide modifications include methylation, cyclization and 'caps' and substitution of one or more of the naturally occurring nucleotides with an analogue such as inosine. Other modifications of nucleotides are well known in the art.<!-- EPO <DP n="26"> --></p><p id="p0070" num="0070">The antisense nucleic acid sequence can be produced biologically using an expression vector into which a nucleic acid sequence has been subcloned in an antisense orientation (i.e., RNA transcribed from the inserted nucleic acid will be of an antisense orientation to a target nucleic acid of interest). Preferably, production of antisense nucleic acid sequences in plants occurs by means of a stably integrated nucleic acid construct comprising a promoter, an operably linked antisense oligonucleotide, and a terminator.</p><p id="p0071" num="0071">The nucleic acid molecules used for silencing in the methods as described herein (whether introduced into a plant or generated in situ) hybridize with or bind to mRNA transcripts and/or genomic DNA encoding a polypeptide to thereby inhibit expression of the protein, e.g., by inhibiting transcription and/or translation. The hybridization can be by conventional nucleotide complementarity to form a stable duplex, or, for example, in the case of an antisense nucleic acid sequence which binds to DNA duplexes, through specific interactions in the major groove of the double helix. Antisense nucleic acid sequences may be introduced into a plant by transformation or direct injection at a specific tissue site. Alternatively, antisense nucleic acid sequences can be modified to target selected cells and then administered systemically. For example, for systemic administration, antisense nucleic acid sequences can be modified such that they specifically bind to receptors or antigens expressed on a selected cell surface, e.g., by linking the antisense nucleic acid sequence to peptides or antibodies which bind to cell surface receptors or antigens. The antisense nucleic acid sequences can also be delivered to cells using the vectors described herein.</p><p id="p0072" num="0072">As described herein, the antisense nucleic acid sequence is an a-anomeric nucleic acid sequence. An a-anomeric nucleic acid sequence forms specific double-stranded hybrids with complementary RNA in which, contrary to the usual b-units, the strands run parallel to each other (<nplcit id="ncit0100" npl-type="s"><text>Gaultier et al. (1987) Nucl Ac Res 15: 6625-6641</text></nplcit>). The antisense nucleic acid sequence may also comprise a 2'-o-methylribonucleotide (<nplcit id="ncit0101" npl-type="s"><text>Inoue et al. (1987) Nucl Ac Res 15, 6131-6148</text></nplcit>) or a chimeric RNA-DNA analogue (<nplcit id="ncit0102" npl-type="s"><text>Inoue et al. (1987) FEBS Lett. 215, 327-330</text></nplcit>).</p><p id="p0073" num="0073">The reduction or substantial elimination of endogenous gene expression may also be performed using ribozymes. Ribozymes are catalytic RNA molecules with ribonuclease activity that are capable of cleaving a single-stranded nucleic acid sequence, such as an mRNA, to which they have a complementary region. Thus, ribozymes (e.g., hammerhead ribozymes (described in <nplcit id="ncit0103" npl-type="s"><text>Haselhoff and Gerlach (1988) Nature 334, 585-591</text></nplcit>) can be used to catalytically cleave mRNA transcripts encoding a polypeptide, thereby substantially reducing the number of mRNA transcripts to be translated into a polypeptide. A ribozyme having specificity for a<!-- EPO <DP n="27"> --> nucleic acid sequence can be designed (see for example: <patcit id="pcit0024" dnum="US4987071A"><text>Cech et al. U.S. Patent No. 4,987,071</text></patcit>; and <patcit id="pcit0025" dnum="US5116742A"><text>Cech et al. U.S. Patent No. 5,116,742</text></patcit>). Alternatively, mRNA transcripts corresponding to a nucleic acid sequence can be used to select a catalytic RNA having a specific ribonuclease activity from a pool of RNA molecules (<nplcit id="ncit0104" npl-type="s"><text>Bartel and Szostak (1993) Science 261, 1411-1418</text></nplcit>). The use of ribozymes for gene silencing in plants is known in the art (e.g., <patcit id="pcit0026" dnum="WO9400012A"><text>Atkins et al. (1994) WO 94/00012</text></patcit>; <patcit id="pcit0027" dnum="WO9503404A"><text>Lenne et al. (1995) WO 95/03404</text></patcit>; <patcit id="pcit0028" dnum="WO0000619A"><text>Lutziger et al. (2000) WO 00/00619</text></patcit>; <patcit id="pcit0029" dnum="WO9713865A"><text>Prinsen et al. (1997) WO 97/13865</text></patcit> and <patcit id="pcit0030" dnum="WO9738116A"><text>Scott et al. (1997) WO 97/38116</text></patcit>).</p><p id="p0074" num="0074">Gene silencing may also be achieved by insertion mutagenesis (for example, T-DNA insertion or transposon insertion) or by strategies as described by, among others, <nplcit id="ncit0105" npl-type="s"><text>Angell and Baulcombe ((1999) Plant J 20(3): 357-62</text></nplcit>), (Amplicon VIGS <patcit id="pcit0031" dnum="WO9836083A"><text>WO 98/36083</text></patcit>), or Baulcombe (<patcit id="pcit0032" dnum="WO9915682A"><text>WO 99/15682</text></patcit>).</p><p id="p0075" num="0075">Gene silencing may also occur if there is a mutation on an endogenous gene and/or a mutation on an isolated gene/nucleic acid subsequently introduced into a plant. The reduction or substantial elimination may be caused by a non-functional polypeptide. For example, the polypeptide may bind to various interacting proteins; one or more mutation(s) and/or truncation(s) may therefore provide for a polypeptide that is still able to bind interacting proteins (such as receptor proteins) but that cannot exhibit its normal function (such as signalling ligand).</p><p id="p0076" num="0076">A further approach to gene silencing is by targeting nucleic acid sequences complementary to the regulatory region of the gene (e.g., the promoter and/or enhancers) to form triple helical structures that prevent transcription of the gene in target cells. See <nplcit id="ncit0106" npl-type="s"><text>Helene, C., Anticancer Drug Res. 6, 569-84, 1991</text></nplcit>; <nplcit id="ncit0107" npl-type="s"><text>Helene et al., Ann. N.Y. Acad. Sci. 660, 27-36 1992</text></nplcit>; and <nplcit id="ncit0108" npl-type="s"><text>Maher, L.J. Bioassays 14, 807-15, 1992</text></nplcit>.</p><p id="p0077" num="0077">Other methods, such as the use of antibodies directed to an endogenous polypeptide for inhibiting its function in planta, or interference in the signalling pathway in which a polypeptide is involved, will be well known to the skilled man. In particular, it can be envisaged that manmade molecules may be useful for inhibiting the biological function of a target polypeptide, or for interfering with the signalling pathway in which the target polypeptide is involved.</p><p id="p0078" num="0078">Alternatively, a screening program may be set up to identify in a plant population natural variants of a gene, which variants encode polypeptides with reduced activity. Such natural variants may also be used for example, to perform homologous recombination.<!-- EPO <DP n="28"> --></p><p id="p0079" num="0079">Artificial and/or natural microRNAs (miRNAs) may be used to knock out gene expression and/or mRNA translation. Endogenous miRNAs are single stranded small RNAs of typically 19-24 nucleotides long. They function primarily to regulate gene expression and/ or mRNA translation. Most plant microRNAs (miRNAs) have perfect or near-perfect complementarity with their target sequences. However, there are natural targets with up to five mismatches. They are processed from longer non-coding RNAs with characteristic fold-back structures by double-strand specific RNases of the Dicer family. Upon processing, they are incorporated in the RNA-induced silencing complex (RISC) by binding to its main component, an Argonaute protein. MiRNAs serve as the specificity components of RISC, since they base-pair to target nucleic acids, mostly mRNAs, in the cytoplasm. Subsequent regulatory events include target mRNA cleavage and destruction and/or translational inhibition. Effects of miRNA overexpression are thus often reflected in decreased mRNA levels of target genes.</p><p id="p0080" num="0080">Artificial microRNAs (amiRNAs), which are typically 21 nucleotides in length, can be genetically engineered specifically to negatively regulate gene expression of single or multiple genes of interest. Determinants of plant microRNA target selection are well known in the art. Empirical parameters for target recognition have been defined and can be used to aid in the design of specific amiRNAs, (<nplcit id="ncit0109" npl-type="s"><text>Schwab et al., Dev. Cell 8, 517-527, 2005</text></nplcit>). Convenient tools for design and generation of amiRNAs and their precursors are also available to the public (<nplcit id="ncit0110" npl-type="s"><text>Schwab et al., Plant Cell 18, 1121-1133, 2006</text></nplcit>).</p><p id="p0081" num="0081">For optimal performance, the gene silencing techniques used for reducing expression in a plant of an endogenous gene requires the use of nucleic acid sequences from monocotyledonous plants for transformation of monocotyledonous plants, and from dicotyledonous plants for transformation of dicotyledonous plants. Preferably, a nucleic acid sequence from any given plant species is introduced into that same species. For example, a nucleic acid sequence from rice is transformed into a rice plant. However, it is not an absolute requirement that the nucleic acid sequence to be introduced originates from the same plant species as the plant in which it will be introduced. It is sufficient that there is substantial homology between the endogenous target gene and the nucleic acid to be introduced.</p><p id="p0082" num="0082">Described above are examples of various methods for the reduction or substantial elimination of expression in a plant of an endogenous gene. A person skilled in the art would readily be able to adapt the aforementioned methods for silencing so as to achieve reduction of expression of an endogenous gene in a whole plant or in parts thereof through the use of an appropriate promoter, for example.<!-- EPO <DP n="29"> --></p><heading id="h0030"><u>Selectable marker (gene)/Reporter gene</u></heading><p id="p0083" num="0083">"Selectable marker", "selectable marker gene" or "reporter gene" includes any gene that confers a phenotype on a cell in which it is expressed to facilitate the identification and/or selection of cells that are transfected or transformed with a nucleic acid construct as described herein. These marker genes enable the identification of a successful transfer of the nucleic acid molecules via a series of different principles. Suitable markers may be selected from markers that confer antibiotic or herbicide resistance, that introduce a new metabolic trait or that allow visual selection. Examples of selectable marker genes include genes conferring resistance to antibiotics (such as nptII that phosphorylates neomycin and kanamycin, or hpt, phosphorylating hygromycin, or genes conferring resistance to, for example, bleomycin, streptomycin, tetracyclin, chloramphenicol, ampicillin, gentamycin, geneticin (G418), spectinomycin or blasticidin), to herbicides (for example bar which provides resistance to Basta<sup>®</sup>; aroA or gox providing resistance against glyphosate, or the genes conferring resistance to, for example, imidazolinone, phosphinothricin or sulfonylurea), or genes that provide a metabolic trait (such as manA that allows plants to use mannose as sole carbon source or xylose isomerase for the utilisation of xylose, or antinutritive markers such as the resistance to 2-deoxyglucose). Expression of visual marker genes results in the formation of colour (for example β-glucuronidase, GUS or β-galactosidase with its coloured substrates, for example X-Gal), luminescence (such as the luciferin/luceferase system) or fluorescence (Green Fluorescent Protein, GFP, and derivatives thereof). This list represents only a small number of possible markers. The skilled worker is familiar with such markers. Different markers are preferred, depending on the organism and the selection method.</p><p id="p0084" num="0084">It is known that upon stable or transient integration of nucleic acids into plant cells, only a minority of the cells takes up the foreign DNA and, if desired, integrates it into its genome, depending on the expression vector used and the transfection technique used. To identify and select these integrants, a gene coding for a selectable marker (such as the ones described above) is usually introduced into the host cells together with the gene of interest. These markers can for example be used in mutants in which these genes are not functional by, for example, deletion by conventional methods. Furthermore, nucleic acid molecules encoding a selectable marker can be introduced into a host cell on the same vector that comprises the sequence encoding the polypeptides as described herein or used in the methods as described herein, or else in a separate vector. Cells which have been stably transfected with the introduced nucleic acid can be identified for example by selection (for example, cells which have integrated the selectable marker survive whereas the other cells die).<!-- EPO <DP n="30"> --></p><p id="p0085" num="0085">Since the marker genes, particularly genes for resistance to antibiotics and herbicides, are no longer required or are undesired in the transgenic host cell once the nucleic acids have been introduced successfully, the process as described herein for introducing the nucleic acids advantageously employs techniques which enable the removal or excision of these marker genes. One such a method is what is known as co-transformation. The co-transformation method employs two vectors simultaneously for the transformation, one vector bearing the nucleic acid as described herein and a second bearing the marker gene(s). A large proportion of transformants receives or, in the case of plants, comprises (up to 40% or more of the transformants), both vectors. In case of transformation with Agrobacteria, the transformants usually receive only a part of the vector, i.e. the sequence flanked by the T-DNA, which usually represents the expression cassette. The marker genes can subsequently be removed from the transformed plant by performing crosses. In another method, marker genes integrated into a transposon are used for the transformation together with desired nucleic acid (known as the Ac/Ds technology). The transformants can be crossed with a transposase source or the transformants are transformed with a nucleic acid construct conferring expression of a transposase, transiently or stable. In some cases (approx. 10%), the transposon jumps out of the genome of the host cell once transformation has taken place successfully and is lost. In a further number of cases, the transposon jumps to a different location. In these cases the marker gene must be eliminated by performing crosses. In microbiology, techniques were developed which make possible, or facilitate, the detection of such events. A further advantageous method relies on what is known as recombination systems; whose advantage is that elimination by crossing can be dispensed with. The best-known system of this type is what is known as the Cre/lox system. Cre1 is a recombinase that removes the sequences located between the IoxP sequences. If the marker gene is integrated between the IoxP sequences, it is removed once transformation has taken place successfully, by expression of the recombinase. Further recombination systems are the HIN/HIX, FLP/FRT and REP/STB system (<nplcit id="ncit0111" npl-type="s"><text>Tribble et al., J. Biol. Chem., 275, 2000: 22255-22267</text></nplcit>; <nplcit id="ncit0112" npl-type="s"><text>Velmurugan et al., J. Cell Biol., 149, 2000: 553-566</text></nplcit>). A site-specific integration into the plant genome of the nucleic acid sequences as described herein is possible. Naturally, these methods can also be applied to microorganisms such as yeast, fungi or bacteria.</p><heading id="h0031"><u>Transgenic/Transgene/Recombinant</u></heading><p id="p0086" num="0086">For the purposes of the invention, "transgenic", "transgene" or "recombinant" means with regard to, for example, a nucleic acid sequence, an expression cassette, gene construct or a vector comprising the nucleic acid sequence or an organism transformed with the nucleic acid sequences, expression cassettes or vectors as described herein, all those constructions brought about by recombinant methods in which either<!-- EPO <DP n="31"> -->
<ol><li>(a) the nucleic acid sequences encoding proteins useful in the methods as described herein, or</li><li>(b) genetic control sequence(s) which is operably linked with the nucleic acid sequence as described herein, for example a promoter, or</li><li>(c) a) and b)</li></ol>
are not located in their natural genetic environment or have been modified by recombinant methods, it being possible for the modification to take the form of, for example, a substitution, addition, deletion, inversion or insertion of one or more nucleotide residues. The natural genetic environment is understood as meaning the natural genomic or chromosomal locus in the original plant or the presence in a genomic library. In the case of a genomic library, the natural genetic environment of the nucleic acid sequence is preferably retained, at least in part. The environment flanks the nucleic acid sequence at least on one side and has a sequence length of at least 50 bp, preferably at least 500 bp, especially preferably at least 1000 bp, most preferably at least 5000 bp. A naturally occurring expression cassette - for example the naturally occurring combination of the natural promoter of the nucleic acid sequences with the corresponding nucleic acid sequence encoding a polypeptide useful in the methods as described herein, as defined above - becomes a transgenic expression cassette when this expression cassette is modified by non-natural, synthetic ("artificial") methods such as, for example, mutagenic treatment. Suitable methods are described, for example, in <patcit id="pcit0033" dnum="US5565350A"><text>US 5,565,350</text></patcit> or <patcit id="pcit0034" dnum="WO0015815A"><text>WO 00/15815</text></patcit>.</p><p id="p0087" num="0087">A transgenic plant as described herein is thus understood as meaning, as above, that the nucleic acids used in the method as described herein are not at their natural locus in the genome of said plant, it being possible for the nucleic acids to be expressed homologously or heterologously. However, as mentioned, transgenic also means that, while the nucleic acids as described herein or used in the inventive method are at their natural position in the genome of a plant, the sequence has been modified with regard to the natural sequence, and/or that the regulatory sequences of the natural sequences have been modified. Transgenic is preferably understood as meaning the expression of the nucleic acids as described herein at an unnatural locus in the genome, i.e. homologous or, preferably, heterologous expression of the nucleic acids takes place. Preferred transgenic plants are mentioned herein.</p><heading id="h0032"><u>Transformation</u></heading><p id="p0088" num="0088">The term "introduction" or "transformation" as referred to herein encompasses the transfer of an exogenous polynucleotide into a host cell, irrespective of the method used for transfer. Plant tissue capable of subsequent clonal propagation, whether by organogenesis or embryogenesis,<!-- EPO <DP n="32"> --> may be transformed with a genetic construct as described herein and a whole plant regenerated there from. The particular tissue chosen will vary depending on the clonal propagation systems available for, and best suited to, the particular species being transformed. Exemplary tissue targets include leaf disks, pollen, embryos, cotyledons, hypocotyls, megagametophytes, callus tissue, existing meristematic tissue (e.g., apical meristem, axillary buds, and root meristems), and induced meristem tissue (e.g., cotyledon meristem and hypocotyl meristem). The polynucleotide may be transiently or stably introduced into a host cell and may be maintained non-integrated, for example, as a plasmid. Alternatively, it may be integrated into the host genome. The resulting transformed plant cell may then be used to regenerate a transformed plant in a manner known to persons skilled in the art.</p><p id="p0089" num="0089">The transfer of foreign genes into the genome of a plant is called transformation. Transformation of plant species is now a fairly routine technique. Advantageously, any of several transformation methods may be used to introduce the gene of interest into a suitable ancestor cell. The methods described for the transformation and regeneration of plants from plant tissues or plant cells may be utilized for transient or for stable transformation. Transformation methods include the use of liposomes, electroporation, chemicals that increase free DNA uptake, injection of the DNA directly into the plant, particle gun bombardment, transformation using viruses or pollen and microprojection. Methods may be selected from the calcium/polyethylene glycol method for protoplasts (<nplcit id="ncit0113" npl-type="s"><text>Krens, F.A. et al., (1982) Nature 296, 72-74</text></nplcit>; <nplcit id="ncit0114" npl-type="s"><text>Negrutiu I et al. (1987) Plant Mol Biol 8: 363-373</text></nplcit>); electroporation of protoplasts (<nplcit id="ncit0115" npl-type="s"><text>Shillito R.D. et al. (1985) Bio/Technol 3, 1099-1102</text></nplcit>); microinjection into plant material (<nplcit id="ncit0116" npl-type="s"><text>Crossway A et al., (1986) Mol. Gen Genet 202: 179-185</text></nplcit>); DNA or RNA-coated particle bombardment (<nplcit id="ncit0117" npl-type="s"><text>Klein TM et al., (1987) Nature 327: 70</text></nplcit>) infection with (non-integrative) viruses and the like. Transgenic plants, including transgenic crop plants, are preferably produced via <i>Agrobacterium-</i>mediated transformation. An advantageous transformation method is the transformation <i>in planta.</i> To this end, it is possible, for example, to allow the agrobacteria to act on plant seeds or to inoculate the plant meristem with agrobacteria. It has proved particularly expedient as described herein to allow a suspension of transformed agrobacteria to act on the intact plant or at least on the flower primordia. The plant is subsequently grown on until the seeds of the treated plant are obtained (<nplcit id="ncit0118" npl-type="s"><text>Clough and Bent, Plant J. (1998) 16, 735-743</text></nplcit>). Methods for <i>Agrobacterium-</i>mediated transformation of rice include well known methods for rice transformation, such as those described in any of the following: European patent application <patcit id="pcit0035" dnum="EP1198985A1"><text>EP 1198985 A1</text></patcit>, <nplcit id="ncit0119" npl-type="s"><text>Aldemita and Hodges (Planta 199: 612-617, 1996</text></nplcit>); <nplcit id="ncit0120" npl-type="s"><text>Chan et al. (Plant Mol Biol 22 (3): 491-506, 1993</text></nplcit>), <nplcit id="ncit0121" npl-type="s"><text>Hiei et al. (Plant J 6 (2): 271-282, 1994</text></nplcit>), which disclosures are incorporated by reference herein as if fully set forth. In<!-- EPO <DP n="33"> --> the case of corn transformation, the preferred method is as described in either <nplcit id="ncit0122" npl-type="s"><text>Ishida et al. (Nat. Biotechnol 14(6): 745-50, 1996</text></nplcit>) or <nplcit id="ncit0123" npl-type="s"><text>Frame et al. (Plant Physiol 129(1): 13-22, 2002</text></nplcit>), which disclosures are incorporated by reference herein as if fully set forth. Said methods are further described by way of example in <nplcit id="ncit0124" npl-type="b"><text>B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, eds. S.D. Kung and R. Wu, Academic Press (1993) 128-143</text></nplcit> and in <nplcit id="ncit0125" npl-type="s"><text>Potrykus Annu. Rev. Plant Physiol. Plant Molec. Biol. 42 (1991) 205-225</text></nplcit>). The nucleic acids or the construct to be expressed is preferably cloned into a vector, which is suitable for transforming <i>Agrobacterium tumefaciens,</i> for example pBin19 (<nplcit id="ncit0126" npl-type="s"><text>Bevan et al., Nucl. Acids Res. 12 (1984) 8711</text></nplcit>). Agrobacteria transformed by such a vector can then be used in known manner for the transformation of plants, such as plants used as a model, like <i>Arabidopsis</i> (<i>Arabidopsis thaliana</i> is not considered as a crop plant), or crop plants such as, by way of example, tobacco plants, for example by immersing bruised leaves or chopped leaves in an agrobacterial solution and then culturing them in suitable media. The transformation of plants by means of <i>Agrobacterium tumefaciens</i> is described, for example, by<nplcit id="ncit0127" npl-type="s"><text> Höfgen and Willmitzer in Nucl. Acid Res. (1988) 16, 9877 </text></nplcit>or is known inter alia from<nplcit id="ncit0128" npl-type="b"><text> F.F. White, Vectors for Gene Transfer in Higher Plants; in Transgenic Plants, Vol. 1, Engineering and Utilization, eds. S.D. Kung and R. Wu, Academic Press, 1993, pp. 15-38</text></nplcit>.</p><p id="p0090" num="0090">In addition to the transformation of somatic cells, which then have to be regenerated into intact plants, it is also possible to transform the cells of plant meristems and in particular those cells which develop into gametes. In this case, the transformed gametes follow the natural plant development, giving rise to transgenic plants. Thus, for example, seeds of <i>Arabidopsis</i> are treated with agrobacteria and seeds are obtained from the developing plants of which a certain proportion is transformed and thus transgenic [<nplcit id="ncit0129" npl-type="s"><text>Feldman, KA and Marks MD (1987). Mol Gen Genet 208:274-289</text></nplcit>; <nplcit id="ncit0130" npl-type="b"><text>Feldmann K (1992). In: C Koncz, N-H Chua and J Shell, eds, Methods in Arabidopsis Research. Word Scientific, Singapore, pp. 274-289</text></nplcit>]. Alternative methods are based on the repeated removal of the inflorescences and incubation of the excision site in the center of the rosette with transformed agrobacteria, whereby transformed seeds can likewise be obtained at a later point in time (<nplcit id="ncit0131" npl-type="s"><text>Chang (1994). Plant J. 5: 551-558</text></nplcit>; <nplcit id="ncit0132" npl-type="s"><text>Katavic (1994). Mol Gen Genet, 245: 363-370</text></nplcit>). However, an especially effective method is the vacuum infiltration method with its modifications such as the "floral dip" method. In the case of vacuum infiltration of <i>Arabidopsis,</i> intact plants under reduced pressure are treated with an agrobacterial suspension [<nplcit id="ncit0133" npl-type="s"><text>Bechthold, N (1993). C R Acad Sci Paris Life Sci, 316: 1194-1199</text></nplcit>], while in the case of the "floral dip" method the developing floral tissue is incubated briefly with a surfactant-treated agrobacterial suspension [<nplcit id="ncit0134" npl-type="s"><text>Clough, SJ and Bent AF (1998) The Plant J. 16, 735-743</text></nplcit>]. A certain proportion of transgenic seeds are harvested in both cases, and these seeds can be<!-- EPO <DP n="34"> --> distinguished from non-transgenic seeds by growing under the above-described selective conditions. In addition the stable transformation of plastids is of advantages because plastids are inherited maternally is most crops reducing or eliminating the risk of transgene flow through pollen. The transformation of the chloroplast genome is generally achieved by a process which has been schematically displayed in <nplcit id="ncit0135" npl-type="s"><text>Klaus et al., 2004 [Nature Biotechnology 22 (2), 225-229</text></nplcit>]. Briefly the sequences to be transformed are cloned together with a selectable marker gene between flanking sequences homologous to the chloroplast genome. These homologous flanking sequences direct site specific integration into the plastome. Plastidal transformation has been described for many different plant species and an overview is given in<nplcit id="ncit0136" npl-type="s"><text> Bock (2001) Transgenic plastids in basic research and plant biotechnology. J Mol Biol. 2001 Sep 21; 312 (3):425-38</text></nplcit> or <nplcit id="ncit0137" npl-type="s"><text>Maliga, P (2003) Progress towards commercialization of plastid transformation technology. Trends Biotechnol. 21, 20-28</text></nplcit>. Further biotechnological progress has recently been reported in form of marker free plastid transformants, which can be produced by a transient co-integrated maker gene (<nplcit id="ncit0138" npl-type="s"><text>Klaus et al., 2004, Nature Biotechnology 22(2), 225-229</text></nplcit>).</p><heading id="h0033"><u>T-DNA activation tagging</u></heading><p id="p0091" num="0091">T-DNA activation tagging (Hayashi et al. Science (1992) 1350-1353), involves insertion of T-DNA, usually containing a promoter (may also be a translation enhancer or an intron), in the genomic region of the gene of interest or 10 kb up- or downstream of the coding region of a gene in a configuration such that the promoter directs expression of the targeted gene. Typically, regulation of expression of the targeted gene by its natural promoter is disrupted and the gene falls under the control of the newly introduced promoter. The promoter is typically embedded in a T-DNA. This T-DNA is randomly inserted into the plant genome, for example, through <i>Agrobacterium</i> infection and leads to modified expression of genes near the inserted T-DNA. The resulting transgenic plants show dominant phenotypes due to modified expression of genes close to the introduced promoter.</p><heading id="h0034"><u>TILLING</u></heading><p id="p0092" num="0092">The term "TILLING" is an abbreviation of "Targeted Induced Local Lesions In Genomes" and refers to a mutagenesis technology useful to generate and/or identify nucleic acids encoding proteins with modified expression and/or activity. TILLING also allows selection of plants carrying such mutant variants. These mutant variants may exhibit modified expression, either in strength or in location or in timing (if the mutations affect the promoter for example). These mutant variants may exhibit higher activity than that exhibited by the gene in its natural form. TILLING combines high-density mutagenesis with high-throughput screening methods. The steps typically followed in TILLING are: (a) EMS mutagenesis (<nplcit id="ncit0139" npl-type="b"><text>Redei GP and Koncz C (1992) In Methods in Arabidopsis Research, Koncz C, Chua NH, Schell J, eds. Singapore, World<!-- EPO <DP n="35"> --> Scientific Publishing Co, pp. 16-82</text></nplcit>;<nplcit id="ncit0140" npl-type="b"><text> Feldmann et al., (1994) In Meyerowitz EM, Somerville CR, eds, Arabidopsis. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp 137-172</text></nplcit>; <nplcit id="ncit0141" npl-type="b"><text>Lightner J and Caspar T (1998) In J Martinez-Zapater, J Salinas, eds, Methods on Molecular Biology, Vol. 82. Humana Press, Totowa, NJ, pp 91-104</text></nplcit>); (b) DNA preparation and pooling of individuals; (c) PCR amplification of a region of interest; (d) denaturation and annealing to allow formation of heteroduplexes; (e) DHPLC, where the presence of a heteroduplex in a pool is detected as an extra peak in the chromatogram; (f) identification of the mutant individual; and (g) sequencing of the mutant PCR product. Methods for TILLING are well known in the art (<nplcit id="ncit0142" npl-type="s"><text>McCallum et al., (2000) Nat Biotechnol 18: 455-457</text></nplcit>; reviewed by <nplcit id="ncit0143" npl-type="s"><text>Stemple (2004) Nat Rev Genet 5(2): 145-50</text></nplcit>).</p><heading id="h0035"><u>Homologous recombination</u></heading><p id="p0093" num="0093">Homologous recombination allows introduction in a genome of a selected nucleic acid at a defined selected position. Homologous recombination is a standard technology used routinely in biological sciences for lower organisms such as yeast or the moss <i>Physcomitrella.</i> Methods for performing homologous recombination in plants have been described not only for model plants (<nplcit id="ncit0144" npl-type="s"><text>Offringa et al. (1990) EMBO J 9(10): 3077-84</text></nplcit>) but also for crop plants, for example rice (<nplcit id="ncit0145" npl-type="s"><text>Terada et al. (2002) Nat Biotech 20(10): 1030-4</text></nplcit>; <nplcit id="ncit0146" npl-type="s"><text>lida and Terada (2004) Curr Opin Biotech 15(2): 132-8</text></nplcit>).</p><heading id="h0036"><u>Yield</u></heading><p id="p0094" num="0094">The term "yield" in general means a measurable produce of economic value, typically related to a specified crop, to an area, and to a period of time. Individual plant parts directly contribute to yield based on their number, size and/or weight, or the actual yield is the yield per square meter for a crop and year, which is determined by dividing total production (includes both harvested and appraised production) by planted square meters. The term "yield" of a plant may relate to vegetative biomass (root and/or shoot biomass), to reproductive organs, and/or to propagules (such as seeds) of that plant.</p><heading id="h0037"><u>Early vigour</u></heading><p id="p0095" num="0095">"Early vigour" refers to active healthy well-balanced growth especially during early stages of plant growth, and may result from increased plant fitness due to, for example, the plants being better adapted to their environment (i.e. optimizing the use of energy resources and partitioning between shoot and root). Plants having early vigour also show increased seedling survival and a better establishment of the crop, which often results in highly uniform fields (with the crop growing in uniform manner, i.e. with the majority of plants reaching the various stages of development at substantially the same time), and often better and higher yield. Therefore,<!-- EPO <DP n="36"> --> early vigour may be determined by measuring various factors, such as thousand kernel weight, percentage germination, percentage emergence, seedling growth, seedling height, root length, root and shoot biomass and many more.</p><heading id="h0038"><u>Increase/Improve/Enhance</u></heading><p id="p0096" num="0096">The terms "increase", "improve" or "enhance" are interchangeable and shall mean in the sense of the application at least a 3%, 4%, 5%, 6%, 7%, 8%, 9% or 10%, preferably at least 15% or 20%, more preferably 25%, 30%, 35% or 40% more yield and/or growth in comparison to control plants as defined herein.</p><heading id="h0039"><u>Seed yield</u></heading><p id="p0097" num="0097">Increased seed yield may manifest itself as one or more of the following: a) an increase in seed biomass (total seed weight) which may be on an individual seed basis and/or per plant and/or per square meter; b) increased number of flowers per plant; c) increased number of (filled) seeds; d) increased seed filling rate (which is expressed as the ratio between the number of filled seeds divided by the total number of seeds); e) increased harvest index, which is expressed as a ratio of the yield of harvestable parts, such as seeds, divided by the total biomass; and f) increased thousand kernel weight (TKW), which is extrapolated from the number of filled seeds counted and their total weight. An increased TKW may result from an increased seed size and/or seed weight, and may also result from an increase in embryo and/or endosperm size.</p><p id="p0098" num="0098">An increase in seed yield may also be manifested as an increase in seed size and/or seed volume. Furthermore, an increase in seed yield may also manifest itself as an increase in seed area and/or seed length and/or seed width and/or seed perimeter. Increased yield may also result in modified architecture, or may occur because of modified architecture.</p><heading id="h0040"><u>Greenness Index</u></heading><p id="p0099" num="0099">The "greenness index" as used herein is calculated from digital images of plants. For each pixel belonging to the plant object on the image, the ratio of the green value versus the red value (in the RGB model for encoding color) is calculated. The greenness index is expressed as the percentage of pixels for which the green-to-red ratio exceeds a given threshold. Under normal growth conditions, under salt stress growth conditions, and under reduced nutrient availability growth conditions, the greenness index of plants is measured in the last imaging before flowering. In contrast, under drought stress growth conditions, the greenness index of plants is measured in the first imaging after drought.<!-- EPO <DP n="37"> --></p><heading id="h0041"><u>Plant</u></heading><p id="p0100" num="0100">The term "plant" as used herein encompasses whole plants, ancestors and progeny of the plants and plant parts, including seeds, shoots, stems, leaves, roots (including tubers), flowers, and tissues and organs, wherein each of the aforementioned comprise the gene/nucleic acid of interest. The term "plant" also encompasses plant cells, suspension cultures, callus tissue, embryos, meristematic regions, gametophytes, sporophytes, pollen and microspores, again wherein each of the aforementioned comprises the gene/nucleic acid of interest.</p><p id="p0101" num="0101">Plants that are particularly useful in the methods of the invention include all plants which belong to the superfamily Viridiplantae, in particular monocotyledonous and dicotyledonous plants including fodder or forage legumes, ornamental plants, food crops, trees or shrubs selected from the list comprising <i>Acer</i> spp., <i>Actinidia</i> spp., <i>Abelmoschus</i> spp., <i>Agave sisalana, Agropyron</i> spp., <i>Agrostis stolonifera, Allium</i> spp., <i>Amaranthus</i> spp., <i>Ammophila arenaria, Ananas comosus, Annona</i> spp., <i>Apium graveolens, Arachis spp, Artocarpus</i> spp., <i>Asparagus officinalis, Avena</i> spp. <i>(e.g. Avena sativa, Avena fatua, Avena byzantina, Avena fatua var. sativa, Avena hybrida), Averrhoa carambola, Bambusa sp., Benincasa hispida, Bertholletia excelsea, Beta vulgaris, Brassica</i> spp. <i>(e.g. Brassica napus, Brassica rapa</i> ssp. [canola, oilseed rape, turnip rape]), <i>Cadaba farinosa, Camellia sinensis, Canna indica, Cannabis sativa, Capsicum</i> spp., <i>Carex elata, Carica papaya, Carissa macrocarpa, Carya</i> spp., <i>Carthamus tinctorius, Castanea</i> spp., <i>Ceiba pentandra, Cichorium endivia, Cinnamomum</i> spp., <i>Citrullus lanatus, Citrus</i> spp., <i>Cocos</i> spp., <i>Coffea</i> spp., <i>Colocasia esculenta, Cola</i> spp., <i>Corchorus sp., Coriandrum sativum, Corylus</i> spp., <i>Crataegus</i> spp., <i>Crocus sativus, Cucurbita</i> spp., <i>Cucumis</i> spp., <i>Cynara</i> spp., <i>Daucus carota, Desmodium</i> spp., <i>Dimocarpus longan, Dioscorea</i> spp., <i>Diospyros</i> spp., <i>Echinochloa</i> spp., <i>Elaeis (e.g. Elaeis guineensis, Elaeis oleifera), Eleusine coracana, Erianthus sp., Eriobotrya japonica, Eucalyptus sp., Eugenia uniflora, Fagopyrum</i> spp., <i>Fagus</i> spp., <i>Festuca arundinacea, Ficus carica, Fortunella</i> spp., <i>Fragaria</i> spp., <i>Ginkgo biloba, Glycine</i> spp. <i>(e.g. Glycine max, Soja hispida or Soja max), Gossypium hirsutum, Helianthus</i> spp. <i>(e.g. Helianthus annuus), Hemerocallis fulva, Hibiscus</i> spp., <i>Hordeum</i> spp. <i>(e.g. Hordeum vulgare), Ipomoea batatas, Juglans</i> spp., <i>Lactuca sativa, Lathyrus</i> spp., <i>Lens culinaris, Linum usitatissimum, Litchi chinensis, Lotus</i> spp., <i>Luffa acutangula, Lupinus</i> spp., <i>Luzula sylvatica, Lycopersicon</i> spp. <i>(e.g. Lycopersicon esculentum, Lycopersicon lycopersicum, Lycopersicon pyriforme), Macrotyloma</i> spp., <i>Malus</i> spp., <i>Malpighia emarginata, Mammea americana, Mangifera indica, Manihot</i> spp., <i>Manilkara zapota, Medicago sativa, Melilotus</i> spp., <i>Mentha</i> spp., <i>Miscanthus sinensis, Momordica</i> spp., <i>Morus nigra, Musa</i> spp., <i>Nicotiana</i> spp., <i>Olea</i> spp., <i>Opuntia</i> spp., <i>Ornithopus</i> spp., <i>Oryza</i> spp. <i>(e.g. Oryza sativa, Oryza latifolia), Panicum miliaceum, Panicum virgatum, Passiflora edulis, Pastinaca sativa, Pennisetum sp., Persea</i> spp., <i>Petroselinum crispum, Phalaris arundinacea, Phaseolus</i> spp.,<!-- EPO <DP n="38"> --> <i>Phleum pratense, Phoenix</i> spp., <i>Phragmites australis, Physalis</i> spp., <i>Pinus</i> spp., <i>Pistacia vera, Pisum</i> spp., <i>Poa</i> spp., <i>Populus</i> spp., <i>Prosopis</i> spp., <i>Prunus</i> spp., <i>Psidium</i> spp., <i>Punica granatum, Pyrus communis, Quercus</i> spp., <i>Raphanus sativus, Rheum rhabarbarum, Ribes</i> spp., <i>Ricinus communis, Rubus</i> spp., <i>Saccharum</i> spp., <i>Salix sp., Sambucus</i> spp., <i>Secale cereale, Sesamum</i> spp., <i>Sinapis sp., Solanum</i> spp. <i>(e.g. Solanum tuberosum, Solanum integrifolium or Solanum lycopersicum), Sorghum bicolor, Spinacia</i> spp., <i>Syzygium</i> spp., <i>Tagetes</i> spp., <i>Tamarindus indica, Theobroma cacao, Trifolium</i> spp., <i>Triticosecale rimpaui, Triticum</i> spp. <i>(e.g. Triticum aestivum, Triticum durum, Triticum turgidum, Triticum hybernum, Triticum macha, Triticum sativum or Triticum vulgare), Tropaeolum minus, Tropaeolum majus, Vaccinium</i> spp., <i>Vicia</i> spp., <i>Vigna</i> spp., <i>Viola odorata, Vitis</i> spp., <i>Zea mays, Zizania palustris, Ziziphus</i> spp., amongst others.</p><heading id="h0042"><b>Detailed description</b></heading><heading id="h0043"><b>Detailed description for the Ankyrin - Zn finger polypeptide</b></heading><p id="p0102" num="0102">Surprisingly, the specificiation describes that modulating expression in a plant of a nucleic acid encoding the AZ polypeptide from <i>Arabidopsis</i> (AtAZ) or a homologue thereof gives plants having increased yield relative to control plants. According to one embodiment of the present invention, the specificiation describes a method for increasing plant yield, comprising modulating expression in a plant of a nucleic acid encoding the AZ polypeptide or a homologue thereof. Advantageously, performance of the methods according to the present specification results in plants having increased yield, particularly seed yield, relative to corresponding wild type plants.</p><p id="p0103" num="0103">A "reference", "reference plant", "control", "control plant", "wild type" or "wild type plant" is in particular a cell, a tissue, an organ, a plant, or a part thereof, which was not produced according to the method as described herein. Accordingly, the terms "wild type", "control" or "reference" are exchangeable and can be a cell or a part of the plant such as an organelle or tissue, or a plant, which was not modified or treated according to the herein described method. Accordingly, the cell or a part of the plant such as an organelle or a plant used as wild type, control or reference corresponds to the cell, plant or part thereof as much as possible and is in any other property but in the result of the process as described herein as identical to the subject matter as described herein as possible. Thus, the wild type, control or reference is treated identically or as identical as possible, saying that only conditions or properties might be different which do not influence the quality of the tested property. That means in other words that the wild type denotes (1) a plant, which carries the unaltered or not modulated form of a gene or allele or (2)<!-- EPO <DP n="39"> --> the starting material/plant from which the plants produced by the process or method as described herein are derived.</p><p id="p0104" num="0104">Preferably, any comparison between the wild type plants and the plants produced by the method of the invention is carried out under analogous conditions. The term "analogous conditions" means that all conditions such as, for example, culture or growing conditions, assay conditions (such as buffer composition, temperature, substrates, pathogen strain, concentrations and the like) are kept identical between the experiments to be compared.</p><p id="p0105" num="0105">The "reference", "control", or "wild type" is preferably a subject, e.g. an organelle, a cell, a tissue, a plant, which was not modulated, modified or treated according to the herein described process as described herein and is in any other property as similar to the subject matter as described herein as possible. The reference, control or wild type is in its genome, transcriptome, proteome or metabolome as similar as possible to the subject as described herein. Preferably, the term "reference-" "control-" or "wild type-"-organelle, -cell, -tissue or plant, relates to an organelle, cell, tissue or plant, which is nearly genetically identical to the organelle, cell, tissue or plant, as described herein or a part thereof preferably 95%, more preferred are 98%, even more preferred are 99,00%, in particular 99,10%, 99,30%, 99,50%, 99,70%, 99,90%, 99,99%, 99, 999% or more. Most preferably the "reference", "control", or "wild type" is a subject, e.g. an organelle, a cell, a tissue, a plant, which is genetically identical to the plant, cell organelle used according to the method as described herein except that nucleic acid molecules or the gene product encoded by them are changed, modulated or modified according to the inventive method.</p><p id="p0106" num="0106">The term "expression" or "gene expression" is as defined herein, preferably it results in the appearance of a phenotypic trait as a consequence of the transcription of a specific gene or specific genes.</p><p id="p0107" num="0107">The increase referring to the activity of the polypeptide amounts in a cell, a tissue, a organelle, an organ or an organism or a part thereof preferably to at least 5%, preferably to at least 10% or at to least 15%, especially preferably to at least 20%, 25%, 30% or more, very especially preferably are to at least 40%, 50% or 60%, most preferably are to at least 70% or more in comparison to the control, reference or wild type.</p><p id="p0108" num="0108">The term "increased yield" as defined herein is taken to mean an increase in biomass (weight) of one or more parts of a plant, which may include aboveground (harvestable) parts and/or<!-- EPO <DP n="40"> --> (harvestable) parts below ground. In a preferred embodiment, the increased yield is increased seed yield.</p><p id="p0109" num="0109">Therefore, such harvestable parts are preferably seeds, and performance of the methods of the invention results in plants having increased seed yield relative to the seed yield of control plants.</p><p id="p0110" num="0110">An increase in seed yield may also be manifested as an increase in seed size and/or seed volume, which may also influence the composition of seeds (including oil, protein and carbohydrate total content and composition).</p><p id="p0111" num="0111">Taking corn as an example, a yield increase may be manifested as one or more of the following: increase in the number of plants per square meter, an increase in the number of ears per plant, an increase in the number of rows, number of kernels per row, kernel weight, thousand kernel weight, ear length/diameter, increase in seed filling rate (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), among others. Taking rice as an example, a yield increase may be manifested by an increase in one or more of the following: number of plants per square meter, number of panicles per plant, number of spikelets per panicle, number of flowers (florets) per panicle (which is expressed as a ratio of the number of filled seeds over the number of primary panicles), increase in the seed filling rate, (which is the number of filled seeds divided by the total number of seeds and multiplied by 100), increase in thousand kernel weight, among others. An increase in yield may also result in modified architecture, or may occur as a result of modified architecture.</p><p id="p0112" num="0112">According to the specification, performance of the methods of the invention result in plants having increased yield, particularly seed yield. Therefore, according to the present specification, there is provided a method for increasing plant yield, which method comprises modulating expression in a plant of a nucleic acid encoding the AZ polypeptide or a homologue thereof.</p><p id="p0113" num="0113">Since the transgenic plants as described herein have increased yield, it is likely that these plants exhibit an increased growth rate (during at least part of their life cycle), relative to the growth rate of control plants at a corresponding stage in their life cycle. The increased growth rate may be specific to one or more parts of a plant (including seeds), or may be throughout substantially the whole plant. Plants having an increased growth rate may have a shorter life cycle. The life cycle of a plant may be taken to mean the time needed to grow from a dry mature seed up to the stage where the plant has produced dry<!-- EPO <DP n="41"> --> mature seeds, similar to the starting material. This life cycle may be influenced by factors such as early vigour, growth rate, greenness index, flowering time and speed of seed maturation. The increase in growth rate may take place at one or more stages in the life cycle of a plant or during substantially the whole plant life cycle. Increased growth rate during the early stages in the life cycle of a plant may reflect enhanced vigour. The increase in growth rate may alter the harvest cycle of a plant allowing plants to be sown later and/or harvested sooner than would otherwise be possible (a similar effect may be obtained with earlier flowering time). If the growth rate is sufficiently increased, it may allow for the further sowing of seeds of the same plant species (for example sowing and harvesting of rice plants followed by sowing and harvesting of further rice plants all within one conventional growing period). Similarly, if the growth rate is sufficiently increased, it may allow for the further sowing of seeds of different plants species (for example the planting and harvesting of corn plants followed by, for example, the planting and optional harvesting of soy bean, potato or any other suitable plant). Harvesting additional times from the same rootstock in the case of some crop plants may also be possible. Altering the harvest cycle of a plant may lead to an increase in annual biomass production per square meter (due to an increase in the number of times (say in a year) that any particular plant may be grown and harvested). An increase in growth rate may also allow for the cultivation of transgenic plants in a wider geographical area than their wild-type counterparts, since the territorial limitations for growing a crop are often determined by adverse environmental conditions either at the time of planting (early season) or at the time of harvesting (late season). Such adverse conditions may be avoided if the harvest cycle is shortened. The growth rate may be determined by deriving various parameters from growth curves, such parameters may be: T-Mid (the time taken for plants to reach 50% of their maximal size) and T-90 (time taken for plants to reach 90% of their maximal size), amongst others.</p><p id="p0114" num="0114">According to a preferred feature of the present specification, performance of the methods of the invention gives plants having an increased growth rate or increased yield in comparison to control plants. Therefore, according to the present specification, there is provided a method for increasing yield and/or growth rate in plants, which method comprises modulating expression in a plant of a nucleic acid encoding the AZ polypeptide or a homologue thereof.</p><p id="p0115" num="0115">An increase in yield and/or growth rate occurs whether the plant is under non-stress conditions or whether the plant is exposed to various stresses compared to control plants. Plants typically respond to exposure to stress by growing more slowly. In conditions of severe stress, the plant may even stop growing altogether. Mild stress on the other hand is defined herein as being<!-- EPO <DP n="42"> --> any stress to which a plant is exposed which does not result in the plant ceasing to grow altogether without the capacity to resume growth. Mild stress as described herein leads to a reduction in the growth of the stressed plants of less than 40%, 35% or 30%, preferably less than 25%, 20% or 15%, more preferably less than 14%, 13%, 12%, 11 % or 10% or less in comparison to the control plant under non-stress conditions. Due to advances in agricultural practices (irrigation, fertilization, pesticide treatments) severe stresses are not often encountered in cultivated crop plants. As a consequence, the compromised growth induced by mild stress is often an undesirable feature for agriculture. Mild stresses are the everyday biotic and/or abiotic (environmental) stresses to which a plant is exposed. Abiotic stresses may be due to drought or excess water, anaerobic stress, salt stress, chemical toxicity, oxidative stress and hot, cold or freezing temperatures. The abiotic stress may be an osmotic stress caused by a water stress (particularly due to drought), salt stress, oxidative stress or an ionic stress. Biotic stresses are typically those stresses caused by pathogens, such as bacteria, viruses, fungi and insects.</p><p id="p0116" num="0116">In particular, the methods as described herein may be performed under non-stress conditions or under conditions of mild drought to give plants having increased yield relative to control plants. As reported in <nplcit id="ncit0147" npl-type="s"><text>Wang et al. (Planta (2003) 218: 1-14</text></nplcit>), abiotic stress leads to a series of morphological, physiological, biochemical and molecular changes that adversely affect plant growth and productivity. Drought, salinity, extreme temperatures and oxidative stress are known to be interconnected and may induce growth and cellular damage through similar mechanisms. <nplcit id="ncit0148" npl-type="s"><text>Rabbani et al. (Plant Physiol (2003) 133: 1755-1767</text></nplcit>) describes a particularly high degree of "cross talk" between drought stress and high-salinity stress. For example, drought and/or salinisation are manifested primarily as osmotic stress, resulting in the disruption of homeostasis and ion distribution in the cell. Oxidative stress, which frequently accompanies high or low temperature, salinity or drought stress, may cause denaturing of functional and structural proteins. As a consequence, these diverse environmental stresses often activate similar cell signaling pathways and cellular responses, such as the production of stress proteins, up-regulation of anti-oxidants, accumulation of compatible solutes and growth arrest. The term "non-stress" conditions as used herein are those environmental conditions that do not impose stress, such as the stresses described above, on plants. Non-stress conditions allow optimal growth of plants. Persons skilled in the art are aware of normal soil conditions and climatic conditions for a given location.</p><p id="p0117" num="0117">Performance of the methods as described herein gives plants grown under non-stress conditions or under mild drought conditions increased yield relative to control plants grown under comparable conditions. Therefore, according to the present specification,<!-- EPO <DP n="43"> --> there is provided a method for increasing yield in plants grown under non-stress conditions or under mild drought conditions, which method comprises increasing expression in a plant of a nucleic acid encoding a AZ polypeptide.</p><p id="p0118" num="0118">As described herein, the increase in yield and/or growth rate occurs according to the methods of the present specification under non-stress conditions.</p><p id="p0119" num="0119">Performance of the methods as described herein gives plants grown under conditions of nutrient deficiency, particularly under conditions of nitrogen deficiency, increased yield relative to control plants grown under comparable conditions. Therefore, according to the present specification, there is provided a method for increasing yield in plants grown under conditions of nutrient deficiency, which method comprises increasing expression in a plant of a nucleic acid encoding a AZ polypeptide. Nutrient deficiency may result from a lack of nutrients such as nitrogen, phosphates and other phosphorous-containing compounds, potassium, calcium, cadmium, magnesium, manganese, iron and boron, amongst others.</p><p id="p0120" num="0120">The methods as described herein are advantageously applicable to any plant. The abovementioned growth characteristics may advantageously be modified in any plant. Plants that are particularly useful in the methods as described herein include all plants which belong to the superfamily Viridiplantae, in particular monocotyledonous and dicotyledonous plants including fodder or forage legumes, ornamental plants, food crops, trees or shrubs. As described herein, the plant is a crop plant. Examples of crop plants include soybean, sunflower, canola, alfalfa, rapeseed, cotton, tomato, potato and tobacco. Further preferably, the plant is a monocotyledonous plant. Examples of monocotyledonous plants include sugarcane. More preferably the plant is a cereal. Examples of cereals include rice, maize, wheat, barley, millet, rye, triticale, sorghum and oats.</p><p id="p0121" num="0121">Other advantageous plants are selected from the group consisting of Asteraceae such as the genera <i>Helianthus, Tagetes</i> e.g. the species <i>Helianthus annuus</i> [sunflower], <i>Tagetes lucida, Tagetes erecta</i> or <i>Tagetes tenuifolia</i> [Marigold]; Brassicaceae such as the genus <i>Brassica,</i> e.g. the species <i>Brassica napus, Brassica rapa</i> ssp. [canola, oilseed rape, turnip rape]; Fabaceae such as the genera <i>Glycine</i> e.g. the species <i>Glycine max, Soja hispida</i> or <i>Soja max</i> [soybean]; Linaceae such as the genera <i>Linum</i> e.g. the species <i>Linum usitatissimum,</i> [flax, linseed]; Poaceae such as the genera <i>Hordeum, Secale, Avena, Sorghum, Oryza, Zea, Triticum</i> e.g. the species <i>Hordeum vulgare</i> [barley], <i>Secale cereale</i> [rye], <i>Avena sativa, Avena fatua, Avena<!-- EPO <DP n="44"> --> byzantina, Avena fatua</i> var. sativa, <i>Avena hybrida</i> [oat], <i>Sorghum bicolor</i> [sorghum, millet], <i>Oryza sativa, Oryza latifolia</i> [rice], <i>Zea mays</i> [corn, maize] <i>Triticum aestivum, Triticum durum, Triticum turgidum, Triticum hybernum, Triticum macha, Triticum sativum</i> or <i>Triticum vulgare</i> [wheat, bread wheat, common wheat]; Solanaceae such as the genera <i>Solanum, Lycopersicon</i> e.g. the species <i>Solanum tuberosum</i> [potato], <i>Lycopersicon esculentum, Lycopersicon lycopersicum, Lycopersicon pyriforme, Solanum integrifolium</i> or <i>Solanum lycopersicum</i> [tomato].</p><p id="p0122" num="0122">The term "AtAZ polypeptide or a homologue thereof" as defined herein refers to proteins that comprise at least one ankyrin repeat and at least one Zinc-finger C3H1 domain, which ankyrin repeat is located upstream of the C3H1 domain. Preferably, the AZ protein comprises two ankyrin repeats and two Zinc-finger C3H1 domains such as in the protein represented in SEQ ID NO: 2. Also preferably, the two ankyrin repeats are located close to each other. Further preferably, the Zinc-finger C3H1 domains are also located close to each other and C-terminally of the ankyrin repeats. In SEQ ID NO: 2, the ankyrin repeats are located on positions D90 to R120 and D125 to L157, the two Zn-finger domains are located on positions H301 to V327 and Q336 to P359 (<figref idrefs="f0001">Figure 1</figref>).</p><p id="p0123" num="0123">Also preferably, the AtAZ protein comprises at least one of the following consensus sequences:
<ul><li>(P/A)CSRAY(S/T)HDWTEC (motif 1, SEQ ID NO: 3)</li><li>HPGENARRRDPR (motif 2, SEQ ID NO: 4)</li><li>HG(V/I)FE(C/S)WLHP(A/S)QY(R/K)TRLCK (motif 3, SEQ ID NO: 5)</li><li>CFFAH (motif 4, SEQ ID NO: 6)</li></ul></p><p id="p0124" num="0124">Preferably motif 1 is PCSRAYSHDWTEC, and motif 3 is preferably HGVFECWLHPAQYRTRLCK.</p><p id="p0125" num="0125">More preferably, the AtAZ protein comprises two of the above-mentioned motifs, especially preferably 3 of the above-mentioned motifs, most preferably all four motifs.</p><p id="p0126" num="0126">The ankyrin repeat (SMART SM00248, Interpro IPR002110), as described in the Interpro database, is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are (usually tandemly) repeated modules of usually about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known<!-- EPO <DP n="45"> --> from several crystal and solution structures. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90° angle. The repeats stack together to form an L-shaped structure.</p><p id="p0127" num="0127">The Zinc-finger domain ZnF_C3H1 (also known as Znf_CCCH, SMART SM00356; Interpro IPR000571), as described in the Interpro database is thought to be involved in DNA-binding. Zinc fingers exist as different types, depending on the positions of the cysteine residues. Proteins containing zinc finger domains of the C-x8-C-x5-C-x3-H type (wherein x represents any amino acid and the digits 8, 5 and 3 represent the number of amino acids between the conserved C or H residues) include zinc finger proteins from eukaryotes involved in cell cycle or growth phase-related regulation, e.g. human TIS11B (butyrate response factor 1), a probable regulatory protein involved in regulating the response to growth factors, and the mouse TTP growth factor-inducible nuclear protein, which has the same function. The mouse TTP protein is induced by growth factors. Another protein containing this domain is the human splicing factor U2AF 35 kD subunit, which plays a critical role in both constitutive and enhancer-dependent splicing by mediating essential protein-protein interactions and protein-RNA interactions required for 3' splice site selection. It has been shown that different CCCH zinc finger proteins interact with the 3' untranslated region of various mRNA. This type of zinc finger is very often present in two copies.</p><p id="p0128" num="0128"><figref idrefs="f0001">Figure 2</figref> describes the consensus sequences as defined in the SMART database for the ankyrin domain and the zinc-finger domain; however it should be noted that these consensus sequences might be biased towards animal protein sequences.</p><p id="p0129" num="0129">The terms "domain" and "motif" are defined in the "definitions" section herein. Specialist databases exist for the identification of domains. The C3H1 or ankyrin domain in a AZ protein may be identified using, for example, SMART (<nplcit id="ncit0149" npl-type="s"><text>Schultz et al. (1998) Proc. Natl. Acad. Sci. USA 95, 5857-5864</text></nplcit>; <nplcit id="ncit0150" npl-type="s"><text>Letunic et al. (2002) Nucleic Acids Res 30, 242-244</text></nplcit>), InterPro (<nplcit id="ncit0151" npl-type="s"><text>Mulder et al., (2003) Nucl. Acids. Res. 31, 315-318</text></nplcit>), Prosite (<nplcit id="ncit0152" npl-type="b"><text>Bucher and Bairoch (1994), A generalized profile syntax for biomolecular sequences motifs and its function in automatic sequence interpretation. (In) ISMB-94; Proceedings 2nd International Conference on Intelligent Systems for Molecular Biology. Altman R., Brutlag D., Karp P., Lathrop R., Searls D., Eds., pp53-61, AAAIPress, Menlo Park</text></nplcit>; <nplcit id="ncit0153" npl-type="s"><text>Hulo et al., Nucl. Acids. Res. 32:D134-D137, (2004</text></nplcit>)) or Pfam (<nplcit id="ncit0154" npl-type="s"><text>Bateman et al., Nucleic Acids Research 30(1): 276-280 (2002</text></nplcit>)). A set of tools for in silico analysis of protein sequences is available on the ExPASY proteomics server (hosted by the Swiss Institute of Bioinformatics (<nplcit id="ncit0155" npl-type="s"><text>Gasteiger et al., ExPASy: the proteomics server for in-depth protein knowledge and analysis, Nucleic Acids Res. 31:3784-3788(2003</text></nplcit>)). The AZ protein<!-- EPO <DP n="46"> --> sequence was analysed with the SMART tool (version 4.1; <nplcit id="ncit0156" npl-type="s"><text>Schultz et al. (1998) Proc. Natl. Acad. Sci. USA 95, 5857-5864</text></nplcit>; <nplcit id="ncit0157" npl-type="s"><text>Letunic et al. (2002) Nucleic Acids Res 30, 242-244</text></nplcit>) and was used to screen the Pfam (Version 17.0, March 2005; <nplcit id="ncit0158" npl-type="s"><text>Bateman et al. (2004) Nucl. Acids Res. 32, D138-141</text></nplcit>) and InterPro database (Release 11.0, 26 July 2005; <nplcit id="ncit0159" npl-type="s"><text>Mulder et al. (2005) Nucl. Acids. Res. 33, D201-205</text></nplcit>).</p><p id="p0130" num="0130">By aligning other protein sequences with SEQ ID NO: 2, the corresponding consensus sequences, the C3H1 domain, the ankyrin domain or other sequence motifs may easily be identified. In this way, AZ polypeptides or homologues thereof (encompassing orthologues and paralogues) may readily be identified, using routine techniques well known in the art, such as by sequence alignment. Methods for the alignment of sequences for comparison are well known in the art, such methods include GAP, BESTFIT, BLAST, FASTA and TFASTA. GAP uses the algorithm of <nplcit id="ncit0160" npl-type="s"><text>Needleman and Wunsch ((1970) J Mol Biol 48: 443-453</text></nplcit>) to find the alignment of two complete sequences that maximizes the number of matches and minimizes the number of gaps. The BLAST algorithm (<nplcit id="ncit0161" npl-type="s"><text>Altschul et al. (1990) J Mol Biol 215: 403-10</text></nplcit>) calculates percent sequence identity and performs a statistical analysis of the similarity between the two sequences. The software for performing BLAST analysis is publicly available through the National Centre for Biotechnology Information. Homologues may readily be identified using, for example, the ClustalW multiple sequence alignment algorithm (version 1.83), with the default pairwise alignment parameters, and a scoring method in percentage. Global percentages of similarity and identity may also be determined using one of the methods available in the MatGAT software package (<nplcit id="ncit0162" npl-type="s"><text>Campanella et al., BMC Bioinformatics. 2003 Jul 10;4:29. MatGAT: an application that generates similarity/identity matrices using protein or DNA sequences</text></nplcit>.). Minor manual editing may be performed to optimise alignment between conserved motifs, as would be apparent to a person skilled in the art. Furthermore, instead of using full-length sequences for the identification of homologues, specific domains (such as the C3H1 or ankyrin domain, or one of the motifs defined above) may be used as well. The sequence identity values, which are indicated below as a percentage were determined over the entire conserved domain or nucleic acid or amino acid sequence using the programs mentioned above using the default parameters.</p><p id="p0131" num="0131">Examples of AZ proteins or homologues thereof are given in Table A of Example 1.</p><p id="p0132" num="0132">Sequences falling under the definition of "AZ polypeptide or homologue thereof" are<!-- EPO <DP n="47"> --> as defined in claim 1 and preferably comprise also at least one of the consensus sequence of SEQ ID NO: 3, 4, 5 or 6 as defined above, may be suitable for use in the methods of the invention. Preferably, the polypeptide is a polypeptide from <i>Arabidopsis thaliana.</i></p><p id="p0133" num="0133">Encompassed by the term "homologues" are orthologous sequences and paralogous sequences. Orthologues and paralogues may be found by performing a so-called reciprocal blast search. This may be done by a first BLAST involving BLASTing a query sequence (for example, SEQ ID NO: 1 or SEQ ID NO: 2) against any sequence database, such as the publicly available NCBI database. BLASTN or TBLASTX (using standard default values) may be used when starting from a nucleotide sequence and BLASTP or TBLASTN (using standard default values) may be used when starting from a protein sequence. The BLAST results may optionally be filtered. The full-length sequences of either the filtered results or non-filtered results are then BLASTed back (second BLAST) against sequences from the organism from which the query sequence is derived (where the query sequence is SEQ ID NO: 1 or SEQ ID NO: 2, the second BLAST would therefore be against <i>Arabidopsis</i> sequences). The results of the first and second BLASTs are then compared. A paralogue is identified if a high-ranking hit from the second BLAST is from the same species as from which the query sequence is derived; an orthologue is identified if a high-ranking hit is not from the same species as from which the query sequence is derived. Preferred orthologues are orthologues of SEQ ID NO: 1 or SEQ ID NO: 2. High-ranking hits are those having a low E-value. The lower the E-value, the more significant the score (or in other words the lower the chance that the hit was found by chance). Computation of the E-value is well known in the art. In addition to E-values, comparisons are also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. Preferably the score is greater than 50, more preferably greater than 100; and preferably the E-value is less than e-5, more preferably less than e-6. In the case of large families, ClustalW may be used, followed by the generation of a neighbour joining tree, to help visualize clustering of related genes and to identify orthologues and paralogues. Examples of sequences orthologous to SEQ ID NO: 2 include SEQ ID NO: 11, SEQ ID NO: 15 and SEQ ID NO: 17. SEQ ID NO: 19 is an example of a paralogue of SEQ ID NO: 2.</p><p id="p0134" num="0134">The specification describes AZ proteins that have, besides at least one ankyrin repeat and at least one C3H1 domain, in increasing order of preference, at least 26%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% sequence identity to the protein of<!-- EPO <DP n="48"> --> SEQ ID NO: 2. The matrix shown in <figref idrefs="f0002 f0003">Figure 3</figref> (Matrix A) shows similarities and identities (in bold) over the full-length of various AZ proteins. In case only specific domains are compared, the identity or similarity may be higher among the different proteins (Matrix B: comparison of a Zn-finger domain sequence).</p><p id="p0135" num="0135">An assay may be carried out to determine AZ activity. DNA-binding activity and protein-protein interactions may readily be determined <i>in vitro</i> or <i>in vivo</i> using techniques well known in the art. Examples of <i>in vitro</i> assays for DNA binding activity include: gel retardation analysis or yeast one-hybrid assays. An example of an <i>in vitro</i> assay for protein-protein interactions is the yeast two-hybrid analysis (<nplcit id="ncit0163" npl-type="s"><text>Fields and Song (1989) Nature 340:245-6</text></nplcit>).</p><p id="p0136" num="0136">Furthermore, as described herein expression of the AZ protein or of a homologue thereof in plants, and in particular in rice, has the effect of increasing yield of the transgenic plant when compared to corresponding wild type plants, wherein increased yield comprises at least one of: total weight of seeds, total number of seeds and number of filled seeds.</p><p id="p0137" num="0137">An AZ polypeptide or homologue thereof as defined herein is encoded by an AZ nucleic acid/gene. Therefore the term "AZ nucleic acid/gene" as defined herein is any nucleic acid/gene encoding an AZ polypeptide or a homologue thereof as defined above. Examples of AZ nucleic acids include but are not limited to those represented in Table A of Example 1. AZ nucleic acids/genes and variants thereof may be suitable in practising the methods as described herein. Preferably, the variants of an AZ gene originate from <i>Arabidopsis thaliana.</i> Variant AZ nucleic acid/genes include portions of an AZ nucleic acid/gene, splice variants, allelic variants and/or nucleic acids capable of hybridising with an AZ nucleic acid/gene.</p><p id="p0138" num="0138">Reference herein to a "nucleic acid sequence" is taken to mean a polymeric form of a deoxyribonucleotide or a ribonucleotide polymer of any length, either double- or single-stranded, or analogues thereof, that has the essential characteristic of a natural ribonucleotide in that it can hybridise to nucleic acid sequences in a manner similar to naturally occurring polynucleotides.</p><p id="p0139" num="0139">The term portion as described herein refers to a piece of DNA encoding a polypeptide comprising at least one ankyrin repeat and at least one C3H1 Zn-finger domain. A portion may be prepared, for example, by making one or more deletions to an AZ nucleic acid. The portions may be used in isolated form or they may be fused to other coding (or non-coding) sequences in order to, for example, produce a protein that combines several activities. When fused to<!-- EPO <DP n="49"> --> other coding sequences, the resulting polypeptide produced upon translation may be bigger than that predicted for the AZ fragment. The portion is typically at least 500, 700 or 900 nucleotides in length, preferably at least 1100, 1300 or 1500 nucleotides in length, more preferably at least 1700, 1900 or 2100 nucleotides in length and most preferably at least 2300 or 2400 nucleotides in length. Preferably, the portion is a portion of a nucleic acid as represented in Table A of Example 1. Most preferably the portion of an AZ nucleic acid is as represented by SEQ ID NO: 1 or SEQ ID NO: 53.</p><p id="p0140" num="0140">The terms "fragment", "fragment of a sequence" or "part of a sequence" "portion" or "portion thereof" mean a truncated sequence of the original sequence referred to. The truncated sequence (nucleic acid or protein sequence) can vary widely in length; the minimum size being a sequence of sufficient size to provide a sequence with at least a comparable function and/or activity of the original sequence referred to or hybridising with the nucleic acid molecule as described herein or used in the process as described herein under stringent conditions, while the maximum size is not critical. In some applications, the maximum size usually is not substantially greater than that required to provide the desired activity and/or function(s) of the original sequence. A comparable function means at least 40%, 45% or 50%, preferably at least 60%, 70%, 80% or 90% or more of the function of the original sequence.</p><p id="p0141" num="0141">Another variant of an AZ nucleic acid/gene as defined herein is a nucleic acid capable of hybridising under reduced stringency conditions, preferably under stringent conditions, with an AZ nucleic acid/gene as hereinbefore defined or with a portion as hereinbefore defined. The hybridizing sequence is typically at least 300 nucleotides in length, preferably at least 400 nucleotides in length, more preferably at least 500 nucleotides in length and most preferably at least 600 nucleotides in length.</p><p id="p0142" num="0142">Preferably, the hybridising sequence is one that is capable of hybridising to a nucleic acid as represented by SEQ ID NO: 1, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, SEQ ID NO: 32, SEQ ID NO: 34, SEQ ID NO: 36, SEQ ID NO: 38, SEQ ID NO: 40, SEQ ID NO: 42 or SEQ ID NO: 53, or to a portion of any of the aforementioned sequences, a portion being defined as above. Most preferably the hybridising sequence is capable of hybridising to SEQ ID NO: 1, to SEQ ID NO: 53, or to portions (or probes) thereof. Methods for designing probes are well known in the art. Probes are generally less than 1000 bp, 900 bp, 800 bp, 700 bp, 600 bp in length, preferably less than 500 bp, 400 bp, 300 bp 200 bp or 100 bp in length. Commonly, probe lengths for DNA-DNA hybridizations such as<!-- EPO <DP n="50"> --> Southern blotting, vary between 100 and 500 bp, whereas the hybridizing region in probes for DNA-DNA hybridizations such as in PCR amplification generally are shorter than 50 but longer than 10 nucleotides, preferably they are 15, 20, 25, 30, 35, 40, 45 or 50 bp in length.</p><p id="p0143" num="0143">Also useful in the methods of the invention are nucleic acids encoding homologues (including orthologues or paralogues) of the amino acid sequence represented by SEQ ID NO: 2, or derivatives thereof.</p><p id="p0144" num="0144">Another nucleic acid variant useful in the methods as described herein is a splice variant encoding an AZ polypeptide as defined above. As described herein splice variants are splice variants of the nucleic acid encoding a polypeptide comprising at least on ankyrin repeat and at least one C3H1 domain. Preferably, the AZ polypeptide or the homologue thereof encoded by the splice variant has at least 26%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98% or 99% sequence identity to SEQ ID NO: 2. Further the specification describes splice variants represented by the nucleic acids represented in Table A of Example 1. For example, SEQ ID NO: 25 and SEQ ID NO: 47 are encoded by splice variants of the same gene. For example the splice variant represented by SEQ ID NO: 1 or SEQ ID NO: 53.</p><p id="p0145" num="0145">Another nucleic acid variant useful in the methods as described herein is an allelic variant of a nucleic acid encoding an AZ polypeptide as defined above. Preferably, the polypeptide encoded by the allelic variant is represented by the polypeptide sequences listed in Table A of Example 1. Most preferably, the allelic variant encoding the AZ polypeptide is represented by SEQ ID NO: 1.</p><p id="p0146" num="0146">A further nucleic acid variant useful in the methods as described herein is a nucleic acid variant obtained by gene shuffling. Furthermore, site-directed mutagenesis may be used to generate variants of AZ nucleic acids. Several methods are available to achieve site-directed mutagenesis; the most common being PCR based methods (<nplcit id="ncit0164" npl-type="b"><text>Current Protocols in Molecular Biology. Wiley Eds</text></nplcit>.).</p><p id="p0147" num="0147">Therefore, the specification describes a method for increasing yield and/or growth rate of a plant, comprising modulating expression in a plant of a variant of an AZ nucleic acid selected from:
<ol><li>(i) a portion of an AZ nucleic acid;</li><li>(ii) a nucleic acid hybridising to an AZ nucleic acid;</li><li>(iii) a splice variant of a nucleic acid encoding an AZ polypeptide;<!-- EPO <DP n="51"> --></li><li>(iv) an allelic variant of a nucleic acid encoding an AZ polypeptide; and</li><li>(v) a nucleic acid variant encoding an AZ polypeptide obtained by gene shuffling or site directed mutagenesis.</li></ol></p><p id="p0148" num="0148">The AZ nucleic acid or variant thereof as defined herein may be derived from any natural or artificial source. This nucleic acid may be modified from its native form in composition and/or genomic environment through deliberate human manipulation. The nucleic acid is preferably of plant origin, further preferably from a dicotyledonous species, further preferably from the family Brassicaceae, more preferably from <i>Arabidopsis thaliana.</i> Most preferably, the AZ nucleic acid is the <i>Arabidopsis thaliana</i> sequence represented by SEQ ID NO: 1, and the AZ amino acid sequence is as represented by SEQ ID NO: 2. Alternatively, the AZ nucleic acid represented by SEQ ID NO: 53 or the AZ amino acid sequence as represented by SEQ ID NO: 47 may also be useful in the methods of the present invention.</p><p id="p0149" num="0149">Any reference herein to an AZ polypeptide is therefore taken to mean an AZ protein as defined above. Any nucleic acid encoding such an AZ protein is suitable for use in the methods as described herein.</p><p id="p0150" num="0150">According to the present specification, modulated, preferably increased expression of the AZ nucleic acid or variant thereof is envisaged. Methods for increasing the expression of genes or gene products are well documented in the art. The expression of a nucleic acid sequence encoding an AZ polypeptide may be modulated by introducing a genetic modification, which may be introduced, for example, by any one (or more) of the following methods: T-DNA activation, TILLING, site-directed mutagenesis, directed evolution and homologous recombination or by introducing and expressing in a plant a nucleic acid encoding an AZ polypeptide or a homologue thereof. Following introduction of the genetic modification, there follows a step of selecting for modified expression of a nucleic acid encoding an AZ polypeptide or a homologue thereof, which modification in expression gives plants having increased yield. Also methods for decreasing the expression of genes or gene products are known in the art.</p><p id="p0151" num="0151">T-DNA activation is described above. A genetic modification may also be introduced in the locus of an AZ gene using the technique of TILLING (Targeted Induced Local Lesions In Genomes). The locus of a gene as defined herein is taken to mean a genomic region, which includes the gene of interest and 10 kb up- or down stream of the coding region. Site-directed mutagenesis may be used to generate variants of AZ nucleic acids. Several methods are available to achieve site-directed mutagenesis; the most common being PCR based methods<!-- EPO <DP n="52"> --> (<nplcit id="ncit0165" npl-type="b"><text>Current Protocols in Molecular Biology. Wiley Eds</text></nplcit>.). According to the present specification homologous recombination may be applied.</p><p id="p0152" num="0152">The specification describes a method for introducing a genetic modification is to introduce and express in a plant a nucleic acid encoding an AZ polypeptide or a homologue thereof, as defined above. The nucleic acid to be introduced into a plant may be a full-length nucleic acid or may be a portion or a hybridising sequence as hereinbefore defined.</p><p id="p0153" num="0153">The specification furthermore describes genetic constructs and vectors to facilitate introduction and/or expression of the nucleotide sequences useful in the methods as described herein.</p><p id="p0154" num="0154">Therefore, there is described a gene construct comprising:
<ol><li>(i) an AZ nucleic acid or variant thereof, as defined hereinabove;</li><li>(ii) one or more control sequences operably linked the nucleic acid sequence of (i);</li></ol></p><p id="p0155" num="0155">Constructs useful in the methods as described herein may be created using recombinant DNA technology well known to persons skilled in the art. The gene constructs may be inserted into vectors, which may be commercially available, suitable for transforming into plants and suitable for expression of the gene of interest in the transformed cells. The specification therefore describes the use of a gene construct as defined hereinabove in the methods as described herein.</p><p id="p0156" num="0156">Plants are transformed with a vector comprising the sequence of interest (i.e., a nucleic acid encoding an AZ polypeptide or homologue thereof). The skilled artisan is well aware of the genetic elements that must be present on the vector in order to successfully transform, select and propagate host cells containing the sequence of interest. The sequence of interest is operably linked to one or more control sequences (at least to a promoter). The terms "regulatory element", "control sequence" and "promoter" are defined above. Advantageously, any type of promoter may be used to drive expression of the nucleic acid sequence.</p><p id="p0157" num="0157">Suitable promoters, which are functional in plants, are generally known. They may take the form of constitutive or inducible promoters. Suitable promoters can enable the developmental- and/or tissue-specific expression in multi-cellular eukaryotes; thus, leaf-, root-, flower-, seed-, stomata-, tuber- or fruit-specific promoters may advantageously be used in plants.<!-- EPO <DP n="53"> --></p><p id="p0158" num="0158">Different plant promoters usable in plants are promoters such as, for example, the USP, the LegB4-, the DC3 promoter or the ubiquitin promoter from parsley.</p><p id="p0159" num="0159">A "plant" promoter comprises regulatory elements, which mediate the expression of a coding sequence segment in plant cells. Accordingly, a plant promoter need not be of plant origin, but may originate from viruses or micro-organisms, in particular for example from viruses which attack plant cells.</p><p id="p0160" num="0160">The "plant" promoter can also originate from a plant cell, e.g. from the plant which is transformed with the nucleic acid sequence to be expressed in the inventive process and described herein. This also applies to other "plant" regulatory signals, for example in "plant" terminators.</p><p id="p0161" num="0161">For expression in plants, the nucleic acid molecule must, as described above, be linked operably to or comprise a suitable promoter which expresses the gene at the right point in time and in a cell- or tissue-specific manner. Useful promoters are constitutive promoters (<nplcit id="ncit0166" npl-type="s"><text>Benfey et al., EMBO J. 8 (1989) 2195-2202</text></nplcit>), such as those which originate from plant viruses, such as 35S CAMV (<nplcit id="ncit0167" npl-type="s"><text>Franck et al., Cell 21 (1980) 285-294</text></nplcit>), 19S CaMV (see also <patcit id="pcit0036" dnum="US5352605A"><text>US 5352605</text></patcit> and <patcit id="pcit0037" dnum="WO8402913A"><text>WO 84/02913</text></patcit>), 34S FMV (<nplcit id="ncit0168" npl-type="s"><text>Sanger et al., Plant. Mol. Biol., 14, 1990: 433-443</text></nplcit>), the parsley ubiquitin promoter, or plant promoters such as the Rubisco small subunit promoter described in <patcit id="pcit0038" dnum="US4962028A"><text>US 4,962,028</text></patcit> or the plant promoters PRP1 [<nplcit id="ncit0169" npl-type="s"><text>Ward et al., Plant. Mol. Biol. 22 (1993</text></nplcit>)], SSU, PGEL1, OCS [<nplcit id="ncit0170" npl-type="s"><text>Leisner (1988) Proc Natl Acad Sci USA 85(5): 2553-2557</text></nplcit>], lib4, usp, mas [<nplcit id="ncit0171" npl-type="s"><text>Comai (1990) Plant Mol Biol 15 (3):373-381</text></nplcit>], STLS1, ScBV (<nplcit id="ncit0172" npl-type="s"><text>Schenk (1999) Plant Mol Biol 39(6):1221-1230</text></nplcit>), B33, SAD1 or SAD2 (flax promoters, <nplcit id="ncit0173" npl-type="s"><text>Jain et al., Crop Science, 39 (6), 1999: 1696-1701</text></nplcit>) or nos [<nplcit id="ncit0174" npl-type="s"><text>Shaw et al. (1984) Nucleic Acids Res. 12(20):7831-7846</text></nplcit>]. Further examples of constitutive plant promoters are the sugar beet V-ATPase promoters (<patcit id="pcit0039" dnum="WO0114572A"><text>WO 01/14572</text></patcit>). Examples of synthetic constitutive promoters are the Super promoter (<patcit id="pcit0040" dnum="WO9514098A"><text>WO 95/14098</text></patcit>) and promoters derived from G-boxes (<patcit id="pcit0041" dnum="WO9412015A"><text>WO 94/12015</text></patcit>). If appropriate, chemically inducible promoters may furthermore also be used, compare <patcit id="pcit0042" dnum="EP388186A"><text>EP-A 388186</text></patcit>, <patcit id="pcit0043" dnum="EP335528A"><text>EP-A 335528</text></patcit>, <patcit id="pcit0044" dnum="WO9706268A"><text>WO 97/06268</text></patcit>. Stable, constitutive expression of the proteins as described herein a plant can be advantageous. However, inducible expression of the polypeptide as described herein is advantageous, if, for example, late expression before the harvest is of advantage, as metabolic manipulation may lead to plant growth retardation.</p><p id="p0162" num="0162">The expression of plant genes can also be facilitated via a chemically inducible promoter. Chemically inducible promoters are particularly suitable when it is desired to express the gene in a time-specific manner. Examples of such promoters are a salicylic acid inducible promoter<!-- EPO <DP n="54"> --> (<patcit id="pcit0045" dnum="WO9519443A"><text>WO 95/19443</text></patcit>), and abscisic acid-inducible promoter (<patcit id="pcit0046" dnum="EP335528A"><text>EP 335 528</text></patcit>), a tetracyclin-inducible promoter (<nplcit id="ncit0175" npl-type="s"><text>Gatz et al. (1992) Plant J. 2, 397-404</text></nplcit>), a cyclohexanol- or ethanol-inducible promoter (<patcit id="pcit0047" dnum="WO9321334A"><text>WO 93/21334</text></patcit>) or others as described herein.</p><p id="p0163" num="0163">Other suitable promoters are those which react to biotic or abiotic stress conditions, for example the pathogen-induced PRP1 gene promoter (<nplcit id="ncit0176" npl-type="s"><text>Ward et al., Plant. Mol. Biol. 22 (1993) 361-366</text></nplcit>), the tomato heat-inducible hsp80 promoter (<patcit id="pcit0048" dnum="US5187267A"><text>US 5,187,267</text></patcit>), the potato chill-inducible alpha-amylase promoter (<patcit id="pcit0049" dnum="WO9612814A"><text>WO 96/12814</text></patcit>) or the wound-inducible pinll promoter (<patcit id="pcit0050" dnum="EP0375091A"><text>EP-A-0 375 091</text></patcit>) or others as described herein.</p><p id="p0164" num="0164">Promoters as described herein are in particular those which bring gene expression in tissues and organs, in seed cells, such as endosperm cells and cells of the developing embryo. Suitable promoters are the oilseed rape napin gene promoter (<patcit id="pcit0051" dnum="US5608152A"><text>US 5,608,152</text></patcit>), the <i>Vicia faba</i> USP promoter (<nplcit id="ncit0177" npl-type="s"><text>Baeumlein et al., Mol Gen Genet, 1991, 225 (3): 459-67</text></nplcit>), the <i>Arabidopsis</i> oleosin promoter (<patcit id="pcit0052" dnum="WO9845461A"><text>WO 98/45461</text></patcit>), the <i>Phaseolus vulgaris</i> phaseolin promoter (<patcit id="pcit0053" dnum="US5504200A"><text>US 5,504,200</text></patcit>), the <i>Brassica</i> Bce4 promoter (<patcit id="pcit0054" dnum="WO9113980A"><text>WO 91/13980</text></patcit>), the bean arc5 promoter, the carrot DcG3 promoter, or the Legumin B4 promoter (LeB4; <nplcit id="ncit0178" npl-type="s"><text>Baeumlein et al., 1992, Plant Journal, 2 (2): 233-9</text></nplcit>), and promoters which bring about the seed-specific expression in monocotyledonous plants such as maize, barley, wheat, rye, rice and the like. Advantageous seed-specific promoters are the sucrose binding protein promoter (<patcit id="pcit0055" dnum="WO0026388A"><text>WO 00/26388</text></patcit>), the phaseolin promoter and the napin promoter. Suitable promoters which must be considered are the barley Ipt2 or Ipt1 gene promoter (<patcit id="pcit0056" dnum="WO9515389A"><text>WO 95/15389</text></patcit> and <patcit id="pcit0057" dnum="WO9523230A"><text>WO 95/23230</text></patcit>), and the promoters described in <patcit id="pcit0058" dnum="WO9916890A"><text>WO 99/16890</text></patcit> (promoters from the barley hordein gene, the rice glutelin gene, the rice oryzin gene, the rice prolamin gene, the wheat gliadin gene, the wheat glutelin gene, the maize zein gene, the oat glutelin gene, the sorghum kasirin gene and the rye secalin gene). Further suitable promoters are Amy32b, Amy 6-6 and Aleurain [<patcit id="pcit0059" dnum="US5677474A"><text>US 5,677,474</text></patcit>], Bce4 (oilseed rape) [<patcit id="pcit0060" dnum="US5530149A"><text>US 5,530,149</text></patcit>], glycinin (soya) [<patcit id="pcit0061" dnum="EP571741A"><text>EP 571 741</text></patcit>], phosphoenolpyruvate carboxylase (soya) [<patcit id="pcit0062" dnum="JP6062870A"><text>JP 06/62870</text></patcit>], ADR12-2 (soya) [<patcit id="pcit0063" dnum="WO9808962A"><text>WO 98/08962</text></patcit>], isocitrate lyase (oilseed rape) [<patcit id="pcit0064" dnum="US5689040A"><text>US 5,689,040</text></patcit>] or α-amylase (barley) [<patcit id="pcit0065" dnum="EP781849A"><text>EP 781 849</text></patcit>]. Other promoters which are available for the expression of genes in plants are leaf-specific promoters such as those described in <patcit id="pcit0066" dnum="DE19644478A"><text>DE-A 19644478</text></patcit> or light-regulated promoters such as, for example, the pea petE promoter.</p><p id="p0165" num="0165">Further suitable plant promoters are the cytosolic FBPase promoter or the potato ST-LSI promoter (<nplcit id="ncit0179" npl-type="s"><text>Stockhaus et al., EMBO J. 8, 1989, 2445</text></nplcit>), the Glycine max phosphoribosylpyrophosphate amidotransferase promoter (GenBank Accession No. U87999) or the node-specific promoter described in <patcit id="pcit0067" dnum="EP0249676A"><text>EP-A-0 249 676</text></patcit>.<!-- EPO <DP n="55"> --></p><p id="p0166" num="0166">According to one preferred feature of the invention, the AZ nucleic acid or variant thereof as defined herein is operably linked to a seed-specific promoter. The seed-specific promoter may be active during seed development and/or during germination. Seed-specific promoters are well known in the art. Preferably, the seed-specific promoter is an embryo specific / endosperm specific / aleurone specific promoter. Further preferably, the seed-specific promoter drives expression in at least one of: the embryo, the endosperm, the aleurone. More preferably, the promoter is a WSI18 or a functionally equivalent promoter. Most preferably, the promoter sequence is as represented by SEQ ID NO: 9 or SEQ ID NO: 55. Examples of other seed-specific promoters (embryo specific / endosperm specific / aleurone specific promoters) which may also be used to drive expression of an AZ nucleic acid are provided above.</p><p id="p0167" num="0167">According to the specification, the AZ nucleic acid or variant thereof as defined herein is operably linked to a constitutive promoter. A constitutive promoter is a constitutive promoter that is also substantially ubiquitously expressed. Further preferably the promoter is derived from a plant, more preferably a monocotyledonous plant. An example of such a promoter is the GOS2 promoter from rice (SEQ ID NO: 54 or SEQ ID NO: 56). Examples of other constitutive promoters which may also be used to drive expression of an AZ nucleic acid as defined above are shown above.</p><p id="p0168" num="0168">Optionally, one or more terminator sequences may be used in the construct introduced into a plant. Additional regulatory elements may include transcriptional as well as translational enhancers. Those skilled in the art will be aware of terminator and enhancer sequences that may be suitable. An intron sequence may also be added to the 5' untranslated region (UTR) or in the coding sequence to increase the amount of the mature message that accumulates in the cytosol, as described in the definitions section. Other control sequences (besides promoter, enhancer, silencer, intron sequences, 3'UTR and/or 5'UTR regions) may be protein and/or RNA stabilizing elements. Such sequences would be known or may readily be obtained by a person skilled in the art.</p><p id="p0169" num="0169">The genetic constructs as described herein may further include an origin of replication sequence that is required for maintenance and/or replication in a specific cell type.<!-- EPO <DP n="56"> --></p><p id="p0170" num="0170">One example is when a genetic construct is required to be maintained in a bacterial cell as an episomal genetic element (e.g. plasmid or cosmid molecule). Preferred origins of replication include, but are not limited to, the f1-ori and colE1.</p><p id="p0171" num="0171">For the detection of the successful transfer of the nucleic acid sequences as used in the methods as described herein and/or selection of transgenic plants comprising these nucleic acids, it is advantageous to use marker genes (or reporter genes). Therefore, the genetic construct may optionally comprise a selectable marker gene. Selectable markers are described in more detail in the "definitions" section herein. The marker genes may be removed or excised from the transgenic cell once they are no longer needed. Techniques for marker removal are known in the art, useful techniques are described above in the definitions section.</p><p id="p0172" num="0172">The present specification also describes plants, plant parts or plant cells obtainable by the methods as described herein. The present specification therefore describes plants obtainable by the method as described herein, which plants have introduced therein an AZ nucleic acid or variant thereof, as defined above.</p><p id="p0173" num="0173">The specification also describes a method for the production of transgenic plants having increased yield, comprising introduction and expression in a plant of an AZ nucleic acid or a variant thereof as defined above.</p><p id="p0174" num="0174">Host plants for the nucleic acids or the vector used in the method as described herein, the expression cassette or construct or vector are, in principle, advantageously all plants, which are capable of synthesizing the polypeptides used in the method as described herein.</p><p id="p0175" num="0175">More specifically, the present specification describes a method for the production of transgenic plants having increased yield, which method comprises:
<ol><li>(i) introducing and expressing in a plant or plant cell an AZ nucleic acid or variant thereof; and</li><li>(ii) cultivating the plant cell under conditions promoting plant growth and development.</li></ol></p><p id="p0176" num="0176">The nucleic acid may be introduced directly into a plant cell or into the plant itself (including introduction into a tissue, organ or any other part of a plant). According to a feature of the present specification, the nucleic acid is introduced into a plant by<!-- EPO <DP n="57"> --> transformation. The terms "introduction" or "transformation" are described in more detail in the definitions section.</p><p id="p0177" num="0177">Generally after transformation, plant cells or cell groupings are selected for the presence of one or more markers which are encoded by plant-expressible genes co-transferred with the gene of interest, following which the transformed material is regenerated into a whole plant.</p><p id="p0178" num="0178">As mentioned, Agrobacteria transformed with an expression vector as described herein may also be used in the manner known per se for the transformation of plants such as plants used as a model, like <i>Arabidopsis</i>, or crop plants, such as cereals, maize, oats, rye, barley, wheat, soybean, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potato, tobacco, tomato, carrot, bell peppers, oilseed rape, tapioca, cassava, arrow root, tagetes, alfalfa, lettuce and the various tree, nut, and grapevine species, in particular oil-containing crop plants such as soy, peanut, castor-oil plant, sunflower, maize, cotton, flax, oilseed rape, coconut, oil palm, safflower <i>(Carthamus tinctorius)</i> or cocoa beans, for example by bathing scarred leaves or leaf segments in an agrobacterial solution and subsequently culturing them on suitable media.</p><p id="p0179" num="0179">The genetically modified plant cells can be regenerated via all methods with which the skilled worker is familiar. Suitable methods can be found in the abovementioned publications by S.D. Kung and R. Wu, Potrykus or Höfgen and Willmitzer.</p><p id="p0180" num="0180">Generally after transformation, plant cells or cell groupings are selected for the presence of one or more markers which are encoded by plant-expressible genes co-transferred with the gene of interest, following which the transformed material is regenerated into a whole plant. To select transformed plants, the plant material obtained in the transformation is, as a rule, subjected to selective conditions so that transformed plants can be distinguished from untransformed plants. For example, the seeds obtained in the above-described manner can be planted and, after an initial growing period, subjected to a suitable selection by spraying. A further possibility consists in growing the seeds, if appropriate after sterilization, on agar plates using a suitable selection agent so that only the transformed seeds can grow into plants. Alternatively, the transformed plants are screened for the presence of a selectable marker such as the ones described above.</p><p id="p0181" num="0181">Following DNA transfer and regeneration, putatively transformed plants may be evaluated, for instance using Southern analysis, for the presence of the gene of interest, copy number and/or<!-- EPO <DP n="58"> --> genomic organisation. Alternatively or additionally, expression levels of the newly introduced DNA may be monitored using Northern and/or Western analysis, both techniques being well known to persons having ordinary skill in the art.</p><p id="p0182" num="0182">The generated transformed plants may be propagated by a variety of means, such as by clonal propagation or classical breeding techniques. For example, a first generation (or T1) transformed plant may be selfed and homozygous second-generation (or T2) transformants selected, and the T2 plants may then further be propagated through classical breeding techniques.</p><p id="p0183" num="0183">The generated transformed organisms may take a variety of forms. For example, they may be chimeras of transformed cells and non-transformed cells; clonal transformants (e.g., all cells transformed to contain the expression cassette); grafts of transformed and untransformed tissues (e.g., in plants, a transformed rootstock grafted to an untransformed scion).</p><p id="p0184" num="0184">The present specification describes to any plant cell or plant produced by any of the methods described herein, and to all plant parts and propagules thereof. The present specification describes further to encompass the progeny of a primary transformed or transfected cell, tissue, organ or whole plant that has been produced by any of the aforementioned methods, the only requirement being that progeny exhibit the same genotypic and/or phenotypic characteristic(s) as those produced by the parent in the methods as described herein. Described are host cells containing an isolated AZ nucleic acid or variant thereof. Preferred host cells are plant cells. Also described are harvestable parts of a plant such as, but not limited to seeds, leaves, fruits, flowers, stem, roots, rhizomes, tubers and bulbs. Furthermore described are products directly derived from a harvestable part of such a plant, such as dry pellets or powders, oil, fat and fatty acids, starch or proteins.</p><p id="p0185" num="0185">The present specification describes use of <i>AZ</i> nucleic acids or variants thereof and use of AZ polypeptides or homologues thereof.</p><p id="p0186" num="0186">One such use relates to improving the growth characteristics of plants, in particular in improving yield, especially seed yield. The increased seed yield preferably comprises increased thousand kernel weight.<!-- EPO <DP n="59"> --></p><p id="p0187" num="0187">Nucleic acids encoding AZ polypeptides as defined herein may find use in breeding programmes in which a DNA marker is identified which may be genetically linked to an AZ gene. The nucleic acids/ genes may be used to define a molecular marker. This DNA or protein marker may then be used in breeding programmes to select plants having increased yield.</p><p id="p0188" num="0188">Allelic variants of an AZ nucleic acid/gene as defined herein may also find use in marker-assisted breeding programmes. Such breeding programmes sometimes require introduction of allelic variation by mutagenic treatment of the plants, using for example EMS mutagenesis; alternatively, the programme may start with a collection of allelic variants of so called "natural" origin caused unintentionally. Identification of allelic variants then takes place, for example, by PCR. This is followed by a step for selection of superior allelic variants of the sequence in question and which give increased yield. Selection is typically carried out by monitoring growth performance of plants containing different allelic variants of the sequence in question, for example, different allelic variants of any one of the nucleic acids listed in Table A of Example 1. Growth performance may be monitored in a greenhouse or in the field. Further optional steps include crossing plants, in which the superior allelic variant was identified, with another plant. This could be used, for example, to make a combination of interesting phenotypic features.</p><p id="p0189" num="0189">An AZ nucleic acid as defined herein may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes. Such use of AZ nucleic acids or variants thereof requires only a nucleic acid sequence of at least 15 nucleotides in length. The AZ nucleic acids or variants thereof may be used as restriction fragment length polymorphism (RFLP) markers. Southern blots (<nplcit id="ncit0180" npl-type="b"><text>Sambrook J, Fritsch EF and Maniatis T (1989) Molecular Cloning, A Laboratory Manual</text></nplcit>) of restriction-digested plant genomic DNA may be probed with the AZ nucleic acids. The resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (<nplcit id="ncit0181" npl-type="s"><text>Lander et al. (1987) Genomics 1: 174-181</text></nplcit>) in order to construct a genetic map. In addition, the nucleic acids may be used to probe Southern blots containing restriction endonuclease-treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross. Segregation of the DNA polymorphisms is noted and used to calculate the position of the AZ nucleic acid in the genetic map previously obtained using this population (<nplcit id="ncit0182" npl-type="s"><text>Botstein et al. (1980) Am. J. Hum. Genet. 32: 314-331</text></nplcit>).</p><p id="p0190" num="0190">The production and use of plant gene-derived probes for use in genetic mapping is described in <nplcit id="ncit0183" npl-type="s"><text>Bernatzky and Tanksley (1986) Plant Mol. Biol. Reporter 4: 37-41</text></nplcit>. Numerous publications<!-- EPO <DP n="60"> --> describe genetic mapping of specific cDNA clones using the methodology outlined above or variations thereof. For example, F2 intercross populations, backcross populations, randomly mated populations, near isogenic lines, and other sets of individuals may be used for mapping. Such methodologies are well known to those skilled in the art.</p><p id="p0191" num="0191">The nucleic acid probes may also be used for physical mapping (i.e., placement of sequences on physical maps; see <nplcit id="ncit0184" npl-type="b"><text>Hoheisel et al. In: Non-mammalian Genomic Analysis: A Practical Guide, Academic press 1996, pp. 319-346</text></nplcit>, and references cited therein).</p><p id="p0192" num="0192">According to the specification the nucleic acid probes may be used in direct fluorescence <i>in situ</i> hybridization (FISH) mapping (<nplcit id="ncit0185" npl-type="s"><text>Trask (1991) Trends Genet. 7:149-154</text></nplcit>). Although current methods of FISH mapping favour use of large clones (several kb to several hundred kb; see <nplcit id="ncit0186" npl-type="s"><text>Laan et al. (1995) Genome Res. 5:13-20</text></nplcit>), improvements in sensitivity may allow performance of FISH mapping using shorter probes.</p><p id="p0193" num="0193">A variety of nucleic acid amplification-based methods for genetic and physical mapping may be carried out using the nucleic acids. Examples include allele-specific amplification (<nplcit id="ncit0187" npl-type="s"><text>Kazazian (1989) J. Lab. Clin. Med 11:95-96</text></nplcit>), polymorphism of PCR-amplified fragments (CAPS; <nplcit id="ncit0188" npl-type="s"><text>Sheffield et al. (1993) Genomics 16:325-332</text></nplcit>), allele-specific ligation (<nplcit id="ncit0189" npl-type="s"><text>Landegren et al. (1988) Science 241:1077-1080</text></nplcit>), nucleotide extension reactions (<nplcit id="ncit0190" npl-type="s"><text>Sokolov (1990) Nucleic Acid Res. 18:3671</text></nplcit>), Radiation Hybrid Mapping (<nplcit id="ncit0191" npl-type="s"><text>Walter et al. (1997) Nat. Genet. 7:22-28</text></nplcit>) and Happy Mapping (<nplcit id="ncit0192" npl-type="s"><text>Dear and Cook (1989) Nucleic Acid Res. 17:6795-6807</text></nplcit>). For these methods, the sequence of a nucleic acid is used to design and produce primer pairs for use in the amplification reaction or in primer extension reactions. The design of such primers is well known to those skilled in the art. In methods employing PCR-based genetic mapping, it may be necessary to identify DNA sequence differences between the parents of the mapping cross in the region corresponding to the instant nucleic acid sequence. This, however, is generally not necessary for mapping methods.</p><p id="p0194" num="0194">The methods according to the present specification result in plants having increased yield, as described hereinbefore. These advantageous growth characteristics may also be combined with other economically advantageous traits, such as further yield-enhancing traits, tolerance to various stresses, traits modifying various architectural features and/or biochemical and/or physiological features.<!-- EPO <DP n="61"> --></p><heading id="h0044"><b>Description of figures</b></heading><p id="p0195" num="0195">The present invention will now be described with reference to the following figures in which:<!-- EPO <DP n="62"> -->
<ul><li><figref idrefs="f0001">Fig. 1</figref> shows an example of the domain structure of an AZ polypeptide. The protein encoded by SEQ ID NO: 2 comprises two ankyrin repeats (bold, underlined) and two C3H1 domains (italics, underlined).</li><li><figref idrefs="f0001">Fig. 2</figref> shows the Ankyrin (ANK) and C3H1 Zinc finger (C3H1) consensus sequences according to the SMART database, the symbols for the various amino acid groups are given in the legend.</li><li><figref idrefs="f0002 f0003">Fig. 3</figref> represents a sequence identity/similarity matrix prepared with MATGAT (BLOSUM62, gap opening penalty 11, gap extension penalty 1). Above the diagonal, in bold, the sequence identities are displayed, below the diagonal, sequence similarities are given for: A) full length protein sequences, B) partial protein sequences comprising the most C-terminal putative Zn-finger domain.</li><li><figref idrefs="f0004">Fig. 4</figref> shows the binary vector p056, for expression in <i>Oryza sativa</i> of an <i>Arabidopsis thaliana</i> AZ coding sequence under the control of a WSI18 promoter (internal reference PRO0151).</li></ul><!-- EPO <DP n="63"> --></p><heading id="h0045"><b>Examples</b></heading><p id="p0196" num="0196">The present invention will now be described with reference to the following examples.</p><p id="p0197" num="0197">DNA manipulation: unless otherwise stated, recombinant DNA techniques are performed according to standard protocols described in (<nplcit id="ncit0193" npl-type="b"><text>Sambrook (2001) Molecular Cloning: a laboratory manual, 3rd Edition Cold Spring Harbor Laboratory Press, CSH, New York</text></nplcit>) or in <nplcit id="ncit0194" npl-type="b"><text>Volumes 1 and 2 of Ausubel et al. (1994), Current Protocols in Molecular Biology, Current Protocols</text></nplcit>. Standard materials and methods for plant molecular work are described in <nplcit id="ncit0195" npl-type="b"><text>Plant Molecular<!-- EPO <DP n="64"> --> Biology Labfax (1993) by R.D.D. Croy, published by BIOS Scientific Publications Ltd (UK) and Blackwell Scientific Publications (UK)</text></nplcit>.</p><heading id="h0046"><b><i>Example 1: Identification of sequences related to the nucleic acid sequence used in the methods as described herein</i></b></heading><p id="p0198" num="0198">Sequences (full length cDNA, ESTs or genomic) related to the nucleic acid sequence used in the methods as described were identified amongst those maintained in the Entrez Nucleotides database at the National Center for Biotechnology Information (NCBI) using database sequence search tools, such as the Basic Local Alignment Tool (BLAST) (<nplcit id="ncit0196" npl-type="s"><text>Altschul et al. (1990) J. Mol. Biol. 215:403-410</text></nplcit>; and <nplcit id="ncit0197" npl-type="s"><text>Altschul et al. (1997) Nucleic Acids Res. 25:3389-3402</text></nplcit>). The program is used to find regions of local similarity between sequences by comparing nucleic acid or polypeptide sequences to sequence databases and by calculating the statistical significance of matches. For example, the polypeptide encoded by the nucleic acid as defined herein was used for the TBLASTN algorithm, with default settings and the filter to ignore low complexity sequences set off. The output of the analysis was viewed by pairwise comparison, and ranked according to the probability score (E-value), where the score reflect the probability that a particular alignment occurs by chance (the lower the E-value, the more significant the hit). In addition to E-values, comparisons were also scored by percentage identity. Percentage identity refers to the number of identical nucleotides (or amino acids) between the two compared nucleic acid (or polypeptide) sequences over a particular length. In some instances, the default parameters may be adjusted to modify the stringency of the search. For example the E-value may be increased to show less stringent matches. This way, short nearly exact matches may be identified.</p><p id="p0199" num="0199">Table A provides a list of nucleic acid sequences related to the nucleic acid sequence used in the methods as described herein.
<tables id="tabl0007" num="0007"><table frame="all"><title><b>Table A:</b> Examples of AZ polypeptides:</title><tgroup cols="3"><colspec colnum="1" colname="col1" colwidth="34mm"/><colspec colnum="2" colname="col2" colwidth="41mm"/><colspec colnum="3" colname="col3" colwidth="34mm"/><thead><row><entry valign="top"><b>Plant Source</b></entry><entry valign="top"><b>Nucleic acid SEQ ID NO:</b></entry><entry valign="top"><b>Protein SEQ ID NO:</b></entry></row></thead><tbody><row><entry><i>Arabidopsis thaliana</i></entry><entry>1</entry><entry>2</entry></row><row><entry><i>Eucalyptus grandis</i></entry><entry>10</entry><entry>11</entry></row><row><entry><i>Oryza sativa</i></entry><entry>12</entry><entry>13</entry></row><row><entry><i>Medicago truncatula</i></entry><entry>14</entry><entry>15</entry></row><row><entry><i>Oryza sativa</i></entry><entry>16</entry><entry>17</entry></row><row><entry><i>Arabidopsis thaliana</i></entry><entry>18</entry><entry>19</entry></row><row><entry><i>Oryza sativa</i></entry><entry>20</entry><entry>21</entry></row><!-- EPO <DP n="65"> --><row><entry><i>Arabidopsis thaliana</i></entry><entry>22</entry><entry>23</entry></row><row><entry><i>Arabidopsis thaliana</i></entry><entry>24</entry><entry>25</entry></row><row><entry><i>Eucalyptus grandis</i></entry><entry>26</entry><entry>27</entry></row><row><entry><i>Eucalyptus grandis</i></entry><entry>28</entry><entry>29</entry></row><row><entry><i>Glycine max</i></entry><entry>30</entry><entry>31</entry></row><row><entry><i>Eucalyptus grandis</i></entry><entry>32</entry><entry>33</entry></row><row><entry><i>Arabidopsis thaliana</i></entry><entry>34</entry><entry>35</entry></row><row><entry><i>Oryza sativa</i></entry><entry>36</entry><entry>37</entry></row><row><entry><i>Hordeum_vulgare</i></entry><entry>38</entry><entry>39</entry></row><row><entry><i>Pinus radiata</i></entry><entry>40</entry><entry>41</entry></row><row><entry><i>Pinus radiata</i></entry><entry>42</entry><entry>43</entry></row><row><entry><i>Glycine max</i></entry><entry/><entry>44</entry></row><row><entry><i>Glycine max</i></entry><entry/><entry>45</entry></row><row><entry><i>Glycine max</i></entry><entry/><entry>46</entry></row><row><entry><i>Arabidopsis thaliana</i></entry><entry/><entry>47</entry></row><row><entry><i>Arabidopsis thaliana</i></entry><entry/><entry>48</entry></row><row><entry><i>Arabidopsis fhaliana</i></entry><entry/><entry>49</entry></row><row><entry><i>Arabidopsis thaliana</i></entry><entry/><entry>50</entry></row><row><entry><i>Arabidopsis thaliana</i></entry><entry/><entry>51</entry></row><row><entry><i>Arabidopsis thaliana</i></entry><entry/><entry>52</entry></row><row><entry><i>Arabidopsis thaliana</i></entry><entry>53</entry><entry/></row></tbody></tgroup></table></tables></p><p id="p0200" num="0200">In some instances, related sequences have tentatively been assembled and publicly disclosed by research institutions, such as The Institute for Genomic Research (TIGR). The Eukaryotic Gene Orthologs (EGO) database may be used to identify such related sequences, either by keyword search or by using the BLAST algorithm with the nucleic acid or polypeptide sequence of interest.</p><heading id="h0047"><b><i>Example 2: Gene Cloning of AZ</i></b></heading><p id="p0201" num="0201">The <i>Arabidopsis AZ</i> encoding gene (CDS3104) was amplified by PCR using as template an <i>Arabidopsis thaliana</i> seedling cDNA library (Invitrogen, Paisley, UK). After reverse transcription of RNA extracted from seedlings, the cDNAs were cloned into pCMV Sport 6.0. Average insert size of the bank was 1.5 kb, and the original number of clones was of 1.59x10<sup>7</sup> cfu. Original titer was determined to be 9.6x10<sup>5</sup> cfu/ml, after a first amplification of 6x10<sup>11</sup> cfu/ml. After plasmid extraction, 200 ng of template was used in a 50 µl PCR mix. Primers prm06717 (sense, AttB1 site in italic, start codon in bold: 5'-<i>ggggacaagtttgtacaaaaaagcaggcttaaaca</i><b>atg</b>tgctgtggatcagacc-3') (SEQ ID NO 7) and prm06718 (reverse, complementary, AttB2 site in italic: 5'-185<!-- EPO <DP n="66"> --> <i>ggggaccactttgtacaagaaagctgggt</i>ggttaggtctctcaattctgc-3') (SEQ ID NO 8), which include the AttB sites for Gateway recombination, were used for PCR amplification. PCR was performed using Hifi Taq DNA polymerase in standard conditions. A PCR fragment of the expected size was amplified and purified also using standard methods. The first step of the Gateway procedure, the BP reaction, was then performed, during which the PCR fragment recombines <i>in vivo</i> with the pDONR201 plasmid to produce, according to the Gateway terminology, an "entry clone", p07. Plasmid pDONR201 was purchased from Invitrogen, as part of the Gateway<sup>®</sup> technology.</p><heading id="h0048"><b><i>Example 3: Vector Construction</i></b></heading><p id="p0202" num="0202">The entry clone p07 were subsequently used in an LR reaction with p02417, a destination vector used for plant (<i>Oryza sativa)</i> transformation. This vector contains as functional elements within the T-DNA borders: a plant selectable marker; a screenable marker expression cassette; and a Gateway cassette intended for LR <i>in vivo</i> recombination with the sequence of interest already cloned in the entry clone. A rice WSI18 promoter (SEQ ID NO: 9) for seed specific expression (PRO0151) was located upstream of this Gateway cassette (p056, <figref idrefs="f0004">Figure 4</figref>).</p><p id="p0203" num="0203">Many different binary (and super binary) vector systems have been described for plant transformation (e.g. <nplcit id="ncit0198" npl-type="b"><text>An, G. in Agrobacterium Protocols. Methods in Molecular Biology vol 44, pp 47-62, Gartland KMA and MR Davey eds. Humana Press, Totowa, New Jersey</text></nplcit>). Many are based on the vector pBIN19 described by <nplcit id="ncit0199" npl-type="s"><text>Bevan (Nucleic Acid Research. 1984. 12:8711-8721</text></nplcit>) that includes a plant gene expression cassette flanked by the left and right border sequences from the Ti plasmid of <i>Agrobacterium tumefaciens.</i> A plant gene expression cassette consists of at least two genes - a selection marker gene and a plant promoter regulating the transcription of the cDNA or genomic DNA of the trait gene. Various selection marker genes can be used including the <i>Arabidopsis</i> gene encoding a mutated acetohydroxy acid synthase (AHAS) enzyme (<patcit id="pcit0068" dnum="US57673666B"><text>US patents 57673666</text></patcit> and <patcit id="pcit0069" dnum="US6225105B"><text>6225105</text></patcit>). Similarly, various promoters can be used to regulate the trait gene to provide constitutive, developmental, tissue or environmental regulation of gene transcription.</p><p id="p0204" num="0204">After the LR recombination step, the resulting expression vector, p056 (<figref idrefs="f0004">Figure 4</figref>), was transformed into <i>Agrobacterium</i> strain LBA4044 using heat shock or electroporation protocols. Transformed colonies were grown on YEP media and selected by respective antibiotics for two days at 28°C. These <i>Agrobacterium</i> cultures were used for the plant transformation.</p><p id="p0205" num="0205">Other <i>Agrobacterium tumefaciens</i> strains can be used for plant transformation and are well known in the art. Examples of such strains are C58C1 or EHA105.<!-- EPO <DP n="67"> --></p><heading id="h0049"><b><i>Example 4: Plant transformation</i></b></heading><heading id="h0050"><i>Rice transformation</i></heading><p id="p0206" num="0206">The <i>Agrobacterium</i> containing the expression vector was used to transform <i>Oryza sativa</i> plants. Mature dry seeds of the rice japonica cultivar Nipponbare were dehusked. Sterilization was carried out by incubating for one minute in 70% ethanol, followed by 30 minutes in 0.2%HgCl<sub>2</sub>, followed by a 6 times 15 minutes wash with sterile distilled water. The sterile seeds were then germinated on a medium containing 2,4-D (callus induction medium). After incubation in the dark for four weeks, embryogenic, scutellum-derived calli were excised and propagated on the same medium. After two weeks, the calli were multiplied or propagated by subculture on the same medium for another 2 weeks. Embryogenic callus pieces were subcultured on fresh medium 3 days before co-cultivation (to boost cell division activity).</p><p id="p0207" num="0207"><i>Agrobacterium</i> strain LBA4404 containing the expression vector was used for cocultivation. <i>Agrobacterium</i> was inoculated on AB medium with the appropriate antibiotics and cultured for 3 days at 28°C. The bacteria were then collected and suspended in liquid co-cultivation medium to a density (OD600) of about 1. The suspension was then transferred to a Petri dish and the calli immersed in the suspension for 15 minutes. The callus tissues were then blotted dry on a filter paper and transferred to solidified, co-cultivation medium and incubated for 3 days in the dark at 25°C. Co-cultivated calli were grown on 2,4-D-containing medium for 4 weeks in the dark at 28°C in the presence of a selection agent. During this period, rapidly growing resistant callus islands developed. After transfer of this material to a regeneration medium and incubation in the light, the embryogenic potential was released and shoots developed in the next four to five weeks. Shoots were excised from the calli and incubated for 2 to 3 weeks on an auxin-containing medium from which they were transferred to soil. Hardened shoots were grown under high humidity and short days in a greenhouse.</p><p id="p0208" num="0208">Approximately 35 independent T0 rice transformants were generated for one construct. The primary transformants were transferred from a tissue culture chamber to a greenhouse. After a quantitative PCR analysis to verify copy number of the T-DNA insert, only single copy transgenic plants that exhibit tolerance to the selection agent were kept for harvest of T1 seed. Seeds were then harvested three to five months after transplanting. The method yielded single locus transformants at a rate of over 50 % (Aldemita and Hodges1996, Chan <i>et al.</i> 1993, Hiei et <i>al.</i> 1994).</p><heading id="h0051"><i>Corn transformation</i></heading><p id="p0209" num="0209">Transformation of maize <i>(Zea mays)</i> is performed with a modification of the method described by <nplcit id="ncit0200" npl-type="s"><text>Ishida et al. (1996) Nature Biotech 14(6): 745-50</text></nplcit>. Transformation is genotype-dependent in<!-- EPO <DP n="68"> --> corn and only specific genotypes are amenable to transformation and regeneration. The inbred line A188 (University of Minnesota) or hybrids with A188 as a parent are good sources of donor material for tansformation, but other genotypes can be used successfully as well. Ears are harvested from corn plant approximately 11 days after pollination (DAP) when the length of the immature embryo is about 1 to 1.2 mm. Immature embryos are cocultivated with <i>Agrobacterium tumefaciens</i> containing the expression vector, and transgenic plants are recovered through organogenesis. Excised embryos are grown on callus induction medium, then maize regeneration medium, containing the selection agent (for example imidazolinone but various selection markers can be used). The Petri plates are incubated in the light at 25 °C for 2-3 weeks, or until shoots develop. The green shoots are transferred from each embryo to maize rooting medium and incubated at 25 °C for 2-3 weeks, until roots develop. The rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert.</p><heading id="h0052"><i>Wheat transformation</i></heading><p id="p0210" num="0210">Transformation of wheat is performed with the method described by <nplcit id="ncit0201" npl-type="s"><text>Ishida et al. (1996) Nature Biotech 14(6): 745-50</text></nplcit>. The cultivar Bobwhite (available from CIMMYT, Mexico) is commonly used in transformation. Immature embryos are co-cultivated with <i>Agrobacterium tumefaciens</i> containing the expression vector, and transgenic plants are recovered through organogenesis. After incubation with Agrobacterium, the embryos are grown <i>in vitro</i> on callus induction medium, then regeneration medium, containing the selection agent (for example imidazolinone but various selection markers can be used). The Petri plates are incubated in the light at 25 °C for 2-3 weeks, or until shoots develop. The green shoots are transferred from each embryo to rooting medium and incubated at 25 °C for 2-3 weeks, until roots develop. The rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert.</p><heading id="h0053"><i>Soybean transformation</i></heading><p id="p0211" num="0211">Soybean is transformed according to a modification of the method described in the Texas A&amp;M patent <patcit id="pcit0070" dnum="US5164310A"><text>US 5,164,310</text></patcit>. Several commercial soybean varieties are amenable to transformation by this method. The cultivar Jack (available from the Illinois Seed foundation) is commonly used for transformation. Soybean seeds are sterilised for <i>in vitro</i> sowing. The hypocotyl, the radicle and one cotyledon are excised from seven-day old young seedlings. The epicotyl and the remaining cotyledon are further grown to develop axillary nodes. These axillary nodes are excised and incubated with <i>Agrobacterium tumefaciens</i> containing the expression vector. After the cocultivation treatment, the explants are washed and transferred to selection media. Regenerated shoots are excised and placed on a shoot elongation medium. Shoots no longer<!-- EPO <DP n="69"> --> than 1 cm are placed on rooting medium until roots develop. The rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert.</p><heading id="h0054"><i>Rapeseed</i>/<i>canola transformation</i></heading><p id="p0212" num="0212">Cotyledonary petioles and hypocotyls of 5-6 day old young seedling are used as explants for tissue culture and transformed according to <nplcit id="ncit0202" npl-type="s"><text>Babic et al. (1998, Plant Cell Rep 17: 183-188</text></nplcit>). The commercial cultivar Westar (Agriculture Canada) is the standard variety used for transformation, but other varieties can also be used. Canola seeds are surface-sterilized for <i>in vitro</i> sowing. The cotyledon petiole explants with the cotyledon attached are excised from the <i>in vitro</i> seedlings, and inoculated with <i>Agrobacterium</i> (containing the expression vector) by dipping the cut end of the petiole explant into the bacterial suspension. The explants are then cultured for 2 days on MSBAP-3 medium containing 3 mg/l BAP, 3 % sucrose, 0.7 % Phytagar at 23 °C, 16 hr light. After two days of co-cultivation with <i>Agrobacterium,</i> the petiole explants are transferred to MSBAP-3 medium containing 3 mg/l BAP, cefotaxime, carbenicillin, or timentin (300 mg/l) for 7 days, and then cultured on MSBAP-3 medium with cefotaxime, carbenicillin, or timentin and selection agent until shoot regeneration. When the shoots are 5 - 10 mm in length, they are cut and transferred to shoot elongation medium (MSBAP-0.5, containing 0.5 mg/l BAP). Shoots of about 2 cm in length are transferred to the rooting medium (MS0) for root induction. The rooted shoots are transplanted to soil in the greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert.</p><heading id="h0055"><i>Alfalfa transformation</i></heading><p id="p0213" num="0213">A regenerating clone of alfalfa (<i>Medicago sativa)</i> is transformed using the method of (<nplcit id="ncit0203" npl-type="s"><text>McKersie et al., 1999 Plant Physiol 119: 839-847</text></nplcit>). Regeneration and transformation of alfalfa is genotype dependent and therefore a regenerating plant is required. Methods to obtain regenerating plants have been described. For example, these can be selected from the cultivar Rangelander (Agriculture Canada) or any other commercial alfalfa variety as described by <nplcit id="ncit0204" npl-type="s"><text>Brown DCW and A Atanassov (1985. Plant Cell Tissue Organ Culture 4: 111-112</text></nplcit>). Alternatively, the RA3 variety (University of Wisconsin) has been selected for use in tissue culture (<nplcit id="ncit0205" npl-type="s"><text>Walker et al., 1978 Am J Bot 65:654-659</text></nplcit>). Petiole explants are cocultivated with an overnight culture of <i>Agrobacterium tumefaciens</i> C58C1 pMP90 (<nplcit id="ncit0206" npl-type="s"><text>McKersie et al., 1999 Plant Physiol 119: 839-847</text></nplcit>) or LBA4404 containing the expression vector. The explants are cocultivated for 3 d in the dark on SH induction medium containing 288 mg/ L Pro, 53 mg/ L thioproline, 4.35 g/ L K2SO4, and 100 µm acetosyringinone. The explants are washed in half-strength Murashige-Skoog medium (Murashige and Skoog, 1962) and plated on the same SH<!-- EPO <DP n="70"> --> induction medium without acetosyringinone but with a suitable selection agent and suitable antibiotic to inhibit <i>Agrobacterium</i> growth. After several weeks, somatic embryos are transferred to BOi2Y development medium containing no growth regulators, no antibiotics, and 50 g/ L sucrose. Somatic embryos are subsequently germinated on half-strength Murashige-Skoog medium. Rooted seedlings were transplanted into pots and grown in a greenhouse. T1 seeds are produced from plants that exhibit tolerance to the selection agent and that contain a single copy of the T-DNA insert.</p><heading id="h0056"><b><i>Example 5: Evaluation setup of AZ expression in rice under the control of the rice WSI18 promoter</i></b></heading><p id="p0214" num="0214">Approximately 15 to 20 independent T0 rice transformants were generated. The primary transformants were transferred from a tissue culture chamber to a greenhouse for growing and harvest of T1 seed. Seven events, of which the T1 progeny segregated 3:1 for presence/absence of the transgene, were retained. For each of these events, approximately 10 T1 seedlings containing the transgene (hetero- and homo-zygotes) and approximately 10 T1 seedlings lacking the transgene (nullizygotes) were selected by monitoring visual marker expression. The selected T1 plants were transferred to a greenhouse. Each plant received a unique barcode label to link unambiguously the phenotyping data to the corresponding plant. The selected T1 plants were grown on soil in 10 cm diameter, specially designed pots with transparent bottoms to allow visualization of the roots, under the following environmental settings: photoperiod= 11.5 h, daylight intensity= 30,000 lux or more, daytime temperature= 28°C, night time temperature= 22°C, relative humidity= 60-70%. Transgenic plants and the corresponding nullizygotes were grown side-by-side at random positions. Care was taken that the plants were not subjected to any stress. From the stage of sowing until the stage of maturity the plants were passed several times through a digital imaging cabinet. At each time point digital images (2048x1536 pixels, 16 million colours) were taken of each plant from at least 6 different angles. A digital camera also recorded images through the bottom of the pot during plant growth.</p><heading id="h0057"><i>Drought screen</i></heading><p id="p0215" num="0215">Plants from T2 seeds are grown in potting soil under normal conditions until they approached the heading stage. They are then transferred to a "dry" section where irrigation is withheld. Humidity probes are inserted in randomly chosen pots to monitor the soil water content (SWC). When SWC goes below certain thresholds, the plants are automatically re-watered continuously until a normal level was reached again. The plants are then re-transferred again to normal conditions. The rest of the cultivation (plant maturation, seed harvest) is the same as<!-- EPO <DP n="71"> --> for plants not grown under abiotic stress conditions. Growth and yield parameters are recorded as detailed for growth under normal conditions.</p><heading id="h0058"><i>Nitrogen use efficiency screen</i></heading><p id="p0216" num="0216">Rice plants from T2 seeds are grown in potting soil under normal conditions except for the nutrient solution. The pots are watered from transplantation to maturation with a specific nutrient solution containing reduced N nitrogen (N) content, usually between 7 to 8 times less. The rest of the cultivation (plant maturation, seed harvest) is the same as for plants not grown under abiotic stress. Growth and yield parameters are recorded as detailed for growth under normal conditions.</p><p id="p0217" num="0217">The plant aboveground area (or leafy biomass) was determined by counting the total number of pixels on the digital images from aboveground plant parts discriminated from the background. This value was averaged for the pictures taken on the same time point from the different angles and was converted to a physical surface value expressed in square mm by calibration. Experiments show that the aboveground plant area measured this way correlates with the biomass of plant parts above ground. The above ground area is the time point at which the plant had reached its maximal leafy biomass. Root features such as total projected area (which can be correlated to total root volume), average diameter and length of roots above a certain thickness threshold (length of thick roots, or length of thin roots) were deduced from the generated image using appropriate software.</p><p id="p0218" num="0218">The mature primary panicles were harvested, bagged, barcode-labelled and then dried for three days in the oven at 37°C. The panicles were then threshed and all the seeds collected. The filled husks were separated from the empty ones using an air-blowing device. After separation, both seed lots were then counted using a commercially available counting machine. The empty husks were discarded. The filled husks were weighed on an analytical balance and the cross-sectional area of the seeds was measured using digital imaging. This procedure resulted in the set of the following seed-related parameters:
<ul><li>The number of filled seeds was determined by counting the number of filled husks that remained after the separation step. The total seed yield (total seed weight) was measured by weighing all filled husks harvested from a plant. Total seed number per plant was measured by counting the number of husks harvested from a plant. The harvest index (HI) in the present invention is defined as the ratio between the total seed yield and the above ground area (mm<sup>2</sup>), multiplied by a factor 10<sup>6</sup>. Thousand Kernel Weight (TKW) is extrapolated from the number of filled seeds counted and their total weight. The seed fill rate as defined in the present invention is the proportion (expressed as a %) of the number of filled seeds over the total number of<!-- EPO <DP n="72"> --> seeds (or florets). These parameters were derived in an automated way from the digital images using image analysis software and were analysed statistically. Individual seed parameters (including width, length, area, weight) were measured using a custom-made device consisting of two main components, a weighing and imaging device, coupled to software for image analysis.</li></ul></p><p id="p0219" num="0219">A two factor ANOVA (analyses of variance) corrected for the unbalanced design was used as statistical model for the overall evaluation of plant phenotypic characteristics. An F-test was carried out on all the parameters measured of all the plants of all the events transformed with that gene. The F-test was carried out to check for an effect of the gene over all the transformation events and to verify for an overall effect of the gene, also named herein "global gene effect". If the value of the F test shows that the data are significant, than it is concluded that there is a "gene" effect, meaning that not only presence or the position of the gene is causing the effect. The threshold for significance for a true global gene effect is set at 5% probability level for the F test.</p><p id="p0220" num="0220">To check for an effect of the genes within an event, i.e., for a line-specific effect, a t-test was performed within each event using data sets from the transgenic plants and the corresponding null plants. "Null plants" or "null segregants" or "nullizygotes" are the plants treated in the same way as the transgenic plant, but from which the transgene has segregated. Null plants can also be described as the homozygous negative transformed plants. The threshold for significance for the t-test is set at 10% probability level. The results for some events can be above or below this threshold. This is based on the hypothesis that a gene might only have an effect in certain positions in the genome, and that the occurrence of this position-dependent effect is not uncommon. This kind of gene effect is also named herein a "line effect of the gene". The p-value is obtained by comparing the t-value to the t-distribution or alternatively, by comparing the F-value to the F-distribution. The p-value then gives the probability that the null hypothesis (i.e., that there is no effect of the transgene) is correct.</p><p id="p0221" num="0221">The data obtained for <i>AZ</i> in the first experiment were confirmed in a second experiment with T2 plants. Four lines that had the correct expression pattern were selected for further analysis. Seed batches from the positive plants (both hetero- and homozygotes) in T1, were screened by monitoring marker expression. For each chosen event, the heterozygote seed batches were then retained for T2 evaluation. Within each seed batch an equal number of positive and negative plants were grown in the greenhouse for evaluation.<!-- EPO <DP n="73"> --></p><p id="p0222" num="0222">A total number of 120 AZ transformed plants were evaluated in the T2 generation, that is 30 plants per event of which 15 positives for the transgene, and 15 negatives.</p><p id="p0223" num="0223">Because two experiments with overlapping events had been carried out, a combined analysis was performed. This is useful to check consistency of the effects over the two experiments, and if this is the case, to accumulate evidence from both experiments in order to increase confidence in the conclusion. The method used was a mixed-model approach that takes into account the multilevel structure of the data (i.e. experiment - event - segregants). P-values are obtained by comparing likelihood ratio test to chi square distributions.</p><heading id="h0059"><b><i>Example 6: Evaluation</i> of <i>AZ transformants: measurement of yield-related parameters</i></b></heading><p id="p0224" num="0224">Upon analysis of the seeds as described above, the inventors found that plants transformed with the AZ gene construct had a higher seed yield, expressed as thousand kernel weight, compared to plants lacking the AZ transgene. Furthermore, increased emergence vigour and increased greenness index was observed in plants carrying the transgene compared to the control plants.</p><p id="p0225" num="0225">For one of the constructs, thousand-kernel weight was increased with 2.7% in the T1 generation. These positive results were again obtained in the T2 generation (increase of 2.1 %). The T2 data were re-evaluated in a combined analysis with the results for the T1 generation, and the obtained p-values showed that the observed effects were highly significant.<!-- EPO <DP n="74"> --></p><heading id="h0060">SEQUENCE LISTING</heading><p id="p0226" num="0226"><ul><li>&lt;110&gt; CropDesign N.V.</li><li>&lt;120&gt; Plants having increased yield and method for making the same</li><li>&lt;130&gt; PF58401-prio</li><li>&lt;160&gt; 347</li><li>&lt;170&gt; PatentIn version 3.3</li><li>&lt;210&gt; 1<br/>
&lt;211&gt; 2151<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Arabidopsis thaliana</li><li>&lt;400&gt; 1
<img id="ib0003" file="imgb0003.tif" wi="158" he="144" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 2<br/>
&lt;211&gt; 716<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Arabidopsis thaliana<!-- EPO <DP n="75"> --></li><li>&lt;400&gt; 2
<img id="ib0004" file="imgb0004.tif" wi="139" he="228" img-content="dna" img-format="tif"/><!-- EPO <DP n="76"> -->
<img id="ib0005" file="imgb0005.tif" wi="138" he="132" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 3<br/>
&lt;211&gt; 13<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; motif 1</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; (1) .. (1)<br/>
&lt;223&gt; \replace = "Ala"</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; (7) .. (7)<br/>
&lt;223&gt; \replace = "Thr"</li><li>&lt;400&gt; 3
<img id="ib0006" file="imgb0006.tif" wi="112" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 4<br/>
&lt;211&gt; 12<br/>
&lt;212&gt; PRT<br/>
<!-- EPO <DP n="77"> -->&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; motif 2</li><li>&lt;400&gt; 4
<img id="ib0007" file="imgb0007.tif" wi="103" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 5<br/>
&lt;211&gt; 19<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; motif 3</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; (3) .. (3)<br/>
&lt;223&gt; \replace = "Ile"</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; (6)..(6)<br/>
&lt;223&gt; \replace = "Ser"</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; (11)..(11)<br/>
&lt;223&gt; \replace = "Ser"</li><li>&lt;220&gt;<br/>
&lt;221&gt; VARIANT<br/>
&lt;222&gt; (14)..(14)<br/>
&lt;223&gt; \replace = "Lys"</li><li>&lt;400&gt; 5
<img id="ib0008" file="imgb0008.tif" wi="138" he="12" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 6<br/>
&lt;211&gt; 5<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; motif 4</li><li>&lt;400&gt; 6
<img id="ib0009" file="imgb0009.tif" wi="43" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 7<br/>
&lt;211&gt; 54<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Artificial sequence<!-- EPO <DP n="78"> --></li><li>&lt;220&gt;<br/>
&lt;223&gt; primer: prm06717</li><li>&lt;400&gt; 7<br/>
ggggacaagt ttgtacaaaa aagcaggctt aaacaatgtg ctgtggatca gacc    54</li><li>&lt;210&gt; 8<br/>
&lt;211&gt; 50<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Artificial sequence</li><li>&lt;220&gt;<br/>
&lt;223&gt; primer: prm06718</li><li>&lt;400&gt; 8<br/>
ggggaccact ttgtacaaga aagctgggtg gttaggtctc tcaattctgc    50</li><li>&lt;210&gt; 9<br/>
&lt;211&gt; 981<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Oryza sativa</li><li>&lt;400&gt; 9
<img id="ib0010" file="imgb0010.tif" wi="157" he="68" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 10<br/>
&lt;211&gt; 3372<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Eucalyptus grandis</li><li>&lt;400&gt; 10
<img id="ib0011" file="imgb0011.tif" wi="157" he="44" img-content="dna" img-format="tif"/><!-- EPO <DP n="79"> -->
<img id="ib0012" file="imgb0012.tif" wi="158" he="184" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 11<br/>
&lt;211&gt; 704<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Eucalyptus grandis</li><li>&lt;400&gt; 11
<img id="ib0013" file="imgb0013.tif" wi="138" he="24" img-content="dna" img-format="tif"/><!-- EPO <DP n="80"> -->
<img id="ib0014" file="imgb0014.tif" wi="138" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="81"> -->
<img id="ib0015" file="imgb0015.tif" wi="138" he="92" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 12<br/>
&lt;211&gt; 1860<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Oryza sativa</li><li>&lt;400&gt; 12
<img id="ib0016" file="imgb0016.tif" wi="157" he="116" img-content="dna" img-format="tif"/><!-- EPO <DP n="82"> -->
<img id="ib0017" file="imgb0017.tif" wi="157" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 13<br/>
&lt;211&gt; 619<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Oryza sativa</li><li>&lt;400&gt; 13
<img id="ib0018" file="imgb0018.tif" wi="139" he="199" img-content="dna" img-format="tif"/><!-- EPO <DP n="83"> -->
<img id="ib0019" file="imgb0019.tif" wi="138" he="112" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 14<br/>
&lt;211&gt; 2106<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Medicago truncatula</li><li>&lt;400&gt; 14
<img id="ib0020" file="imgb0020.tif" wi="157" he="96" img-content="dna" img-format="tif"/><!-- EPO <DP n="84"> -->
<img id="ib0021" file="imgb0021.tif" wi="157" he="48" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 15<br/>
&lt;211&gt; 701<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Medicago truncatula</li><li>&lt;400&gt; 15
<img id="ib0022" file="imgb0022.tif" wi="138" he="159" img-content="dna" img-format="tif"/><!-- EPO <DP n="85"> -->
<img id="ib0023" file="imgb0023.tif" wi="139" he="192" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 16<br/>
&lt;211&gt; 2841<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Oryza sativa</li><li>&lt;400&gt; 16
<img id="ib0024" file="imgb0024.tif" wi="157" he="16" img-content="dna" img-format="tif"/><!-- EPO <DP n="86"> -->
<img id="ib0025" file="imgb0025.tif" wi="158" he="176" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 17<br/>
&lt;211&gt; 749<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Oryza sativa</li><li>&lt;400&gt; 17
<img id="ib0026" file="imgb0026.tif" wi="138" he="32" img-content="dna" img-format="tif"/><!-- EPO <DP n="87"> -->
<img id="ib0027" file="imgb0027.tif" wi="137" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="88"> -->
<img id="ib0028" file="imgb0028.tif" wi="138" he="108" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 18<br/>
&lt;211&gt; 2769<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Arabidopsis thaliana</li><li>&lt;400&gt; 18
<img id="ib0029" file="imgb0029.tif" wi="157" he="100" img-content="dna" img-format="tif"/><!-- EPO <DP n="89"> -->
<img id="ib0030" file="imgb0030.tif" wi="157" he="88" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 19<br/>
&lt;211&gt; 706<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Arabidopsis thaliana</li><li>&lt;400&gt; 19
<img id="ib0031" file="imgb0031.tif" wi="139" he="120" img-content="dna" img-format="tif"/><!-- EPO <DP n="90"> -->
<img id="ib0032" file="imgb0032.tif" wi="139" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="91"> -->
<img id="ib0033" file="imgb0033.tif" wi="8" he="4" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 20<br/>
&lt;211&gt; 2674<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Oryza sativa</li><li>&lt;400&gt; 20
<img id="ib0034" file="imgb0034.tif" wi="158" he="180" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 21<br/>
&lt;211&gt; 657<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Oryza sativa<!-- EPO <DP n="92"> --></li><li>&lt;400&gt; 21
<img id="ib0035" file="imgb0035.tif" wi="139" he="231" img-content="dna" img-format="tif"/><!-- EPO <DP n="93"> -->
<img id="ib0036" file="imgb0036.tif" wi="138" he="100" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 22<br/>
&lt;211&gt; 2223<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Arabidopsis thaliana</li><li>&lt;400&gt; 22
<img id="ib0037" file="imgb0037.tif" wi="157" he="104" img-content="dna" img-format="tif"/><!-- EPO <DP n="94"> -->
<img id="ib0038" file="imgb0038.tif" wi="157" he="48" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 23<br/>
&lt;211&gt; 597<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Arabidopsis thaliana</li><li>&lt;400&gt; 23
<img id="ib0039" file="imgb0039.tif" wi="139" he="160" img-content="dna" img-format="tif"/><!-- EPO <DP n="95"> -->
<img id="ib0040" file="imgb0040.tif" wi="139" he="143" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 24<br/>
&lt;211&gt; 1761<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Arabidopsis thaliana</li><li>&lt;400&gt; 24
<img id="ib0041" file="imgb0041.tif" wi="157" he="64" img-content="dna" img-format="tif"/><!-- EPO <DP n="96"> -->
<img id="ib0042" file="imgb0042.tif" wi="157" he="56" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 25<br/>
&lt;211&gt; 586<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Arabidopsis thaliana</li><li>&lt;400&gt; 25
<img id="ib0043" file="imgb0043.tif" wi="138" he="151" img-content="dna" img-format="tif"/><!-- EPO <DP n="97"> -->
<img id="ib0044" file="imgb0044.tif" wi="139" he="143" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 26<br/>
&lt;211&gt; 2709<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Eucalyptus grandis</li><li>&lt;400&gt; 26
<img id="ib0045" file="imgb0045.tif" wi="157" he="64" img-content="dna" img-format="tif"/><!-- EPO <DP n="98"> -->
<img id="ib0046" file="imgb0046.tif" wi="157" he="120" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 27<br/>
&lt;211&gt; 659<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Eucalyptus grandis</li><li>&lt;400&gt; 27
<img id="ib0047" file="imgb0047.tif" wi="138" he="88" img-content="dna" img-format="tif"/><!-- EPO <DP n="99"> -->
<img id="ib0048" file="imgb0048.tif" wi="138" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="100"> -->
<img id="ib0049" file="imgb0049.tif" wi="129" he="8" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 28<br/>
&lt;211&gt; 2518<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Eucalyptus grandis</li><li>&lt;400&gt; 28
<img id="ib0050" file="imgb0050.tif" wi="158" he="168" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 29<br/>
&lt;211&gt; 663<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Eucalyptus grandis</li><li>&lt;400&gt; 29<!-- EPO <DP n="101"> -->
<img id="ib0051" file="imgb0051.tif" wi="138" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="102"> -->
<img id="ib0052" file="imgb0052.tif" wi="138" he="100" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 30<br/>
&lt;211&gt; 2001<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Triticum aestivum</li><li>&lt;220&gt;<br/>
&lt;221&gt; misc_feature<br/>
&lt;222&gt; (481)..(530)<br/>
&lt;223&gt; n is a, c, g, or t</li><li>&lt;400&gt; 30
<img id="ib0053" file="imgb0053.tif" wi="157" he="88" img-content="dna" img-format="tif"/><!-- EPO <DP n="103"> -->
<img id="ib0054" file="imgb0054.tif" wi="157" he="49" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 31<br/>
&lt;211&gt; 667<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Triticum aestivum</li><li>&lt;220&gt;<br/>
&lt;221&gt; UNSURE<br/>
&lt;222&gt; (161)..(177)<br/>
&lt;223&gt; Xaa can be any naturally occurring amino acid</li><li>&lt;400&gt; 31
<img id="ib0055" file="imgb0055.tif" wi="138" he="140" img-content="dna" img-format="tif"/><!-- EPO <DP n="104"> -->
<img id="ib0056" file="imgb0056.tif" wi="139" he="195" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 32<br/>
&lt;211&gt; 2683<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Eucalyptus grandis</li><li>&lt;400&gt; 32
<img id="ib0057" file="imgb0057.tif" wi="157" he="12" img-content="dna" img-format="tif"/><!-- EPO <DP n="105"> -->
<img id="ib0058" file="imgb0058.tif" wi="158" he="168" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 33<br/>
&lt;211&gt; 694<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Eucalyptus grandis</li><li>&lt;400&gt; 33
<img id="ib0059" file="imgb0059.tif" wi="138" he="40" img-content="dna" img-format="tif"/><!-- EPO <DP n="106"> -->
<img id="ib0060" file="imgb0060.tif" wi="138" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="107"> -->
<img id="ib0061" file="imgb0061.tif" wi="138" he="76" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 34<br/>
&lt;211&gt; 2499<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Arabidopsis thaliana</li><li>&lt;400&gt; 34
<img id="ib0062" file="imgb0062.tif" wi="158" he="132" img-content="dna" img-format="tif"/><!-- EPO <DP n="108"> -->
<img id="ib0063" file="imgb0063.tif" wi="157" he="36" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 35<br/>
&lt;211&gt; 607<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Arabidopsis thaliana</li><li>&lt;400&gt; 35
<img id="ib0064" file="imgb0064.tif" wi="139" he="172" img-content="dna" img-format="tif"/><!-- EPO <DP n="109"> -->
<img id="ib0065" file="imgb0065.tif" wi="139" he="132" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 36<br/>
&lt;211&gt; 1806<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Oryza sativa</li><li>&lt;400&gt; 36
<img id="ib0066" file="imgb0066.tif" wi="157" he="77" img-content="dna" img-format="tif"/><!-- EPO <DP n="110"> -->
<img id="ib0067" file="imgb0067.tif" wi="157" he="48" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 37<br/>
&lt;211&gt; 601<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Oryza sativa</li><li>&lt;400&gt; 37
<img id="ib0068" file="imgb0068.tif" wi="139" he="159" img-content="dna" img-format="tif"/><!-- EPO <DP n="111"> -->
<img id="ib0069" file="imgb0069.tif" wi="139" he="143" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 38<br/>
&lt;211&gt; 1692<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Hordeum vulgare</li><li>&lt;400&gt; 38
<img id="ib0070" file="imgb0070.tif" wi="157" he="64" img-content="dna" img-format="tif"/><!-- EPO <DP n="112"> -->
<img id="ib0071" file="imgb0071.tif" wi="157" he="52" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 39<br/>
&lt;211&gt; 564<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Hordeum vulgare</li><li>&lt;400&gt; 39
<img id="ib0072" file="imgb0072.tif" wi="138" he="156" img-content="dna" img-format="tif"/><!-- EPO <DP n="113"> -->
<img id="ib0073" file="imgb0073.tif" wi="138" he="128" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 40<br/>
&lt;211&gt; 3610<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Pinus radiata</li><li>&lt;400&gt; 40
<img id="ib0074" file="imgb0074.tif" wi="157" he="76" img-content="dna" img-format="tif"/><!-- EPO <DP n="114"> -->
<img id="ib0075" file="imgb0075.tif" wi="158" he="168" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 41<br/>
&lt;211&gt; 779<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Pinus radiata</li><li>&lt;400&gt; 41
<img id="ib0076" file="imgb0076.tif" wi="138" he="40" img-content="dna" img-format="tif"/><!-- EPO <DP n="115"> -->
<img id="ib0077" file="imgb0077.tif" wi="138" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="116"> -->
<img id="ib0078" file="imgb0078.tif" wi="138" he="116" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 42<br/>
&lt;211&gt; 3610<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Pinus radiata</li><li>&lt;400&gt; 42
<img id="ib0079" file="imgb0079.tif" wi="157" he="92" img-content="dna" img-format="tif"/><!-- EPO <DP n="117"> -->
<img id="ib0080" file="imgb0080.tif" wi="158" he="152" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 43<br/>
&lt;211&gt; 749<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Pinus radiata</li><li>&lt;400&gt; 43
<img id="ib0081" file="imgb0081.tif" wi="138" he="56" img-content="dna" img-format="tif"/><!-- EPO <DP n="118"> -->
<img id="ib0082" file="imgb0082.tif" wi="137" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="119"> -->
<img id="ib0083" file="imgb0083.tif" wi="138" he="84" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 44<br/>
&lt;211&gt; 711<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Glycine max</li><li>&lt;400&gt; 44
<img id="ib0084" file="imgb0084.tif" wi="138" he="124" img-content="dna" img-format="tif"/><!-- EPO <DP n="120"> -->
<img id="ib0085" file="imgb0085.tif" wi="138" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="121"> --></li><li>&lt;210&gt; 45<br/>
&lt;211&gt; 643<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Glycine max</li><li>&lt;400&gt; 45
<img id="ib0086" file="imgb0086.tif" wi="139" he="207" img-content="dna" img-format="tif"/><!-- EPO <DP n="122"> -->
<img id="ib0087" file="imgb0087.tif" wi="138" he="116" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 46<br/>
&lt;211&gt; 669<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Glycine max</li><li>&lt;400&gt; 46
<img id="ib0088" file="imgb0088.tif" wi="138" he="88" img-content="dna" img-format="tif"/><!-- EPO <DP n="123"> -->
<img id="ib0089" file="imgb0089.tif" wi="137" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="124"> -->
<img id="ib0090" file="imgb0090.tif" wi="129" he="12" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 47<br/>
&lt;211&gt; 580<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Arabidopsis thaliana</li><li>&lt;400&gt; 47
<img id="ib0091" file="imgb0091.tif" wi="138" he="196" img-content="dna" img-format="tif"/><!-- EPO <DP n="125"> -->
<img id="ib0092" file="imgb0092.tif" wi="138" he="100" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 48<br/>
&lt;211&gt; 719<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Arabidopsis thaliana</li><li>&lt;400&gt; 48
<img id="ib0093" file="imgb0093.tif" wi="138" he="108" img-content="dna" img-format="tif"/><!-- EPO <DP n="126"> -->
<img id="ib0094" file="imgb0094.tif" wi="138" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="127"> -->
<img id="ib0095" file="imgb0095.tif" wi="138" he="16" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 49<br/>
&lt;211&gt; 686<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Arabidopsis thaliana</li><li>&lt;400&gt; 49
<img id="ib0096" file="imgb0096.tif" wi="139" he="191" img-content="dna" img-format="tif"/><!-- EPO <DP n="128"> -->
<img id="ib0097" file="imgb0097.tif" wi="138" he="152" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 50<br/>
&lt;211&gt; 633<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Arabidopsis thaliana</li><li>&lt;400&gt; 50
<img id="ib0098" file="imgb0098.tif" wi="138" he="56" img-content="dna" img-format="tif"/><!-- EPO <DP n="129"> -->
<img id="ib0099" file="imgb0099.tif" wi="138" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="130"> -->
<img id="ib0100" file="imgb0100.tif" wi="138" he="28" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 51<br/>
&lt;211&gt; 678<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Arabidopsis thaliana</li><li>&lt;400&gt; 51
<img id="ib0101" file="imgb0101.tif" wi="139" he="180" img-content="dna" img-format="tif"/><!-- EPO <DP n="131"> -->
<img id="ib0102" file="imgb0102.tif" wi="139" he="163" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 52<br/>
&lt;211&gt; 640<br/>
&lt;212&gt; PRT<br/>
&lt;213&gt; Arabidopsis thaliana</li><li>&lt;400&gt; 52
<img id="ib0103" file="imgb0103.tif" wi="138" he="44" img-content="dna" img-format="tif"/><!-- EPO <DP n="132"> -->
<img id="ib0104" file="imgb0104.tif" wi="138" he="233" img-content="dna" img-format="tif"/><!-- EPO <DP n="133"> -->
<img id="ib0105" file="imgb0105.tif" wi="138" he="40" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 53<br/>
&lt;211&gt; 2158<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Oryza sativa</li><li>&lt;400&gt; 53
<img id="ib0106" file="imgb0106.tif" wi="157" he="144" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 54<br/>
&lt;211&gt; 2193<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Oryza sativa<!-- EPO <DP n="134"> --></li><li>&lt;400&gt; 54
<img id="ib0107" file="imgb0107.tif" wi="158" he="148" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 55<br/>
&lt;211&gt; 1827<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Oryza sativa</li><li>&lt;400&gt; 55
<img id="ib0108" file="imgb0108.tif" wi="157" he="56" img-content="dna" img-format="tif"/><!-- EPO <DP n="135"> -->
<img id="ib0109" file="imgb0109.tif" wi="157" he="68" img-content="dna" img-format="tif"/></li><li>&lt;210&gt; 56<br/>
&lt;211&gt; 2194<br/>
&lt;212&gt; DNA<br/>
&lt;213&gt; Oryza sativa</li><li>&lt;400&gt; 56
<img id="ib0110" file="imgb0110.tif" wi="157" he="140" img-content="dna" img-format="tif"/><!-- EPO <DP n="136"> -->
<img id="ib0111" file="imgb0111.tif" wi="157" he="8" img-content="dna" img-format="tif"/></li></ul></p></description><claims mxw-id="PCLM56985098" lang="DE" load-source="patent-office"><!-- EPO <DP n="139"> --><claim id="c-de-01-0001" num="0001"><claim-text>Verfahren zum Erhöhen des Samenertrags von Pflanzen im Vergleich zu entsprechenden Pflanzen vom Wildtyp, bei dem man in eine Pflanze eine AZ-Nukleinsäure oder eine Variante davon einbringt und darin exprimiert, wobei die AZ-Nukleinsäure für ein AZ-Polypeptid oder ein Homolog davon codiert, wobei das Homolog Pflanzen mit erhöhtem Ertrag liefert, und wobei das AZ-Polypeptid oder das Homolog davon zwei Ankyrin-Wiederholungseinheiten und zwei C3H1-Zinkfingerdomänen umfasst, und wobei die Ankyrin-Wiederholungseinheiten sich stromaufwärts von den C3H1-Zinkfingerdomänen befinden.</claim-text></claim><claim id="c-de-01-0002" num="0002"><claim-text>Verfahren nach Anspruch 1, wobei das AZ-Polypeptid mindestens eines der folgenden Motive umfasst:
<claim-text>(P/A)CSRAY(S/T)HDWTEC Motiv 1 SEQ ID NR: 3)</claim-text>
<claim-text>HPGENARRRDPR (Motiv 2, SEQ ID NR: 4)</claim-text>
<claim-text>HG(V/I)FE(C/S)WLHP(A/S)QY(R/K)TRLCK (Motiv 3, SEQ ID NR: 5)</claim-text>
<claim-text>CFFAH (Motiv 4, SEQ ID NR: 6).</claim-text></claim-text></claim><claim id="c-de-01-0003" num="0003"><claim-text>Verfahren nach Anspruch 1 oder 2, wobei die AZ-Nukleinsäure für ein AZ-Polypeptid der SEQ ID NR: 2 oder ein Homolog davon codiert.<!-- EPO <DP n="140"> --></claim-text></claim><claim id="c-de-01-0004" num="0004"><claim-text>Verfahren nach einem der Ansprüche 1 bis 3, wobei es sich bei der Variante um einen Teil einer AZ-Nukleinsäure oder eine zum Hybridisieren mit einer AZ-Nukleinsäure fähige Sequenz handelt, wobei der Teil bzw. die Hybridisierungssequenz für ein AZ-Polypeptid mit zwei Ankyrinwiederholungseinheiten und zwei C3H1-Zinkfingerdomänen codiert, und wobei sich die Ankyrin-Wiederholungseinheiten stromaufwärts von den C3H1-Zinkfingerdomänen befinden.</claim-text></claim><claim id="c-de-01-0005" num="0005"><claim-text>Verfahren nach einem der Ansprüche 1 bis 4, wobei die AZ-Nukleinsäure oder die Variante davon in einer Pflanze überexprimiert wird.</claim-text></claim><claim id="c-de-01-0006" num="0006"><claim-text>Verfahren nach einem der Ansprüche 1 bis 5, wobei die AZ-Nukleinsäure oder die Variante davon pflanzlichen Ursprungs ist, vorzugweise aus einer dikotylen Pflanze, besonders bevorzugt aus der Brassicaceae-Familie; ganz besonders bevorzugt stammt die Nukleinsäure aus Arabidopsis thaliana.</claim-text></claim><claim id="c-de-01-0007" num="0007"><claim-text>Verfahren nach einem der Ansprüche 1 bis 6, wobei die AZ-Nukleinsäure oder die Variante davon funktionell mit einem samenspezifischen Promotor verbunden ist.</claim-text></claim><claim id="c-de-01-0008" num="0008"><claim-text>Verfahren nach Anspruch 7, wobei es sich bei dem samenspezifischen Promotor um einen WSI18-Promotor handelt.</claim-text></claim><claim id="c-de-01-0009" num="0009"><claim-text>Verfahren nach einem der Ansprüche 1 bis 8, wobei der erhöhte Samenertrag ein erhöhtes Tausendkerngewicht umfasst.</claim-text></claim><claim id="c-de-01-0010" num="0010"><claim-text>Konstrukt, umfassend:<!-- EPO <DP n="141"> -->
<claim-text>(i) eine wie in einem der Ansprüche 1 bis 4 und 6 definierte AZ-Nukleinsäure oder eine Variante davon;</claim-text>
<claim-text>(ii) einen samenspezifischen WSI18-Promotor oder einen konstitutiven GOS2-Promotor, der funktionell mit der Nukleinsäuresequenz von (i) verbunden ist.</claim-text></claim-text></claim><claim id="c-de-01-0011" num="0011"><claim-text>Konstrukt nach Anspruch 10, wobei der WSI18-Promotor wie in SEQ ID NR: 55 oder SEQ ID NR: 9 wiedergegeben ist.</claim-text></claim><claim id="c-de-01-0012" num="0012"><claim-text>Konstrukt nach Anspruch 10, wobei der GOS2-Promotor wie in SEQ ID NR: 56 oder SEQ ID NR: 54 wiedergegeben ist.</claim-text></claim><claim id="c-de-01-0013" num="0013"><claim-text>Pflanze, transformiert mit einem Konstrukt gemäß einem der Ansprüche 10 bis 12.</claim-text></claim><claim id="c-de-01-0014" num="0014"><claim-text>Verfahren zur Herstellung einer transgenen Pflanze mit erhöhtem Samenertrag im Vergleich zu entsprechenden Pflanzen vom Wildtyp, welches Folgendes umfasst:
<claim-text>(i) Einführen einer wie in einem der Ansprüche 1 bis 4 und 6 definierten AZ-Nukleinsäure oder einer Variante davon in eine Pflanze oder Pflanzenzelle und deren Exprimieren darin; und</claim-text>
<claim-text>(ii) Kultivieren der Pflanzenzelle unter das Pflanzenwachstum und die Pflanzenentwicklung fördernden Bedingungen.</claim-text></claim-text></claim><claim id="c-de-01-0015" num="0015"><claim-text>Transgene Pflanze nach Anspruch 13, wobei es sich bei der Pflanze um eine monokotyle Pflanze wie Zuckerrohr handelt oder wobei es sich bei der Pflanze um ein Getreide wie Reis, Mais, Weizen, Gerste, Hirse, Roggen, Hafer oder Sorghum handelt.<!-- EPO <DP n="142"> --></claim-text></claim><claim id="c-de-01-0016" num="0016"><claim-text>Erntbare Teile einer Pflanze nach einem der Ansprüche 13 oder 15, wobei die erntbaren Teile ein Konstrukt nach einem der Ansprüche 10 bis 12 umfassen.</claim-text></claim><claim id="c-de-01-0017" num="0017"><claim-text>Erntbare Teile einer Pflanze nach Anspruch 16, wobei es sich bei den erntbaren Teilen um Samen handelt.</claim-text></claim><claim id="c-de-01-0018" num="0018"><claim-text>Produkte, direkt gewonnen aus einer Pflanze nach Anspruch 13 oder 15 und/oder aus erntbaren Teilen einer Pflanze nach Anspruch 16 oder 17, wobei die Produkte ein Konstrukt nach einem der Ansprüche 10 bis 12 umfassen.</claim-text></claim><claim id="c-de-01-0019" num="0019"><claim-text>Verwendung einer wie in einem der Ansprüche 1 bis 4 und 6 definierten AZ-Nukleinsäure oder einer Variante davon oder Verwendung eines AZ-Polypeptids oder eines Homologs davon zum Erhöhen des Samenertrags im Vergleich zu entsprechenden Pflanzen vom Wildtyp.</claim-text></claim><claim id="c-de-01-0020" num="0020"><claim-text>Verwendung nach Anspruch 19, wobei der erhöhte Samenertrag ein erhöhtes Tausendkerngewicht umfasst.</claim-text></claim><claim id="c-de-01-0021" num="0021"><claim-text>Verwendung einer wie in einem der Ansprüche 1 bis 4 und 6 definierten AZ-Nukleinsäure oder einer Variante davon oder Verwendung eines AZ-Polypeptids oder eines Homologs davon als molekularer Marker.</claim-text></claim><claim id="c-de-01-0022" num="0022"><claim-text>Verwendung eines Konstrukts nach einem der Ansprüche 10 bis 12 bei einem Verfahren zur Herstellung von Pflanzen mit einem im Vergleich zu Kontrollpflanzen erhöhten Samenertrag.</claim-text></claim></claims><claims mxw-id="PCLM56985099" lang="EN" load-source="patent-office"><!-- EPO <DP n="137"> --><claim id="c-en-01-0001" num="0001"><claim-text>Method for increasing seed yield of plants relative to corresponding wild type plants, comprising introducing and expressing in a plant an AZ nucleic acid or a variant thereof, wherein said AZ nucleic acid encodes an AZ polypeptide or a homologue thereof, wherein the homologue gives plants having increased yield, and wherein said AZ polypeptide or the homologue thereof comprises two ankyrin repeats and two C3H1 Zinc finger domains, and wherein said ankyrin repeats are located upstream of the C3H1 Zinc finger domains.</claim-text></claim><claim id="c-en-01-0002" num="0002"><claim-text>Method according to claim 1, wherein the AZ polypeptide comprises at least one of the following motifs:
<claim-text>(P/A)CSRAY(S/T)HDWTEC (motif 1, SEQ ID NO: 3)</claim-text>
<claim-text>HPGENARRRDPR (motif 2, SEQ ID NO: 4)</claim-text>
<claim-text>HG(V/I)FE(C/S)WLHP(A/S)QY(R/K)TRLCK (motif 3, SEQ ID NO: 5)</claim-text>
<claim-text>CFFAH (motif 4, SEQ ID NO: 6).</claim-text></claim-text></claim><claim id="c-en-01-0003" num="0003"><claim-text>Method according to claim 1 or 2, wherein said AZ nucleic acid encodes an AZ polypeptide of SEQ ID NO: 2 or a homologue thereof.</claim-text></claim><claim id="c-en-01-0004" num="0004"><claim-text>Method according to any one of claims 1 to 3, wherein said variant is a portion of an AZ nucleic acid or a sequence capable of hybridising to an AZ nucleic acid, which portion or hybridising sequence encodes an AZ polypeptide comprising two ankyrin repeats and two C3H1 Zinc finger domains, and wherein said ankyrin repeats are located upstream of the C3H1 Zinc finger domains</claim-text></claim><claim id="c-en-01-0005" num="0005"><claim-text>Method according to any one of claims 1 to 4, wherein said AZ nucleic acid or variant thereof is overexpressed in a plant.</claim-text></claim><claim id="c-en-01-0006" num="0006"><claim-text>Method according to any one of claims 1 to 5, wherein said AZ nucleic acid or variant thereof is of plant origin, preferably from a dicotyledonous plant, more preferably from the family Brassicaceae, most preferably the nucleic acid is from Arabidopsis thaliana.</claim-text></claim><claim id="c-en-01-0007" num="0007"><claim-text>Method according to any one of claims 1 to 6, wherein said AZ nucleic acid or variant thereof is operably linked to a seed specific promoter.</claim-text></claim><claim id="c-en-01-0008" num="0008"><claim-text>Method according to claim 7, wherein said seed-specific promoter is a WSI18 promoter.</claim-text></claim><claim id="c-en-01-0009" num="0009"><claim-text>Method according to any one of claims 1 to 8, wherein said increased seed yield comprises increased thousand kernel weight.</claim-text></claim><claim id="c-en-01-0010" num="0010"><claim-text>Construct comprising:
<claim-text>(i) an AZ nucleic acid or a variant thereof as defined in any of claims 1 to 4 and 6;</claim-text>
<claim-text>(ii) a seed-specific WSI18 promoter or a constitutive GOS2 promoter operably linked to the nucleic acid sequence of (i)</claim-text></claim-text></claim><claim id="c-en-01-0011" num="0011"><claim-text>Construct according to claim 10, wherein said WSI18 promoter is as represented by SEQ ID NO: 55 or SEQ ID NO: 9.</claim-text></claim><claim id="c-en-01-0012" num="0012"><claim-text>Construct according to claim 10, wherein said GOS2 promoter is as represented by SEQ ID NO: 56 or SEQ ID NO: 54.<!-- EPO <DP n="138"> --></claim-text></claim><claim id="c-en-01-0013" num="0013"><claim-text>Plant transformed with a construct according to any one of claims 10 to 12.</claim-text></claim><claim id="c-en-01-0014" num="0014"><claim-text>Method for the production of a transgenic plant having increased seed yield compared to corresponding wild type plants, which method comprises:
<claim-text>(i) introducing and expressing in a plant or plant cell an AZ nucleic acid or variant thereof as defined in any of claims 1 to 4 and 6; and</claim-text>
<claim-text>(ii) cultivating the plant cell under conditions promoting plant growth and development,</claim-text></claim-text></claim><claim id="c-en-01-0015" num="0015"><claim-text>Transgenic plant according to claim 13, wherein said plant is a monocotyledonous plant, such as sugar cane or wherein the plant is a cereal, such as rice, maize, wheat, barley, millet, rye, oats or sorghum.</claim-text></claim><claim id="c-en-01-0016" num="0016"><claim-text>Harvestable parts of a plant according to any one of claims 13 or 15, wherein said harvestable parts comprise a construct according to any one of claims 10 to 12.</claim-text></claim><claim id="c-en-01-0017" num="0017"><claim-text>Harvestable parts of a plant according to claim 16 wherein said harvestable parts are seeds.</claim-text></claim><claim id="c-en-01-0018" num="0018"><claim-text>Products directly derived from a plant according to claim 13 or 15 and/or from harvestable parts of a plant according to claims 16 or 17, wherein said products comprise a construct according to any one of claims 10 to 12.</claim-text></claim><claim id="c-en-01-0019" num="0019"><claim-text>Use of an AZ nucleic acid or variant thereof as defined in any of claims 1 to 4 and 6, or use of an AZ polypeptide or a homologue thereof, in increasing seed yield, relative to corresponding wild type plants.</claim-text></claim><claim id="c-en-01-0020" num="0020"><claim-text>Use according to claim 19, wherein said increased seed yield comprises increased thousand kernel weight.</claim-text></claim><claim id="c-en-01-0021" num="0021"><claim-text>Use of an AZ nucleic acid or variant thereof as defined in any of claims 1 to 4 and 6, or use of an AZ polypeptide or a homologue thereof, as a molecular marker.</claim-text></claim><claim id="c-en-01-0022" num="0022"><claim-text>Use of a construct according to any of claims 10 to 12 in a method for making plants having increased seed yield relative to control plants.</claim-text></claim></claims><claims mxw-id="PCLM56985100" lang="FR" load-source="patent-office"><!-- EPO <DP n="143"> --><claim id="c-fr-01-0001" num="0001"><claim-text>Procédé destiné à augmenter le rendement des graines des plantes, par rapport à des plantes de type sauvage correspondantes, comprenant l'introduction et l'expression dans une plante d'un acide nucléique AZ ou d'un variant de celui-ci, dans lequel ledit acide nucléique AZ code pour un polypeptide AZ ou un homologue de celui-ci, dans lequel l'homologue donne des plantes ayant un rendement accru et dans lequel ledit polypeptide AZ ou l'homologue de celui-ci comprend deux répétitions d'ankyrine et deux domaines C3H1 "en doigt de zinc", et dans lequel lesdites répétitions d'ankyrine sont situées en amont des domaines C3H1 "en doigt de zinc".</claim-text></claim><claim id="c-fr-01-0002" num="0002"><claim-text>Procédé selon la revendication 1, dans lequel le polypeptide AZ comprend au moins un motif parmi les suivantes :
<claim-text>(P/A)CSRAY(S/T)HDWTEC (motif 1, SEQ ID n° : 3)</claim-text>
<claim-text>HPGENARRRDPR (motif 2, SEQ ID n° : 4)</claim-text>
<claim-text>HG(V/I)FE(C/S)WLHP(A/S)QY(R/K)TRLCK (motif 3, SEQ ID n° : 5)</claim-text>
<claim-text>CFFAH (motif 4, SEQ ID n° : 6).</claim-text></claim-text></claim><claim id="c-fr-01-0003" num="0003"><claim-text>Procédé selon la revendication 1 ou 2, dans lequel ledit acide nucléique AZ code pour un polypeptide AZ, de SEQ ID n° : 2, ou un homologue de celui-ci.</claim-text></claim><claim id="c-fr-01-0004" num="0004"><claim-text>Procédé selon l'une quelconque des revendications 1 à 3, dans lequel ledit variant est une partie d'un acide nucléique AZ ou une séquence étant capable de s'hybrider<!-- EPO <DP n="144"> --> avec un acide nucléique AZ, laquelle partie ou séquence d'hybridation code pour un polypeptide AZ comprenant deux répétitions d'ankyrine et deux domaines C3H1 "en doigt de zinc", et dans lequel lesdites répétitions d'ankyrine sont situées en amont des domaines C3H1 "en doigt de zinc".</claim-text></claim><claim id="c-fr-01-0005" num="0005"><claim-text>Procédé selon l'une quelconque des revendications 1 à 4, dans lequel ledit acide nucléique AZ ou ledit variant de celui-ci est surexprimé chez une plante.</claim-text></claim><claim id="c-fr-01-0006" num="0006"><claim-text>Procédé selon l'une quelconque des revendications 1 à 5, dans lequel ledit acide nucléique AZ ou ledit variant de celui-ci est d'origine végétale, de préférence il provient d'une plante dicotylédone, mieux préféré il provient de la famille des Brassicaceae, de manière préférée entre toutes l'acide nucléique provient d'Arabidopsis thaliana.</claim-text></claim><claim id="c-fr-01-0007" num="0007"><claim-text>Procédé selon l'une quelconque des revendications 1 à 6, dans lequel ledit acide nucléique AZ ou ledit variant de celui-ci est lié, de manière opérationnelle, à un promoteur spécifique des graines.</claim-text></claim><claim id="c-fr-01-0008" num="0008"><claim-text>Procédé selon la revendication 7, dans lequel ledit promoteur spécifique des graines est un promoteur WSI18.</claim-text></claim><claim id="c-fr-01-0009" num="0009"><claim-text>Procédé selon l'une quelconque des revendications 1 à 8, dans lequel ledit rendement accru des graines comprend un poids de mille grains accru.</claim-text></claim><claim id="c-fr-01-0010" num="0010"><claim-text>Construit comprenant :
<claim-text>(i) un acide nucléique AZ ou un variant de celui-ci, tel que défini dans l'une quelconque des revendications 1 à 4 et 6 ;</claim-text>
<claim-text>(ii) un promoteur WSI18 spécifique des graines ou un promoteur constitutif GOS2 étant lié, de manière opérationnelle, à la séquence d'acide nucléique de (i).</claim-text></claim-text></claim><claim id="c-fr-01-0011" num="0011"><claim-text>Construit selon la revendication 10, dans lequel ledit promoteur WSI18 est tel que représenté par la SEQ ID n° : 55 ou la SEQ ID n° : 9.<!-- EPO <DP n="145"> --></claim-text></claim><claim id="c-fr-01-0012" num="0012"><claim-text>Construit selon la revendication 10, dans lequel ledit promoteur GOS2 est tel que représenté par la SEQ ID n° : 56 ou la SEQ ID n° : 54.</claim-text></claim><claim id="c-fr-01-0013" num="0013"><claim-text>Plante transformée avec un construit selon l'une quelconque des revendications 10 à 12.</claim-text></claim><claim id="c-fr-01-0014" num="0014"><claim-text>Procédé de production d'une plante transgénique ayant un rendement accru des graines, en comparaison avec des plantes de type sauvage correspondantes, lequel procédé comprend les étapes consistant à :
<claim-text>(i) introduire et exprimer dans une plante ou une cellule végétale un acide nucléique AZ ou un variant de celui-ci, tel que défini dans l'une quelconque des revendications 1 à 4 et 6 ; et</claim-text>
<claim-text>(ii) cultiver la cellule végétale dans des conditions qui favorisent la croissance et le développement des plantes.</claim-text></claim-text></claim><claim id="c-fr-01-0015" num="0015"><claim-text>Plante transgénique selon la revendication 13, dans laquelle ladite plante est une plante monocotylédone, telle que la canne à sucre, ou dans laquelle la plante est une céréale, telle que le riz, le maïs, le blé, l'orge, le millet, le seigle, l'avoine ou le sorgho.</claim-text></claim><claim id="c-fr-01-0016" num="0016"><claim-text>Parties récoltables d'une plante selon l'une quelconque des revendications 13 ou 15, dans laquelle lesdites parties récoltables comprennent un construit selon l'une quelconque des revendications 10 à 12.</claim-text></claim><claim id="c-fr-01-0017" num="0017"><claim-text>Parties récoltables d'une plante selon la revendication 16, dans laquelle lesdites parties récoltables sont des graines.</claim-text></claim><claim id="c-fr-01-0018" num="0018"><claim-text>Produits directement dérivés d'une plante, selon la revendication 13 ou 15, et/ou des parties récoltables d'une plante, selon les revendications 16 ou 17, dans laquelle lesdits produits comprennent un construit selon l'une quelconque des revendications 10 à 12.</claim-text></claim><claim id="c-fr-01-0019" num="0019"><claim-text>Utilisation d'un acide nucléique AZ ou d'un variant de celui-ci, tel que défini dans l'une quelconque des revendications 1 à 4 et 6, ou utilisation d'un<!-- EPO <DP n="146"> --> polypeptide AZ ou d'un homologue de celui-ci, dans l'accroissement du rendement des graines par rapport à des plantes de type sauvage correspondantes.</claim-text></claim><claim id="c-fr-01-0020" num="0020"><claim-text>Utilisation selon la revendication 19, dans laquelle ledit rendement accru des graines comprend un poids de mille grains accru.</claim-text></claim><claim id="c-fr-01-0021" num="0021"><claim-text>Utilisation d'un acide nucléique AZ ou d'un variant de celui-ci, tel que défini dans l'une quelconque des revendications 1 à 4 et 6, ou utilisation d'un polypeptide AZ ou d'un homologue de celui-ci comme marqueur moléculaire.</claim-text></claim><claim id="c-fr-01-0022" num="0022"><claim-text>Utilisation d'un construit, selon l'une quelconque des revendications 10 à 12, dans un procédé destiné à élaborer des plantes ayant un rendement accru des graines par rapport à des plantes témoins.</claim-text></claim></claims><drawings mxw-id="PDW16672058" load-source="patent-office"><!-- EPO <DP n="147"> --><figure id="f0001" num="1,2"><img id="if0001" file="imgf0001.tif" wi="165" he="222" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="148"> --><figure id="f0002" num="3A"><img id="if0002" file="imgf0002.tif" wi="130" he="233" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="149"> --><figure id="f0003" num="3B"><img id="if0003" file="imgf0003.tif" wi="124" he="233" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="150"> --><figure id="f0004" num="4"><img id="if0004" file="imgf0004.tif" wi="152" he="134" img-content="drawing" img-format="tif"/></figure></drawings><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
